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Characterization of the role of the pKM101-encoded T4SS outer membrane core 
complex in substrate transfer, pilus biogenesis, and recipient cell contact 
Jay Gordon, B.S. 
Advisory Professor: Peter Christie, Ph.D. 
 
The bacterial type IV secretion systems (T4SS) encoded on the Escherichia coli pKM101 
and R388 conjugative plasmids and the Agrobacterium tumefaciens virB operon are composed of 
12 subunits arranged in an architecturally similar fashion.   Structural studies of the T4SS from 
R388 (TrwR388) highlighted the presence of a distinct outer membrane core complex (OMCC) 
and inner membrane complex (IMC) joined together by a central stalk. This thesis is focused on 
the development of the pKM101 model system and the role of an OMCC cap region formed by 
alpha helical antenna projections (AP) found in VirB10 and TraFpKM101.  I introduced various 
internal deletions, truncations, and substitutions between TraFpKM101 and VirB10 to study the role 
of the AP cap in (i) substrate transfer to recipient plant or bacterial cells, (ii) pilus biogenesis and 
donor-specific bacteriophage sensitivity, and (iii) recipient cell contact.  My results demonstrate 
that the C-terminal tails of VirB10 and TraFpKM101 are essential for DNA transfer and pilus 
biogenesis, whereas the AP domains are only important for pilus biogenesis.  Neither of these 
domains is critical for recipient cell contact as monitored by sensitivity to Pseudomonas 
aeruginosa containing a functional type VI secretion system.  Finally, I demonstrated that the 
IMC of pKM101 is able to functionally pair with the OMCCs from either VirB/VirD4, TrwR388, 
or the Ptl T4SS of Bordetella pertussis restoring recipient cell contact and plasmid transfer.  
These results highlight the common ancestry between these functionally distinct machines and 
support a model where functionally independent IMCs and OMCCs have co-evolved to form the 
T4SS in Gram-negative bacteria. 
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Chapter 1: Introduction 
 2 
Introduction to the Gram-negative bacterial type IV secretion system 
 Bacteria constantly adapt to their changing environment. Although they are able to sense 
changes in their surroundings and adapt accordingly, many species acclimate to environmental 
shifts by delivering DNA and protein substrates through a type IV secretion system (T4SS).  
These substrates provide a selective advantage to the bacterium when environmental shifts are 
not favorable for survival.  For example, DNA substrates often contain genes conferring 
resistance to antibiotics and heavy metals.  Acquisition of these traits in clinically-relevant 
pathogens has lead to an increase in resistance to most commercially-available antibiotics.  
Additionally, many pathogens contain altered T4SSs for delivery of important protein effectors 
during the course of infection.  Organisms that utilize T4SSs for delivery of protein substrates, 
such as Helicobacter pylori, Legionella pneumophila, and Bordetella pertussis will be discussed 
later in this chapter (1–4).   
These T4SSs can be divided into three classes: (1) Conjugation channels involved in the 
dissemination of DNA substrates to recipient prokaryotic cells (2) Protein translocation machines 
that deliver protein effectors to target eukaryotic cells (3) Substrate uptake and release T4SSs 
responsible for either taking up or releasing protein and DNA substrates into the extracellular 
milieu (5).  Each of these three classes of T4SSs will be described in greater detail in this 
chapter.   
 
Type IV secretion systems are one of many dedicated macromolecular translocation 
systems in bacteria 
 
 The T4SSs are one of six characterized secretion systems in Gram-negative bacteria.  
These secretion systems vary in terms of their overall architecture, subunit makeup, substrate 
repertoire, and target cell range.  Below, I will briefly discuss each of the secretion systems. 
 3 
 The type I secretion systems (T1SSs) are found in pathogens, such as uropathogenic 
Escherichia coli, which utilize them to secrete monomeric protein effectors, such as the pore-
forming toxin hemolysin A (6,7). T1SSs are architecturally the simplest of the dedicated 
secretion pathways, consisting of three components: (i) An inner membrane complex (IMC) 
formed by an ATP-binding cassette (ABC) transporter responsible for energizing the T1SS and 
substrate recognition, (ii) a Membrane Fusion Protein (MFP) that forms the inner membrane 
(IM) platform, and (iii) the TolC outer membrane factor (OMF) (6)  (Figure 1.1). Substrates are 
recognized by the T1SS via a C-terminal signal sequence.  Upon docking of a substrate with the 
ABC transporter/MFP complex, the entire inner membrane platform undergoes a conformational 
change that results in recruitment of TolC to the complex (7).  In turn, ATP-mediated 
conformational changes open a channel enabling passage of the substrate across the cell 
envelope (Figure 1.2).   
 The type II secretion system (T2SS) is ancestrally related to the type IV pilus system 
used by other Gram-negative bacteria for surface adhesion and movement.  As with the T1SSs, 
the T2SSs characteristically secrete toxins or other enzymes to the milieu (7).  For example, 
Vibrio cholerae uses a T2SS to secrete the multisubunit cholera toxin during infection (6).  There 
are four major components to the T2SS: (i) a cytoplasmic ATPase responsible for energizing the 
machine, (ii) an IM platform, (iii) an outer membrane pore-forming secretin, and (iv) a 
periplasmic pseudopilus (7,8). For secretion via this pathway, substrates are delivered to the 
periplasm via the general secretory pathway (GSP) or the twin arginine translocation (TAT) 
pathway.  Substrates then fold and, in some cases, oligomerize.  The folded substrates are then 
recruited to the T2SS, where they are thought to localize at the tip of a pseudopilus.  Through a  
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Figure 1.1 Depiction of the type I through type VI secretion systems: Schematic 
illustrating the compositional and structural differences in Gram-negative bacterial secretion 
systems.  Depicted are examples of RND multiefflux pumps dedicated to pumping out 
antimicrobial compounds, T1SS (uropathogenic Escherichia coli), T2SS (Vibrio cholerae), 
T3SS (Salmonella species), T4SS (Agrobacterium tumefaciens), and T6SS (Pseudomonas 
aeruginosa).  This is Figure 1 in Costa TRD et al. Secretion systems in Gram-negative 
bacteria: structural and mechanistic insights. Nat Rev Microbiol. 2015;13:343–59.  This 
figure was re-published with permission from Nature Publishing Groups.  License number 
4072830049272.   
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Figure 1.2 Secretion of substrates through various bacterial secretion systems. 
Illustration of the substrate pathways outside of the cell. a) In RND pumps and the 
T1SS, substrates are recognized by the ABC transporter at the IM and shunted into the 
periplasm where they are then translocated outside of the cell by the TolC OM protein.   
b) Substrates of the T2SS are first moved into the periplasm either through the GSP or 
TAT pathways.  They are then recognized by the OM secretin which mobilizes them 
into the extracellular mileu using force from the pseudopilus piston.  c) T3SSs utilize a 
needle and translocon protein to form a pore in the target cell membrane.  Substrates are 
then recognized by an N-terminal signal sequence followed by passage outside of the 
cell.  d) T4SS substrates are recognized by the VirD4 substrate receptor and are then 
mobilized into the target cell in a contact-dependent manner (Discussed in more detail in 
this introduction).  e) T6SS effectors are loaded into the hollow Hcp tube located in the 
cytoplasm.  Upon activation, the TssB-TssC tail sheath will contract and move the tail 
and substrates outside of the cell.  The VgrG spike protein will then puncture the target 
cell allowing for the effector and Hcp tube to enter.  These illustrations are from Figure 
3 in Costa TRD et al. Secretion systems in Gram-negative bacteria: structural and 
mechanistic insights. Nat Rev Microbiol. 2015;13:343–59..  This figure was re-
published with permission from Nature Publishing Groups.  License number 
4072830049272.   
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piston-like extension and retraction mechanism, the pseudopilus is thought to push the substrate 
through the secretin pore to the cell exterior (Figure 1.2).   
 Type III secretion systems (T3SSs) are used by pathogens such as Salmonella, Shigella, 
and Yersinia species to inject effector proteins into eukaryotic cells. T3SSs can be divided into 
three functional components: (i) a basal body forming the cell envelope-spanning region of the 
complex, (ii) the hollow needle complex that allows for target cell contact and substrate passage, 
and (iii) translocon proteins at the tip of the needle (7,9).  Interestingly, most of the proteins 
forming the basal structure are related to the proteins forming the base of the flagella system 
involved in motility.  During secretion, needle tip and translocon proteins make contact with 
target cells and form a pore for substrate passage.  Upon pore formation in the target cell, 
effector proteins are recognized by a non-cleavable N-terminal signal sequence and shunted 
through the T3SS into the target cell (Figure 1.2).   
 Type V secretion systems (T5SSs) are unique in that there is no membrane spanning 
channel.  These systems are also known as autotransporters, since the protein being secreted 
mediates its own release (10).  Autotransporters generally consist of a single polypeptide with 
two domains: (i) a C-terminal pore-forming -barrel domain that inserts into the OM and (ii) an 
N-terminal passenger domain.  Autotransporters are delivered into the periplasm via the GSP.  
Once in the periplasm, the autotransporter interacts with chaperones Skp or SurA, and the 
resulting complex is delivered to the-barrel assembly machinery (BAM) at the OM.  The BAM 
complex catalyzes the folding and insertion of the C-terminal -barrel domain and also 
coordinates the surface exposure of the passenger domain.  Passenger domains are either retained  
at the cell surface or released by proteolytic cleavage so that it is free to interact with target cells.  
One example of a clinically-relevant autotransporter is the H. pylori vacuolating toxin A (VacA),   
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which is involved in target cell pore formation (11,12).   
Type VI secretion systems (T6SSs) are employed by Gram-negative bacteria to deliver 
toxic effector proteins to prokaryotic and eukaryotic target cells (13).  One such example of a 
T6SS is the Pseudomonas aeruginosa H1-T6SS.  This T6SS is activated upon membrane 
perturbance and delivers toxic effector proteins to neighboring prokaryotic cells.  Utilization of 
this T6SS for determining requirements within the T4SS for recipient cell contact will be 
discussed later in this thesis.  The T6SS is composed of two primary components: (i) a 
membrane spanning complex with components similar to the T4SS and (ii) a tubular structure 
that delivers the effectors to the recipient cell (14).  The tubular structure is ancestrally related to 
contractile tails from bacteriophages.  This tube can be further divided into three subcomponents: 
(a) a hollow tube comprised of the Hcp proteins, (b) a sheath made of TssB-TssC heterodimers, 
and (c) a VgrG spike protein (7).  Once activated, the TssB-TssC sheath contracts in a similar 
manner to a phage tail.  This contraction forces the Hcp tail protein and toxic effectors through 
the sheath to the cell surface and into target cells (Figure 1.2).  
 Of all the Gram-negative bacterial secretion systems, the T4SS is the most versatile. The 
secretion systems described above have evolved to secrete only protein monomers or 
heteromultimeric complexes.  T4SSs are able to deliver both protein monomers (H. pylori CagA) 
and heteromultimers (B. pertussis Ptx AB toxin) (4,15).  Many are also able to deliver DNA 
substrates to target cells.  Agrobacterium tumefaciens and L. pneumophila utilize the VirB and 
Dot/Icm T4SSs, respectively, to deliver DNA or protein effectors to eukaryotic cells as a natural 
part of their infection processes.  However, these systems also mobilize the transfer of the 
promiscuous IncQ plasmid RSF1010 to recipient prokaryotic cells, highlighting the plasticity of 
these systems with respect to substrate recognition (16,17).  Because these effector translocation 
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T4SSs are similar to their conjugative counterparts in subunit composition and operon structure, 
and several of these machines translocate both DNA and protein substrates, conjugative T4SSs 
likely evolved first as a means to exchange DNA among bacteria.  Then, with the appearance of 
eukaryotic cells, these machines were adapted for specialized functions such as establishing 
commensal, symbiotic, or pathogenic relationships. Interestingly, all of the other dedicated 
secretion systems target either prokaryotic or eukaryotic cells.  By contrast, T4SSs can utilize the 
same channel for substrate delivery into both types of cells.  For example, A. tumefaciens utilizes 
its VirB/VirD4 T4SS to deliver oncogenic T-DNA and effector proteins to plant cells and also to 
mobilize the transfer of promiscuous IncQ plasmids to recipient bacterial cells (18–21).  The 
details of the A. tumefaciens VirB/VirD4 T4SS will be described in more detail below. 
   
Classification of T4SSs   
There are three classes of Gram-negative bacterial T4SSs.  These are a) conjugation 
systems b) effector translocation systems and c) substrate release and uptake systems (Figure 
1.3).  In this section, I will discuss each of the three classes in more detail.   
 Conjugative T4SSs: These are some of the better-studied T4SSs.  They include proteins 
responsible for the dissemination of virulence traits and antibiotic resistance genes in clinical 
settings.  Indeed, rapid horizontal transfer of mobile elements encoding multiple antibiotic 
resistance genes is threatening to jeopardize our ability to effectively treat many bacterial 
infections.  These T4SSs are encoded on conjugative plasmids or integrative conjugative 
elements (ICEs; formerly known as conjugative transposons).  
  
 11 
  
Figure 1.3 The role of bacterial type IV secretion systems.  Schematic depicting the 
three different types of type IV secretion systems: a) Conjugations systems used to 
deliver plasmids from a donor cell to a recipient cell. b) DNA uptake and release sytems 
used to exchange genetic information outside of the cell. c) Effector translocators used 
to deliver protein substrates into target eukaryotic cells. This is Figure 1 from “The 
versatile bacterial type IV secretion systems.” Nature Reviews Microbiology 1, 137-14; 
November 2003.  This figure was re-published with permission from Nature Publishing 
Group.  License # 4081060827678  
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Conjugative T4SSs can be divided into two functional sets of proteins.  First, there are 
the mating pair formation (MPF) proteins, which assemble together to form the translocation 
channel (22).  The MPF can be further divided into two subassemblies: (1) The membrane  
spanning complex and (2) the conjugative pilus at the cell surface.  The second set of proteins is 
called DNA transfer and replication (Dtr) factors.  These proteins process the DNA and localize 
it at the entrance of the MPF channel (23).  The Dtr system consists of: (1) the conjugative 
relaxase that catalyzes a DNA nicking reaction required for transfer, (2) accessory factors that 
aid the relaxase in substrate processing and MPF localization, and (3) the substrate receptor, 
termed the type IV coupling protein (T4CP), which recognizes signals within the relaxase and 
accessory factors and delivers the substrate to the MPF channel. 
Protein Translocation T4SSs: Many pathogens utilize the T4SS in order to translocate 
toxic effector proteins to target eukaryotic cells.  There has been much effort spent trying to 
understand the role that these effectors play in the infection process.  Developing new drugs to 
inhibit effector translocation and activity and vaccines against surface-localized T4SS proteins 
are important strategies in fighting these infections.   
 While conjugative T4SSs deliver both DNA and proteins related to DNA metabolism, 
protein translocation T4SSs only deliver protein substrates to their target cell (24).  However, 
these machines are capable of translocating a wide variety of protein substrates.  Although some 
translocation channels only have one recognized substrate, others can recognize and deliver 
hundreds of protein substrates.  H. pylori utilizes the Cag T4SS to infect gastric epithelial cells.  
This system only recognizes and delivers one substrate, CagA, which is critical for H. pylori 
infection (15,25).  However, the Dot/Icm T4SS from L. pneumophila delivers hundreds of 
protein effectors during the course of infection.  Some of these important effectors include DotA 
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(prevents formation of phagolysosome) and RalF (promotes formation of a Legionella-
containing vacuole using membranes from the endoplasmic reticulum) (26–28).  The effect that 
these effectors have in target cells is an area of intense research to develop new strategies aimed 
at prevention and treatment of Legionnaire’s Disease.   
In addition to extracellular pathogens, many obligate intracellular organisms use a T4SS 
to deliver effectors to their hosts.  These include Anaplasma phagocytophilum (human 
granulocytic anaplasmosis) and Rickettsia rickettsii (Rocky Mountain spotted fever) (29–31).  
Due to their inability to grow outside of a host cell, these pathogens have been difficult to study 
and genetically manipulate.  Our lab has recently developed an assay system utilizing chimeric 
T4CPs to identify effector proteins (29).  This assay will be discussed later in this chapter.   
Substrate uptake and release T4SS:  Although conjugative and protein translocation 
T4SSs require recipient-cell contact prior to substrate delivery, there are examples that secrete 
substrates outside of the cell in the absence of target cell interaction.  One well-studied pathogen 
that utilizes this class of T4SS is B. pertussis.  B. pertussis assembles the Ptl T4SS that is 
responsible for secretion of multimeric pertussis toxin.  This channel does not contain a T4CP.  
Instead, individual toxin subunits are delivered into the periplasm through the GSP.  Once in the 
periplasm, all the toxin subunits fold and assemble and then interact with the T4SS prior to 
extracellular release (32–36).  Because there is no need for recipient contact, these cells lack 
detectable pili on the cell surface.   
This class is also able to mediate the extracellular release of DNA.  Neisseria 
gonorrhoeae contains a T4SS encoded on a large 57-kb gonococcal genetic island located on the 
chromosome.  This machine is responsible for DNA release outside of the cell, which can serve 
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as a source of DNA for uptake by other N. gonorrhoeae cells though a process of natural 
transformation (37,38).   
 The H. pylori ComB T4SS is a unique example of a T4SS involved in DNA uptake.  This 
system contains all of the homologs of the Agrobacterium tumefaciens VirB T4SS except VirB1 
and VirB5 (15). This T4SS, however, is not essential for virulence as demonstrated during gerbil 
infection experiments.    
 The initial T4SS classification rubric assigned machines as F-like, P-like, or I-like based 
on their subunit similarity to T4SSs encoded by the F, RP4, or R64 plasmids, respectively.  
However, these systems can alternatively be broadly classified as type IVA or type IVB systems 
(T4SSA and T4SSB).  T4SSA machines are similar to the A. tumefaciens VirB/VirD4 system 
and those encoded by the pKM101, R388, RP4 and F plasmids (P- and F-like systems).  Studies 
of L. phenumophila identified genes on its chromosome that had similarities to those of the T4SS 
encoded on the IncI R64 plasmid (2,3).  Although these loci encode a few proteins distantly 
related to subunits of the T4SSA systems, differences in genetic composition, gene order, and 
relatedness of homologs suggest a distinct phylogenetic origin.  Consequently, these T4SSs were 
classified as T4SSB.   
 I will utilize the functional classification system for the remainder of this thesis, as the 
diversity in the T4SSs mentioned in my results section are best highlighted by their functional 
differences.   
 
Conjugation systems 
 As mentioned above, the conjugation systems represent a major T4SS subfamily.  
Conjugative plasmids encode the necessary processing factors and T4SS channel for delivery of 
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DNA substrates to target cells. Conjugative transfer can be divided into three steps: (i) substrate 
processing, (ii) substrate docking with the substrate receptor, also known as the type IV coupling  
protein (T4CP), and (iii) substrate transfer through the mating channel (Figure 1.4).  Below, I 
will discuss each of these steps. 
Substrate Processing: For this section, I will describe the events prior to DNA 
translocation through the A. tumefaciens VirB system.  Preparation of the T-DNA substrates 
begins with the formation of the nucleoprotein complex termed the relaxosome.  This complex 
consists of VirC1, VirC2, and VirD1.  VirC1 is a member of the ParA family of proteins 
containing a canonical Walker A and B box (39).  Members of the ParA family are localized to 
the cell pole and are responsible for plasmid segregation after DNA replication (40).  VirC1 is a 
critical factor during the initiation steps of T-DNA transfer.  VirC1, with the help of the VirC2 
accessory protein, binds to a sequence adjacent to the right T-DNA border termed overdrive 
(41,42).  Binding to this site results in the melting of the double-stranded DNA and recruitment 
of the VirD2 relaxase (Figure 1.4).  VirD2 relaxase cleaves the T-DNA borders to initiate 
transfer of the T-DNA substrate through the T4SS.  VirC1 recruits the relaxosome to the cell 
pole where the T4SS is located to begin transfer of T-DNA into the target plant cell.   
Substrate recognition: The relaxosome possesses the signals for recognition by the 
substrate receptor or T4CP. In the A. tumefaciens VirB/VirD4 system, the VirD2 relaxase 
contains a cluster of positively charged residues at its C-terminus that mediate docking with the 
VirD4 receptor (43).  Other internal signals and accessory factors, such as VirD1, VirC1, and 
VirC2, also contribute to docking of the relaxosome with VirD4 (39) (Figure 1.4).  
Most Dtr proteins carry signals for docking only with a cognate T4CP/T4SS.  Some Dtr 
proteins, however, appear to carry distinct types of signals enabling relaxosome docking and  
 17 
  
Figure 1.4 Conjugative Transfer of DNA to recipient cells.  Key events during 
conjugation. (1) The relaxase and other accessory factors gather at the oriT on the 
plasmid.  (2) The relaxase catalytically nicks the plasmid at the nic site.  The 
conserved active site Tyr residue covalently binds to the free 5’ end of the nicked 
DNA.  (3)  Utilizing the relaxase translocation signal, the relaxosome docks at MPF 
with the T4CP.  (4) Upon an unidentified signal, the relaxosome is shunted through 
the channel into the MPF.  (5a) The free 3’ end of the nicked strand of the 
conjugative plasmid primes second strand synthesis in order to re-create the double-
stranded plasmid. (5b) The relaxosome inside the recipient cell will prime synthesis 
of a new DNA strand, leading to a new copy of the plasmid in the recipient cell.  
This is Figure 1 in Zechner EL et al. Assembly and mechanisms of bacterial type IV 
secretion machines. Philos Trans R Soc Lond B Biol Sci. 2012 367:1073–87.   This 
article is an open-access article under the terms of The Creative Commons 
Attribution License.  
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subsequent transfer through many different T4SS channels.  One prominent example of a 
promiscuous Dtr protein is the MobA relaxase encoded on plasmid RSF1010 (44).  MobA, along 
with accessory proteins MobB and MobC, is able to mediate the transfer of RSF1010 through 
numerous T4SSs, including VirBAt, TrapKM101, TrwR388, and TrbRP4 (16,21,45–48). MobA contains 
a cluster of positively-charged residues at its C-terminus similar to VirD2, which are important 
for mobilization through the VirBAt T4SS.  However, MobA also contains additional signals 
within its N- and C-terminal regions, distinct from the positively-charged cluster that are 
important for mobilization through the RP4 plasmid-encoded T4SS (44).  This combination of 
various signal domains throughout MobA likely contributes to its ability to recognize a multitude 
of T4CPs.  MobB is a membrane protein that is predicted to act as a chaperone by coupling 
MobA to the T4CP (44).  It is still unclear which regions of the T4CP are responsible for 
recognition of MobA. 
Translocation through the mating channel: Upon engagement of the DNA substrate 
with the T4CP receptor, the substrate is delivered to other subunits of the T4SS for further 
processing and ultimately for transfer through the T4SS. As the transferred strand of DNA (T-
strand) is unwound from its template and delivered through the T4SS, second-strand synthesis 
reconstitutes the mobile element in the donor cell.  Similarly, when the T-strand is delivered to 
the recipient cell, it first re-circularizes and then undergoes second-strand synthesis for 
generation of a double-stranded, circular element which either replicates autonomously or inserts 
into the chromosome (Figure 1.4) (22). The transferred mobile element can reiteratively 
assemble a T4SS for further propagation to plasmid-free recipient cells.  
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T4SSs in Agrobacterium tumefaciens  
 The paradigm T4SS from Agrobacterium tumefaciens consists of 11 VirB proteins and a 
VirD4 T4CP, which is utilized to deliver oncogenic T-DNA into plant cells (5).  This pathogen  
causes devastation of many agriculturally important crop species. Virulent strains of A. 
tumefaciens contain a large 194-kb plasmid termed the tumor-inducing plasmid (Ti plasmid) 
(49).  Infection by the VirB/VirD4 system also requires protein effectors (VirE2, VirE3, and 
VirF), Dtr factors (VirC1, VirC2, VirD1, and VirD2), and a two-component regulatory system 
(VirA and VirG; See below) (39,43,50–57). Another Ti-encoded T4SS is the Trb machine, 
which is responsible for conjugative transfer of the Ti plasmid to A. tumefaciens recipient cells.  
This operon is similar in gene composition to the trb locus carried on the E. coli conjugative 
plasmid RP4, indicative of a common ancestry (58). 
  The VirB and Trb T4SSs are composed of similar sets of T4SS subunits and they are 
both able to transfer the promiscuous plasmid RSF1010 to A. tumefaciens recipient cells (49).  
However, there are notable differences between these two systems.  The Trb T4SS does not 
contain a VirB8 homolog, which is important in the VirB system for T4SS localization, T-DNA 
transfer, and pilus biogenesis (59–67).  Additionally, the VirB6 homolog in the Trb system, 
TrbL, has an extended soluble region at its C-terminus.  TrbL is, therefore, part of the “extended 
VirB6” family (5).  Similar proteins, such as TraG from F-plasmid, are important for mating pair 
stabilization and entry exclusion (discussed later) (68).   
 Once integrated into the plant cell genome, T-DNA gene products synthesize opines, 
which are small molecules that serve as important nitrogen and energy sources for the A. 
tumefaciens cells (49).  Ti plasmids are often categorized based on the opine biosynthetic genes 
encoded on the T-DNA. Two of the primary Ti plasmids studied are the octopine pTiA6 and 
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nopaline pTiC58 plasmids.  Although these plasmids contain similar VirB T4SSs, there is 
sequence variation between the different subunits. The Christie lab has utilized the pTiA6 
plasmid for its studies.   
Both VirB and Trb proteins are absent under non-inducing conditions. Upon wounding, 
plant cells release phenolic compounds, which are sensed by the membrane-bound VirA sensor 
kinase (69–71). VirA will autophosphorylate at a critical histidine residue followed by 
transferring of the phosphate group to an important aspartate residue on the cytoplasmic response 
regulator, VirG. Phosphorylated VirG will, in turn, activate transcription of genes in the vir 
regulon (Figure 1.5) (69).  This initiates T-DNA processing and assembly of the VirB/VirD4 
T4SS culminating in transfer of the oncogenic DNA substrate into plant cells. The VirB/T4SS 
system also translocates effector proteins, such as the VirE2 single-stranded DNA binding 
protein, to plant cells. Upon transfer, VirE2 binds the single-stranded T-DNA to protect it from 
host cell nucleases and transfers it to the plant cell nucleus (51).  In the nucleus, the T-DNA 
integrates into the genome and T-DNA-associated genes are expressed. Once synthesized in the 
plant cell, opines are released from the cell where they can then be imported by A. tumefaciens 
(Figure 1.5).  
Opines are not only useful as a nutrient source, but they can also serve as signaling 
molecules.  The presence of high levels of opines induces the expression of Ti plasmid-encoded 
traR (Figure 1.5) (49,72).  The product, TraR, is a transcriptional regulator that is activated in the 
presence of high concentrations of acylhomoserine-lactones (AHL).  AHL is produced by Ti-
encoded TraI and is secreted outside of the cell (Figure 1.5).  When cell density is high, the 
concentration of AHL outside of the cell will increase as well.  After reaching a threshold 
concentration, AHL will re-enter the cell and interact with TraR.  This AHL-TraR interaction  
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Figure 1.5 Plant cell infection by Agrobacterium tumefaciens.  An overview of the 
A. tumefaciens plant infection process is shown.  Once a wounded plant secretes 
phenolic compounds, these are sensed by the VirA/VirG two-component signaling 
system (1).  The VirG response regulator then actives expression of the virB operon 
(2).  These proteins form the VirB T4SS, which will transmit T-DNA into target plant 
cells (3).  Once T-DNA is in the plant nucleus, it leads to synthesis of opines, which 
are then secreted and taken up by the A. tumefaciens cells (4).  Sensing of opines leads 
to opine metabolism and expression of traR.  TraR is a transcriptional regulator that 
senses the presence of AHL.  TraI is responsible for production of AHL, which is 
secreted outside of the cell (5).  Once cell density rises and the extracellular 
concentration of AHL reaches a threshold, it re-enters the cell where it is detected by 
TraR (6).  TraR then activates Ti plasmid replication and expression of the trb operon 
(7).  The Trb T4SS then allows for the Ti plasmid to be mobilized into other A. 
tumefaciens cells.     
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will lead to activation of the tra/trb operon resulting in increased conjugative transfer 
frequencies of the Ti plasmid (Figure 1.5).  Therefore, while the VirB/VirD4 and Trb T4SSs may 
serve different functions, their activation is tied to an abundant food source released by plant 
cells and high cell density.  
 
T4SS subunit composition and function. 
The A. tumefaciens VirB/VirD4Ti system can be considered an archetypal T4SS.  It 
contains homologs found in most other T4SSs.  For the rest of this chapter, the VirB/VirD4 
nomenclature will be used to describe the various subunits.  The VirB/VirD4 system can be 
divided into different subsets of proteins: (i) The IM ATPases (VirD4 T4CP, VirB11, VirB4), 
(ii) the inner membrane complex (VirB3, VirB6, and VirB8), (iii) the outer membrane “core 
complex” (OMCC) (VirB7, VirB9, and VirB10), (iv) and a conjugative pilus (VirB2 and VirB5) 
(Figure 1.6) (73).  Additionally, most Gram-negative bacterial T4SSs encode a cell wall 
hydrolase responsible for making localized degradations in the cell wall.  Each of these subunits 
will be discussed in greater detail later in this chapter.   
 An important goal in the Christie lab has been to localize the T4SS within live cells and 
determine the genetic and biochemical requirements for its spatial positioning.  Previous work 
involving fluorescent tagging of Vir subunits in A. tumefaciens has identified the cell pole as the 
primary point for machine assembly.  GFP-tagged VirC1 was observed bringing the relaxosome 
to the cell pole (39).  Additionally, our lab has observed polar localization during split-GFP 
fluorescence assays (50).  Briefly, VirE2 was tagged with the N-terminal half of GFP (residues 
1-157) while VirD4 was tagged with its C-terminal half (residues 158-238).  Although neither of 
these two proteins is individually fluorescent, they form bright foci when produced in the same  
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Figure 1.6 Localization of the T4SS subunits relative to the Gram-negative bacterial cell envelope.  
Arrangement of the different T4SS components including the IM ATPases (VirD4, VirB4, and VirB11), the 
IM proteins (VirB3, VirB6, and VirB8), the core complex (VirB7, VirB9, and VirB10), and a conjugative 
pilus (VirB2 and VirB5).  
The structure of TrwB is Figure 2C from Gomis-Rüth FX et al. The bacterial conjugation protein 
TrwB resembles ring helicases and F1-ATPase. Nature 2001 409:637–41.  This image was re-published with 
permission from Nature Publishing Group. License Number 4078401439237.  The image of VirB4-like 
TrwK was derived from Figure 2C in Peña A et al. The hexameric structure of a conjugative VirB4 protein 
ATPase provides new insights for a functional and phylogenetic relationship with DNA translocases. J Biol 
Chem. 2012 287:39925–32.  The American Society for Biochemistry and Molecular Biology does not 
require prior permission for re-publication of figures.  The structure of the VirB11-like HP0525 was 
published as Figure 3C in Yeo HJ et al. Crystal structure of the hexameric traffic ATPase of the Helicobacter 
pylori type IV secretion system Mol Cell. 2000 6:1461–72.  This image was re-published with permission 
from Elsevier.  License Number 4078430588294.  The structure of Brucella suis VirB8 was published in 
Terradot L, et al. Structures of two core subunits of the bacterial type IV secretion system, VirB8 from 
Brucella suis and ComB10 from Helicobacter pylori. Proc Natl Acad Sci U S A. 2005 102:4596–601.  
pKM101-encoded TraC was published in Yeo HJ, et al. Structural and functional characterization of the 
VirB5 protein from the type IV secretion system encoded by the conjugative plasmid pKM101. Proc Natl 
Acad Sci U S A. 2003 100:15947–52. No prior permission is required for reproduction of VirB8 or TraC. 
The structure of the F-pilus generated by electron microscopy was published as Figure 2A in Costa TRD, et 
al. Structure of the bacterial sex F pilus reveals an assembly of a stoichiometric protein-phospholipid 
complex. Cell 2016 166:1436–1444.e10.  No prior permission from Elsevier is required for reproduction of 
this figure.   The pKM101 core complex is figure 2A in Fronzes R, et al. Structure of a Type IV Secretion 
System Core Complex Science 2009 323:266–8.  This figure was re-published with permission from The 
American Association for the Advancement of Science. License # 4113830881899. 
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cell, indicating that VirE2 interacts with VirD4 as full length GFP is reconstituted.  As the green 
foci were localized to the cell pole, these data further validate previous observations with regards 
to machine assembly.  Once the T4SS is localized within the cell, the requirements for  
localization can be uncovered using various deletion mutants and the structure of the channel in 
intact cells can be resolved using high-resolution electron microscopy.  
Another major breakthrough in our lab’s studies of the VirB/VirD4 T4SS was the 
definition of T-DNA translocation pathway.  Eric Cascales, a former postdoctoral researcher in 
the Christie lab, developed the Transfer DNA Immunoprecipitation (TrIP) Assay to specify the 
route of T-DNA (74).  In this assay, A. tumefaciens cells were incubated in the presence of 
inducing phenolic compounds followed by treatment with formaldehyde to crosslink T-DNA to 
the channel components.  After membrane isolation and solubilization, VirB proteins were 
immunoprecipitated and tested for associated T-DNA.   
As predicted based on previous findings, T-DNA first makes contact with the VirD4 
substrate receptor.  The T-DNA is then shunted to the VirB11 ATPase followed by the VirB6 
and VirB8 IM proteins.  Finally, T-DNA is translocated to the OM with assistance from the OM-
associated VirB9 subunit and the VirB2 pilus protein (Figure 1.7).  One striking observation was 
the ability to uncouple proteins in the IM from those in the OM.  Deletion of genes such as 
virB2, virB9, and virB10 still allowed for stable DNA contacts with the IM ATPases and the 
VirB6 and VirB8 IM proteins, but abolished any contacts with OM proteins.  These data 
supported a “Two-Subassembly” model for the T4SS, in which IM proteins function to deliver 
substrates across the IM independently of the OMCC.  This model was further supported by the 
structure of the TrwR388 VirB3-VirB10 structure, which shows a clear demarcation between IM 
and OM proteins (Figure 1.8).    
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Figure 1.7 Pathway of T-DNA through the A. tumefaciens VirB/VirD4 T4SS.  The pathway 
of T-DNA through the T4SS is shown with a red arrow.  T-DNA has been demonstrated to 
interact with VirD4 and VirB11 in the cytoplasm, VirB6 and VirB8 at the inner membrane, and 
VirB2 and VirB9 at the outer membrane.  
The structure of TrwB is Figure 2C from Gomis-Rüth FX et al. The bacterial conjugation 
protein TrwB resembles ring helicases and F1-ATPase. Nature 2001 409:637–41.  This image 
was re-published with permission from Nature Publishing Group. License Number 
4078401439237. The structure of the VirB11-like HP0525 was published as Figure 3C in Yeo 
HJ et al. Crystal structure of the hexameric traffic ATPase of the Helicobacter pylori type IV 
secretion system Mol Cell. 2000 6:1461–72.  This image was re-published with permission from 
Elsevier.  License Number 4078430588294.  This image was re-published with permission from 
Elsevier.  License Number 4078430588294.  The structure of Brucella suis VirB8 was published 
in Terradot L, et al. Structures of two core subunits of the bacterial type IV secretion system, 
VirB8 from Brucella suis and ComB10 from Helicobacter pylori. Proc Natl Acad Sci U S A. 
2005 102:4596–601.  No prior permission is required for reproduction of VirB8.    The pKM101 
core complex structure is Figure 4 from Fronzes R, et al. The structural biology of type IV 
secretion systems. Nat Rev Microbiol. 2009 7:703–14.  This image was re-published with 
permission from Nature Publishing Group. License # 4092681298982. 
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Figure 1.8 Structure of the TrwR388 type IV secretion system along with localization of 
subunits.  (A) Structure of the TrwR388 TrwM/VirB3-TrwE/VirB10 structure generated by the 
Waksman laboratory.  (B) Localization of a subset of subunits including VirB4 (blue; structure of 
VirB4 from plasmid R388), VirB8 (structure of VirB8 periplasmic domain from Brucella suis), 
and the VirB7-VirB9-VirB10 outer membrane complex (yellow, blue, and red; structure of the 
TraN-TraO-TraF outer membrane complex from pKM101).   
 
The image of VirB4-like TrwK was derived from Figure 2C in Peña A et al. The hexameric 
structure of a conjugative VirB4 protein ATPase provides new insights for a functional and 
phylogenetic relationship with DNA translocases. J Biol Chem. 2012 287:39925–32.  The 
American Society for Biochemistry and Molecular Biology does not require prior permission for 
re-publication of figures.  The structure of Brucella suis VirB8 was published in Terradot L, et al. 
Structures of two core subunits of the bacterial type IV secretion system, VirB8 from Brucella suis 
and ComB10 from Helicobacter pylori. Proc Natl Acad Sci U S A. 2005 102:4596–601.  
pKM101-encoded TraC was published in Yeo HJ, et al. Structural and functional characterization 
of the VirB5 protein from the type IV secretion system encoded by the conjugative plasmid 
pKM101. Proc Natl Acad Sci U S A. 2003 100:15947–52. No prior permission is required for 
reproduction of VirB8 or TraC.  The structure of the TraN-TraO-TraF heteromultimer was 
generated using pymol (http://pymol.org) based on the 3ZBI file deposited into the NCBI protein 
database.  The structure of the R388 core complex is Figure 2A from Low H, et al. Structure of a 
type IV secretion system Nature 2014 508:550–3.  This figure was re-published with permission 
from Nature Publishing Group. License #4113871389804. 
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The pKM101 plasmid 
pKM101 has historical significance for its use in the Ames test (75) for detection of 
mutagens. One of the hallmark features of the pKM101 plasmid is the presence of two genes, 
mucA and mucB, which are under the control of a LexA repressor (Figure 1.9) (76).  The proteins 
encoded by these genes, MucA and MucB, form an error-prone DNA polymerase which, similar 
to the DNA polymerase involved in the SOS response, incorporates many mutations into the 
bacterial chromosome and can even synthesize DNA across double-stranded breaks (77–81).  
Besides antibiotic resistance, this plasmid provides the cell with a greater ability to survive 
exposure to UV light and other mutagenic compounds.  For this reason, Salmonella containing 
pKM101 was chosen as the strain for use in the Ames test (75).  
 Recently, structural studies described an overall architecture for the distal portion of 
pKM101-encoded T4SS (82,83). Importantly, this T4SS is highly related to other systems, such 
as the VirB/VirD4Ti and TrwR388 T4SSs (82–85).   The respective tra/virB/trw gene clusters are 
similar in size and are composed of genes encoding functional homologs.  Although the 
sequence identities among homologs of these systems range from 20% to 40%, there have been 
demonstrated instances of cross-complementation between them.  For example, pKM101 deleted 
of its region encoding the Dtr proteins (TraK, TraJ, and TraI) is complemented by the 
corresponding proteins from R388 (TrwA, TrwB, and TrwC) (86). The TrwB substrate receptor, 
therefore interacts productively not only with the R388 relaxosome, but also with the pKM101-
encoded channel.  Furthermore, the TraCpKM101 pilin subunit partially restores pilus biogenesis 
when produced in an A. tumefaciens ∆virB5 mutant (87).  Additionally, complementation of a 
∆virB6 mutant with traD leads to release of VirB2 and VirB5 to the extracellular environment 
(88).  Finally,  expression of TraLpKM101 partially complements a ∆virB1 mutation in  
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Figure 1.9 The pKM101 plasmid.  A linear layout of the pKM101 plasmid depicting the 
regions of interest on the plasmid.  The tra operon is shown associated with the 
conjugation-encoding region of the plasmid.  Additionally, the genes encoding MucA and 
MucB are depicted in the region associated with DNA damage repair.  Other regions of 
interest include the origin of replication (oriV) and beta-lactamase (bla).  
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A. tumefaciens (89).  These results highlight a common ancestry between these three systems, 
which will be explored in further detail throughout this thesis.   
 The Waksman lab has solved structures of both the TrapKM101 and TrwR388 OMCCs 
(82,85,90).  Both subassemblies are composed of 14 copies of homologs of the A. tumefaciens 
VirB7, VirB9, and VirB10 subunits arranged as a 1 MDa tetradecameric structure.  Both 
OMCCs are similar in their overall size of 180Å in width and height.  The Waksman lab also 
solved a larger TrwR388 substructure composed of the OMCC joined to the IMC. The IMC is a 
2.5 MDa structure that contains leg-like structures consisting of two hexamers of VirB4 
homologs. These hexamers are attached to an IM platform composed of 12 copies each of 
homologs of VirB3, VirB5, and VirB8 and 24 copies of a VirB6 homolog.  This IMC is 
connected to the OMCC by a thin central stalk. The IMC and OMCC are two distinct complexes 
(Figure 1.8).  Along with the data from the TrIP assay in A. tumefaciens, these findings suggest 
the possibility that the T4SS is composed of two functionally independent subassemblies.  
  
Contributions of T4SS subunits to channel assembly and functionality 
 Although subunit composition across Gram-negative bacterial T4SSs can vary, many 
resemble that of the type IVA system from A. tumefaciens.  Below, I will discuss each of the 
subunits in detail.  I will use the VirB/VirD4 nomenclature for each of the subunits unless 
otherwise specified. 
VirD4: VirD4 serves two important roles during secretion: (i) Substrate recognition and 
delivery to the MPF and (ii) IM ATPase activity.  This family of proteins can be divided into 
three domains: an N-terminal transmembrane domain, a nucleotide binding domain (NBD), and 
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an all-alpha domain (AAD). The crystal structure of the TrwBR388 soluble domain (SD; NBD and 
AAD) depicts a ball-structure 110Å in diameter and 90Å in height with a 20Å central channel 
(91).  Together with the TM domain, the structure of VirD4 contains a “ball and stem” structure 
similar to the F1F0 ATPases. These proteins are also structurally related to the FtsK and SpoIIIE 
double-stranded DNA pumps found in E. coli and Bacillus species respectively, leading to a 
proposed model of VirD4 pumping DNA through its central channel (92–94) .    
The VirD4 N-terminal domain is located in the first 87 residues and is important for 
anchoring the SD into the membrane.  The Llosa laboratory demonstrated that the TM domain of 
TrwBR388 was necessary for associations with the rest of the channel, particularly with the 
VirB10 homolog, TrwE (95).  While deletion of the TM domain would abolish transfer in most 
T4SSs, there are unique T4CPs that contain separate TM domains.  One notable example is 
Orf10 from the Streptococcus agalactiae pIP501 conjugative plasmid (5,96).  A small open 
reading frame (ORF) upstream of orf10 encodes a protein with transmembrane helices.  
Introduction of a frameshift mutation near the end of this small ORF restored an architecture 
similar to VirD4, indicating that these peculiar T4CPs arose from previous frameshift mutations.  
Interestingly, some SDs can still retain attenuated functionality when the TM is deleted.  The 
TcpA T4CP from the Clostridium perfringens pCW3 plasmid is still able to transfer DNA in the 
absence of a TM domain (5).  These results suggest that the SD is able to associate with the 
T4SS, likely using contacts with IMC subunits.   
The NBD contains a canonical Walker A box (GxxxxGK(T/S)).  It is the region most 
similar to the FtsK and SpoIIIE DNA pumps.  The AAD consists of seven alpha helices and 
bears structural resemblance to the XerD recombinase (5).  The Christie lab has demonstrated 
that SD is primarily involved in substrate recruitment and recognition.  When the SD of VirD4 
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was fused to the DivIVA polar localization protein, VirE2 was then localized at the cell poles 
(50).  Recent work in our lab, however, has focused on substrate recognition.  Neal Whitaker and 
Trista Berry, both former members of the Christie lab, made chimeric T4CPs containing the N-
terminal TM domain of TraJpKM101 and the SD from other VirD4s, including those from A. 
tumefaciens, A. phagocytophilum, and Wolbachia pipientis.  These chimeric T4CPs lost their 
ability to transfer pKM101, but were able to transfer heterologous protein substrates from their 
respective T4SSs (29).  These results highlighted a common ancestry between T4CPs from both 
conjugative and effector T4SSs as well as the conservation of functionality for all of the different 
SDs.  However, the exact mechanism of substrate recognition by the T4CP remains unclear.  
Previous work from our lab using the VirB/VirD4Ti and Prg/PcfpCF10 systems suggests that the 
AAD at the base of the SD is responsible for substrate recognition (97).  Dr. Yang “Grace” Li, a 
current member of the Christie lab, is currently using unnatural amino acid photocrosslinking, a 
technology that will be discussed later in this thesis, to identify amino acids in TraJpKM101 which 
are responsible for recognition of the TraIpKM101 relaxase.          
 VirB4: VirB4 is a universally important IM ATPase among T4SSs in both Gram-
negative and Gram-positive bacteria.  It is a large protein >80kDa in size and contains both a 
Walker A and Walker B box for ATPase activity.  The Walker A domain has been demonstrated 
to be important for substrate transfer in the VirB/VirD4Ti and Trw388 T4SSs (98–101).  Despite 
being important for transfer, the TrIP assay did not detect an interaction between T-DNA and 
VirB4.  However, some evidence suggests that there may be an interaction despite these previous 
results.  The structure of VirB4 C-terminal domain from Thermoanearobacter pseudethanolicus 
was solved by X-ray crystallography and appeared structurally similar to TrwBR388 (91,102). 
Additionally, the VirB4 homolog in the Enterococcus faecalis Prg/Pcf T4SS, PrgJ, was bound to 
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substrates as this system does not contain a VirB11 protein (103).  This is likely the case in other 
Gram-negative bacterial T4SSs, such as the F-plasmid, that also do not contain a VirB11 
homolog.   
 The VirB4 subunit has also been implicated as an important player in pilus biogenesis. 
Studies by the Christie lab highlighted conformational changes in VirB2 pilin subunits induced 
by VirB4 using the substituted cysteine accessibility method (SCAM) (104).  SCAM was also 
used to demonstrate that VirB4 mediates pilin subunit dislodging from the IM as Cys residues 
located in the cytoplasm were labeled in the presence of VirB4 indicating movement of the pilin 
subunit into the periplasm.  It is not known at this time if pilin subunits come into direct contact 
with VirB4.  Using unnatural amino acid photocrosslinking, future studies will address a 
potential VirB4-VirB2 interaction as well as the genetic requirements for this interaction.   
 VirB11:  The VirB11 family of ATPases form a double-ringed hexamer with the N-
terminal ring associated with the inside leaflet of the IM and the C-terminal ring forming a tight 
constriction in the cytoplasm (105).  VirB11 contains Walker A and B boxes in its N-terminal 
ring which is used to power the channel.  The TrIP assay demonstrated close contacts between T-
DNA and VirB11 during substrate transfer with deletions of virB11 blocking movement to the 
IMC (74).  Because substrates going through the T4SS are unfolded prior to translocation, 
VirB11 is predicted to be the “unfoldase” preparing protein substrates for movement into the 
channel.  This prediction is also supported by work from the Galan laboratory in which they 
demonstrated that InvC, a VirB11-like protein, unfolded substrates prior to translocation through 
a Salmonella T3SS (106).   In addition to directly interacting with substrates, VirB11 is also an 
important ATPase for powering translocation across the OM.  VirB11 ATPase activity, along 
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with that of VirD4, is important for switching VirB10 into an active conformation (107).  It is 
likely that VirB10 acts as an energy transducer and activates proteins in the OM. (see below) 
Additional work in our lab highlighted the importance of VirB11-mediated conformational 
changes in VirB2 using SCAM (104).  These results have lead to a model suggesting VirB11 
acts as a “Traffic ATPase”.  VirB11 will associate with VirB4 in order to aid in pilin subunit 
release from the IM during pilus biogenesis and will then associate with VirD4 and VirB10 
during substrate transfer ( 106).   
VirB3: VirB3 is a small peptide containing two TM domains placing the N and C termini 
in the cytoplasm.  VirB3 is not very well characterized, but its importance in T-DNA transfer and 
pilus biogenesis has been well demonstrated.  Interestingly, the placement of the virB3 gene 
directly upstream of the virB4 is seen in other operons encoding T4SSs (5).  VirB4 has been 
shown to be critical for VirB3 stability in A. tumefaciens and this might be the case in other 
systems.  In addition to VirB4, VirB3 also requires VirB2, VirB7, and VirB8 for stability (109).  
However, how these proteins maintain proper levels of VirB3 is still unknown.   
VirB6: VirB6 is a polytopic IM protein which comprises an integral part of the IMC 
(5,110). VirB6 is part of the translocation route for T-DNA across the IM as it makes close 
contact with the substrate (110).  The VirB6 protein family can be divided into two categories: 
(i) Non-extended VirB6 and (ii) extended VirB6.  VirB6Ti and TraDpKM101 are examples of non-
extended VirB6 proteins as they only contain TM helices along with short cytoplasmic and 
periplasmic tails. VirB6 proteins classified as ‘extended-VirB6’s’, by contrast, contain large, 
soluble domains at their C-terminal ends.  This domain in TraGF was shown to interact with 
entry exclusion (Eex) proteins in the IM of the target cell (68). Thus, the soluble C-terminal 
extension could either stretch into the target cell or a C-terminal fragment derived by protease 
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cleavage could be delivered into the target cell to exert its inhibitory function in donor-donor cell 
contacts.  
VirB8:  VirB8 is a bitopic protein found in most Gram-negative T4SSs.  It contains a 
short cytoplasmic N-terminal tail, a TM domain, and a large periplasmic domain consisting of 
extended beta sheets and five alpha helices.  This arrangement has been observed with the 
structures of VirB8 homologs including VirB8B. suis, TcpCpCW3, VirB8B. henselae, and TraEpKM101 
(111–114).  VirB8 is important for T-DNA transfer as it makes contacts with T-DNA going 
across the IM and it has been demonstrated to make contact with VirB5 during pilus biogenesis 
in A. tumefaciens.  Additionally, VirB8 has been postulated to act as a nucleation factor.  The 
Das laboratory demonstrated tight clustering of VirB9 and VirB10 only in the presence of VirB8 
(61).  However, the extent of this role is not resolved as VirB6 and VirD4 also display similar 
localization patterns as VirB8 in the absence of a T4SS (115,116).     
 VirB7: VirB7 was shown to be an OM lipoprotein which is responsible for anchoring the 
core complex into the OM (117,118).  VirB7 is anchored on the periplasmic side of the OM 
where it makes contact with and stabilizes the VirB9 subunit . The VirB7-VirB9 heterodimer 
also stabilizes VirB10 and other components of the IMC (119).  VirB7 forms a disulfide 
crosslink with VirB9 and fits along groove-like structures at the outer face of VirB9 (118,120–
122).  VirB7 was also shown to be critical for movement of T-DNA substrates between VirD4 
and VirB11 during T-DNA translocation (74).  While VirB7 is critical for building a functional 
channel, TrwHR388 is not essential for plasmid transfer of R388 (123).  Therefore, the TrwR388 
T4SS must have another mechanism for anchoring into the OM not seen in other T4SSs.  While 
VirB7 is a small protein in most conjugative T4SSs, some larger versions have been previously 
described.  For example, HP0532 from H. pylori contains a large, surface-displayed C-terminal 
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end which was associated with the pilus structure (124).  The biological significance of this 
observation is not well understood.   
 VirB9: VirB9 is a largely hydrophilic protein localized in the periplasm which is critical 
for structural integrity of the core complex.  As mentioned above, VirB9 makes contacts with 
VirB7 that are necessary for its stability as well as proper positioning in the OM (122). VirB9 
also makes critical contacts with VirB10 which are necessary for the stability of VirB10 (119).  
The crystal structure of the pKM101 core complex reveals that VirB9 is on the outer face of the 
complex while VirB10 is on the inside forming the hollow chamber which likely allows for 
substrates to pass through (82,125).  These essential VirB9-VirB10 contacts occur at the outer 
face of the VirB10 -barrel.  In addition to structural integrity of the T4SS, VirB9 also plays a 
role in substrate discrimination as various insertion mutations alternatively block T-DNA 
transfer or RSF1010 mobilization (126).    
 VirB10: VirB10 is a critical component of the OMC, but unlike the VirB7 and VirB9, it 
is also part of the IMC as it makes contacts with the IM ATPases as well as IM proteins, such as 
VirB8 (59).  VirB10 consists of a small cytoplasmic N-terminal tail, a single -helical domain 
that spans the IM, a large proline-rich region (PRR) in the periplasm, a large periplasmic -
barrel structure, a small alpha helical projection spanning the OM termed the antenna projection 
(AP), and a small C-terminal tail, which folds back into the hollow channel chamber (Figure 
1.10) (82,127).  Because it spans both membranes, VirB10 is predicted to have two critical roles.  
One is that of a scaffolding protein in which VirB10 bridges the two separate IM and OM 
complexes.  Secondly, VirB10 likely acts as an energy transducer between the IM ATPases and 
the OM proteins such as VirB9 (107).  
  
 42 
 
  
Figure 1.10 Structure of the pKM101 core complex.  (A) The structure of the 
pKM101 core complex depicting the arrangement of TraN (yellow), TraO (blue), 
and TraF (red).  Dimensions of the core complex are listed above and below.  (B) 
Crystal structure of the C-terminal half of TraF.  The domains of interest of TraF are 
listed including the cytoplasmic N-terminal tail, the TM domain, the proline-rich 
region, the lever arm, the antenna projection (AP), and the C-terminal tail.  The 
structure of the TraN-TraO-TraF heteromultimer was generated using pymol 
(http://pymol.org) based on the 3ZBI file deposited into the NCBI protein database. 
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VirB10 also plays a critical role in pilus biogenesis.  Previous studies on VirB10 have 
highlighted the importance of the N-terminal half and -barrel of VirB10 for pilus biogenesis 
(128).  But recently, the C-terminal domain of VirB10 has also been examined for its role.  The 
middle of three invariant glycines at the N-terminal end of the AP (G269xxG272xxG275) has been 
shown to be critical for pilus biogenesis and a G272R mutation resulted in a gating defect for 
VirE2 release and loss of detectable pilus (125).  Additionally, deletions and partial deletions 
within the AP resulted in a loss of pilus biogenesis while only moderately affecting substrate 
transfer (127).  Therefore, one intriguing model is that VirB10 also functions as a pilus-building 
platform that interacts with pilin subunits and mediates their assembly into the pilus polymer at 
the outer membrane.  Data presented in the Results section below will address this model.    
The conjugative pilus: One of the key features of most Gram-negative bacterial T4SSs 
is the presence of a conjugative pilus.  Conjugative pili are utilized by the T4SS in order to 
establish mating junctions between donor and recipient cells.  While the VirB2 major pilin 
subunit was previously shown to make contact with DNA substrates in A. tumefaciens, passage 
of substrates through a pilus structure has not yet been demonstrated.  While previous studies 
using the F-plasmid T4SS have demonstrated transfer of substrates across long distances, these 
studies were inconclusive as to whether DNA was passing through a pilus structure (129–132).   
 Pilus biogenesis has also been extensively studied in the A. tumefaciens VirB T4SS 
(Figure 1.11). During pilin subunit maturation, VirB2 subunits are inserted into the IM.  VirB2 
contains a long signal sequence which is cleaved by the LepB signal peptidase (133).  Following 
cleavage of the signal sequence, the N and C termini are joined together by an unidentified 
protein to form a cyclic peptide (133,134).  These subunits are then subsequently used to form a 
mature pilus.    
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Figure 1.11 Pilus biogenesis in Agrobacterium and F-like pED208.  (A) Depiction of the 
pilin subunit processing pathway previously described in A. tumefaciens.  VirB2 is 
composed of two large hydrophobic regions and two hydrophilic regions in the cytoplasm 
and periplasm.  After insertion into the membrane, the 47-residue signal sequence in 
cleaved by the LepB signal peptidase.  The N- and C-terminal tails are covalently joined to 
create a cyclic peptide.  (B) Structure of the pilus from the F-like pED208 plasmid.  The 
pilus is composed of five layers wrapped together.  Each layer is composed of the TraA 
pilin subunit which is joined to a phosphatidylglycerol molecule which orients the head 
group into the pilus channel lumen.   
 
The structures of the F-pilus generated by electron microscopy and TraA subunit 
were published as Figures 2A and 5SB in Costa TRD, et al. Structure of the bacterial sex F 
pilus reveals an assembly of a stoichiometric protein-phospholipid complex. Cell 2016 
166:1436–1444.e10.  No prior permission from Elsevier is required for reproduction of 
these figures.  
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 The pilin subunit of F plasmid, TraAF, is structurally similar to VirB2, but processed 
differently.  TraAF uses proton motive force to drive itself into the IM (135).  TraAF insertion 
also requires the presence of the pilin subunit chaperone, TraQ (136).  Once inside the IM, TraAF  
is subjected to cleavage of its N-terminal signal sequence by LepB followed by acetylation of the 
new N-terminal amino acid by TraX (137,138).  Unlike VirB2, TraAF is not cyclized during 
pilus maturation.  These processed TraAF pilin subunits are then incorporated into a mature pilus.   
Recently, the structure of the pilus from the F-like plasmid pED208 was solved using cryo-
electron microscopy at 3.6Å resolution (139).  The pED208 pilus is comprised of five helical 
arrangements that are all composed of the TraA pilin subunit. TraA subunits are oriented in such 
a way that the N- and C-termini are oriented outward while the small cytoplasmic loop 
connecting the two alpha helices are located inside of the pilus lumen. In addition to TraAF, these 
studies confirmed the presence of phoshatidylglycerol in the pilus contributing to its structure 
(Figure 1.11).  The lipid heads were shown to be localized inside of the pilus lumen giving it a 
slight electronegative charge.  The Waksman laboratory predicts that this allows for efficient 
transfer of DNA through the pilus lumen.  Future studies are needed to confirm the presence of 
DNA or protein substrates inside of the pilus. 
 
T4SSs: Substrate channel vs. Pilus Assembly Machines 
 The Christie lab has identified numerous mutations in the VirBTi and TrapKM101 
(discussed below) that block substrate transfer or pilus biogenesis, but not both (125,127).  These 
types of mutations have been referred to as “uncoupling mutations” as they uncouple these two 
important processes.  Various mutational analyses have uncovered these in different T4SSs 
highlighting some similarities as well as informative differences.  For example, TrwHR388 is not 
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important for R388 plasmid transfer, although its homolog in the VirBTi system, VirB7, is 
essential (67,123).  Additionally, deletion of virB1 in the VirBTi system abolishes detectable pilus 
production while still allowing for attenuated T-DNA transfer (67).  During my analysis of TraF 
and the OMCC from pKM101, I uncovered more of these mutations, which I will discuss in 
more detail later in this thesis. 
Although most uncoupling mutations yield a Tra+Pil- phenotype, mutations and deletions 
of components in the Dtr proteins have revealed a Tra-Pil+ phenotype, including deletions of the 
relaxase and T4CP.  When transposon insertions were constructed in the RP4 Dtr region, E. coli 
cells containing these mutant plasmids were more sensitive to killing by P. aeruginosa 
containing a functional T6SS than cells containing wild-type RP4 (140). These mutants might 
make more pili to provide better contact with recipient cells.   
Taken together, these suggest that the T4SS functions either as “pilus assembly” or a 
“substrate translocation” machine.  In its default mode, the T4SS mediates assembly of the pilus, 
which extends and retracts stochastically in ‘search’ of bacterial recipient cells.  Once the pilus 
establishes contact with a potential recipient, the pilus retracts to bring the two cells together to 
form the mating junction.  The T4SS then switches to the substrate transfer mode, where it 
engages substrates and pumps them into recipient cells. (Figure 1.12).    
 
The goals of my research  
Shortly before I joined the Christie lab, the Waksman laboratory published the crystal 
structure of the pKM101 OMCC O-layer (90).  Similar to the ComB10 crystal structure, VirB10-
like TraF displayed a unique alpha-helical projection at its C-terminal end (90,111).  When  
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Figure 1.12 Substrate versus pilus channel. (a) Cartoon illustration of the T4SS assembly 
pathway with VirB3, VirB6, VirB8, and VirB4 forming the IMC, VirB7, VirB9, and VirB10 
forming the OMC, and VirB2 and VirB5 arranging themselves into a conjugative pilus.  (b) 
During substrate translocation, VirD4 and VirB11 will associate with the MPF channel.  Upon 
substrate docking and ATPase activity, these IM ATPases will trigger VirB10 into an active 
conformation.  This will allow the substrate to pass through the channel.  (c)  During pilus 
biogenesis, VirB4 will associate with VirB11.  These ATPases will trigger the release of 
VirB2 from the membrane in order to form an extracellular pilus.   
 
This is Figure 6 from Fronzes R, et al. The structural biology of type IV secretion 
systems. Nat Rev Microbiol. 2009 7:703–14.  This figure was re-published with permission 
from Nature Publishing Groups.  License number 4073250457937. 
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placed in the context of the core complex, these helices appeared to form the OM substrate pore, 
though previous experiments in the Christie lab identified this region as an important factor in 
pilus biogenesis.  My goal was to further define the role of the AP in building a functional T4SS. 
Some of the questions I sought to address included: (i) Which regions of the AP and C-terminal 
tail are critical for substrate transfer, pilus biogenesis, and recipient-cell contact? (ii) Are the AP 
and C-terminal domains of VirB10 and TraF functionally similar? (iii) Are the IMC and OMCC 
subassemblies separate functional complexes?  Important observations made during my time in  
the Christie lab include: (i) both the AP and C-terminal tail are critical for building of a cognate 
conjugative pilus, although only the C-terminal tail is essential for plasmid transfer, (ii) the C-
terminal half of VirB10 and TraF are functionally similar as demonstrated by mutual 
substitutions between the two proteins, (iii) the IMC and OMCC are functionally-distinct 
subassemblies as demonstrated by the ability to pair heterologous OMCCs and IMCs along with 
the different TraF/VirB10 N-terminal sequence requirements in the IMC.   
 During my investigation into the role of the OMCC in building a functional T4SS, I, 
along with other members of the Christie lab began developing and utilizing the pKM101 T4SS.  
Our initial motivation for choosing a new model system was related to the structural information 
available.  Because a crystal structure of TraF was available, we could use it to make testable 
predictions about the roles of various domains of interest.  Additionally, much less time is 
required to perform genetic analysis using E. coli pKM101 for our model system.  Finally, E. 
coli provided tools that were not available with A. tumefaciens, such as donor-specific 
bacteriophages PRD1 and IKe (141,142).  These phages are not only useful tools for monitoring 
pilus production, but they can also act as morphologically distinct markers when identifying the 
location of the T4SS in the cell membrane.  
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I contributed to this effort by assisting in developing the E. coli pKM101 T4SS as the 
new model system in the Christie lab.  I, along with other members of the Christie lab, developed 
markerless deletions of each pKM101 tra gene on the native plasmid, allowing us to minimize 
polar effects on downstream genes, and complementing plasmids under the arabinose-inducible 
PBAD promoter.  Additionally, I developed the use of new tools and assays not available in the A. 
tumefaciens system, including the use of donor-specific bacteriophages and the Pseudomonas 
aeruginosa T6SS killing assay to monitor T4SS machine function.  These tools allowed for new 
insight into the stages at which mutations block conjugation.    In Chapters 3-6, I will describe 
my efforts to develop the pKM101 T4SS and define the contributions of the VirB10/TraF AP 
and C-terminal tail in building a functional translocation channel.   
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Bacterial strains and growth conditions 
Escherichia coli strain DH5α was used for plasmid construction and the Pseudomonas 
aeruginosa type VI killing assay.  P. aeruginosa strain PW9164, a strain of PAO1 with as 
ISphoA insertion in the retS locus was used for the type VI killing assays.  E. coli strain MG1655 
was used during conjugation assays and phage sensitivity assays (143).  Strain WM1650 was 
used as recipient cell during conjugation assays (144).  Strain MC4100 was used for surface 
display assays and TOP10 was used for p-benzoyl-l-phenylalanine (pBpa) crosslinking 
experiments (145).  All E. coli and P. aeruginosa strains were grown in Lysogeny Broth (LB) at 
37ºC with shaking.  When necessary, E. coli cells were grown in the presence of the following 
antibiotics: carbenicillin (50 g/ml), kanamycin (50 g/ml), spectinomycin (100 g/ml), 
chloramphenicol (20 g/ml), tetracycline (20 g/ml), and rifampicin (50 g/ml).  P. aeruginosa 
was grown in LB without antibiotic selection.   
Agrobacterium tumefaciens strains A348 and PC1010 variants were used for studies exploring 
T4SS function with T-DNA transfer and VirB2 surface assays (67,146). A. tumefaciens cells 
were grown in MG/L at room temperature with shaking (110).  During induction of virulence 
genes, cells were incubated in acidic ABIM along with 100 M acetosyringone for 24 hours 
(125).  When necessary, A. tumefaciens was grown in MG/L in the presence of carbenicillin (100 
g/ml), kanamycin (100 g/ml), and gentamycin sulfate (100 g/ml).  During vir gene induction, 
cells were grown in the absence of antibiotics.   
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Table 2.1 Bacterial strains 
 
 
HME45 W3110 gal490 pgl􏰁8 λcI857 􏰁(cro-bioA) 
 
(154) 
MC4100 Genotype: F- [araD139]B/r Δ(argF-lac)169* 
&lambda- e14- flhD5301 Δ(fruK-yeiR)725 (fruA25)‡ 
relA1 rpsL150(strR) rbsR22 Δ(fimB-fimE)632(::IS1) 
deoC1 
(145) 
TOP10 Genotype: F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 Δ(ara-
leu)7697 galE15 galK16 rpsL(StrR) endA1 λ- 
Invitrogen 
WM1650 CAG18477; Tet linked to priA(+) (144) 
A. tumefaciens   
A348 A136 containing the pTiA6NC plasmid (146) 
PC1010 A348 deleted of the virB10 gene from pTiA6NC (67) 
 
P. aeruginosa   
PW9164 PAO1 containing an ISphoA in the retS locus Pseudomonas 
aeruginosa Stock 
Center, University 
of Washington 
Strains Relevant characteristics Source 
E. coli   
DH5α Genotype: F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– 
thi-1 gyrA96 relA1 
Gibco-BRL/ 
Invitrogen 
MG1655 Genotype: K-12 F– λ– ilvG– rfb-50 rph-1 (143) 
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Table 2.2 E. coli vectors 
 
Name Relevant characteristics Source 
pBAD24 Crbr; ColE1 expression vector with arabinose-
inducible PBAD promoter. 
(147) 
pBAD33 Camr; pACYC184/p15 plasmid with arabinose-
inducible PBAD promoter 
(147) 
pBAD24Spc Spcr; pBAD24 with spectinomycin resistance gene 
from pHP45Ω inserted into bla gene. 
This study 
pBAD24Kan Kanr; pBAD24 with kanamycin resistance gene from 
pUC4K inserted into the bla gene 
(29) 
pHP45Ω Spcr; source of spcr cassette (148) 
pBB50 Kanr; source of sacB-kan cassette (67) 
pGB2 Spcr; plasmid with pSC101 origin of replication (149) 
pUC4K Kanr; source of kan cassette Amersham 
pKVD10 Crbr; source of virB10 cassette (127) 
pSU1443 Kanr; R388 containing a deletion of the trwB locus (150) 
pZZ11 Crbr; pPC914KS expressing PvirB::GST  (110) 
pEVOL Camr; pACYC184/p15 plasmid encoding tRNA 
synthetase/tRNA for incorporation of p-benzoyl-l-
phenylalanine into proteins of interest 
(168) 
pSJ503 Crbr; pZZ11 with a 3xFLAG tag sequence cloned 
between NcoI and BamHI 
This study 
 
 
Table 2.3 E. coli expression plasmids 
 
Name Relevant characteristics Source 
pKM101 Crbr; Deletion derivative of IncN conjugative 
plasmid R46 
(152) 
pJG57 Kanr; pBAD24Kan with PBAD::traF/AP-CTvirB10 This study 
pJG58 Kanr; pBAD24Kan with PBAD::traF/BB-CTvirB10 This study 
pJG59 Spcr; pBAD24Spc with PBAD::traF This study 
pJG60 Spcr; pBAD24Spc with PBAD::traF/APvirB10 This study 
pJG61 Spcr; pBAD24Spc with PBAD::traF/5xGly loop 
substitution 
This study 
pJG62 Spcr; pBAD24Spc with PBAD::traF with NT His tag This study 
pJG65 Spcr; pBAD24Spc with PBAD::traF/AP flexible 
loopvirB10 
This study 
pJG66 Spcr; pBAD24Spc with PBAD::traF/CTvirB10 This study 
pJG68 Spcr; pBAD24Spc with PBAD::traF/NTvirB10 This study 
pJG69 Spcr; pBAD24Spc with PBAD::traF/TMvirB10 This study 
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pJG70 Spcr; pBAD24Spc with PBAD::traF/PRRvirB10 This study 
pJG2005 Spcr; pBAD24Spc with PBAD::traF/TM-CTvirB10 This study 
pJG76 Spcr; pBAD24Spc with PBAD::traFΔ307-354 
(Deletion of the TraF AP domain) 
This study 
pJG95 Spcr; pBAD24Spc with PBAD::traFΔ302-386 
(Deletion of the TraF AP and C-terminal tail) 
This study 
pJG96 Spcr; pBAD24Spc with PBAD::traFΔ354-386 
(Deletion of the TraF C-terminal tail) 
This study 
pJG97 Spcr; pBAD24Spc with PBAD::traFΔCT9 This study 
pJG98 Spcr; pBAD24Spc with PBAD::traFΔCT1 This study 
pJG99 Spcr; pBAD24Spc with PBAD::traFR373E This study 
pJG101 Spcr; pBAD24Spc with PBAD::traFΔ373-377 
(Deletion of the conserved RDLDF domain) 
This study 
pJG134 Spcr; pBAD24Spc with PBAD::traF/BB-APvirB10 This study 
pJG150 Spcr; pBAD24Spc with PBAD::traF/BBvirB10 This study 
pMS22 Kanr; pBAD24Kan with PBAD::traL This study 
pMS24 Kanr; pBAD24Kan with PBAD::traM This study 
pMS26 Kanr; pBAD24Kan with PBAD::traA This study 
pMS28 Kanr; pBAD24Kan with PBAD::traB This study 
pMS30 Kanr; pBAD24Kan with PBAD::traC This study 
pMS32 Kanr; pBAD24Kan with PBAD::traD This study 
pMS35 Crbr; pBAD24 with PBAD::traN This study 
pMS36 Kanr; pBAD24Kan with PBAD::traE This study 
pMS38 Kanr; pBAD24Kan with PBAD::traO This study 
pMS40 Kanr; pBAD24Kan with PBAD::traG This study 
pJG125 Crbr; pCGR108 containing a deletion of traF flanked 
by SacI and XhoI restriction sites 
This study 
pJG142 Spcr; oriT-traI fragment was cloned into the pGB2 
cloning vector 
This study 
pJG143 Crbr; pCGR108 containing a deletion of traN through 
traF flanked by SacI and XhoI restriction sites 
This study 
pJG144 Crbr; pCGR108 encoding the chimeric tra:virB 
operon (virB7-traE-virB9-traF/virB10 fragment 
cloned into pJG143 using SacI and XhoI restriction 
sites.) 
This study 
pJG145 Crbr; pCGR108 encoding chimeric tra:trw operon 
(trwH-traE-trwF-traF/trwE fragment cloned into 
pJG143 using SacI and XhoI restriction sites.) 
This study 
pJG151 Crbr; pCGR108 encoding chimeric tra:ptl operon 
(ptlI-traE-ptlF-traF/ptlG fragment cloned into 
pJG143 using SacI and XhoI restriction sites.) 
This study 
pJG152 Crbr; pJG125 with the allele encoding for NT FLAG This study 
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TraF cloned between the SacI and XhoI restriction 
sites 
pJG160 Crbr; pCGR108 containing a deletion of traC flanked 
by SacI and XhoI restriction sites 
This study 
pJG161 Crbr; pCGR108 containing a deletion of traE flanked 
by SacI and XhoI restriction sites 
This study 
pJG162 Crbr; pJG125 with the allele encoding for AP FLAG 
TraF cloned between the SacI and XhoI restriction 
sites 
This study 
pJG163 Crbr; pJG125 with the allele encoding for CT FLAG 
TraF cloned between the SacI and XhoI restriction 
sites 
This study 
pJG164 Crbr; pJG125 with the allele encoding for Lever 
FLAG TraF cloned between the SacI and XhoI 
restriction sites 
This study 
pJG165 Crbr; pJG160 with the allele encoding for CT FLAG 
TraC cloned between the SacI and XhoI restriction 
sites 
This study 
pJG166 Crbr; pJG161 with the allele encoding for CT FLAG 
TraE cloned between the SacI and XhoI restriction 
sites 
This study 
pJG158 Crbr; pJG125 with the allele encoding for NT FLAG 
TraF Δ307-354 cloned between the SacI and XhoI 
restriction sites 
This study 
pJG153 Crbr; pJG125 with the allele encoding for NT FLAG 
TraF ΔCT9 cloned between the SacI and XhoI 
restriction sites 
This study 
pJG154 Crbr; pJG125 with the allele encoding for NT FLAG 
TraF Δ373-377 cloned between the SacI and XhoI 
restriction sites 
This study 
pJG155 Crbr; pJG125 with the allele encoding for NT FLAG 
TraF / AP-CTvirB10 cloned between the SacI and XhoI 
restriction sites  
This study 
pJG156 Crbr; pJG125 with the allele encoding for NT FLAG 
TraF / AP-CTptlG cloned between the SacI and XhoI 
restriction sites 
This study 
pJG157 Crbr; pJG125 with the allele encoding for NT FLAG 
TraF /AP-CTtrwE cloned between the SacI and XhoI 
restriction sites 
This study 
pJG202 Crbr; pUC57 plasmid containing the tra:virB operon This study 
pJG203 Crbr; pUC57 plasmid containing the tra:ptl operon This study 
pJG1002 Spcr; pKM101 containing a deletion of the traM 
locus 
This study 
pJG1003 Crbr; pKM101 containing a deletion of the traA locus This study 
pJG1004 Spcr; pKM101 containing a deletion of the traB locus This study 
 60 
pJG1005 Spcr; pKM101 containing a deletion of the traC locus This study 
pJG1006 Spcr; pKM101 containing a deletion of the traD locus This study 
pJG1008 Spcr; pKM101 containing a deletion of the traE locus This study 
pJG1010 Crbr; pKM101 containing a deletion of the traF locus This study 
pJG1011 Spcr Kanr; pKM101 containing a sacB-kan insertion 
into the traG locus 
This study 
pCGR100 Camr; mini-pKM101 in pBAD33 (korB-traG cloned 
between the SacI and XbaI sites.  (This plasmid is 
missing the kikA locus.) 
This study 
pJG122 Camr; pCGR100 containing a deletion of traL This study 
pJG123 Camr; pCGR100 containing a deletion of traO This study 
pJG124 Camr; pCGR100 containing a deletion of traN This study 
pCGR108 Crbr; mini-pKM101 in pBAD24 (korB-traG cloned 
between the NcoI and XbaI sites.  This plasmid is 
missing the kikA locus.) 
This study 
pCGR113 Camr; kikA cloned in pBAD33 between SacI and 
XbaI restriction sites 
This study 
pJG111 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG P185Amber mutation 
This study 
pJG112 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG W304Amber mutation 
This study 
pJG113 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG F316Amber mutation 
This study 
pJG114 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG N325Amber mutation 
This study 
pJG115 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG Y334Amber mutation 
This study 
pJG116 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG Q343Amber mutation 
This study 
pJG117 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG Y352Amber mutation 
This study 
pJG118 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG F377Amber mutation 
This study 
pJG119 Spcr; pBAD24Spc with PBAD::traF/NT 6xHis:CT 
FLAG N386Amber mutation 
This study 
pJG204 Crbr; pBAD24 with PBAD::traF/ CT FLAG A2Amber 
mutation 
This study 
pJG205 Crbr; pBAD24 with PBAD::traF/ CT FLAG V6Amber 
mutation 
This study 
pJG206 Crbr; pBAD24 with PBAD::traF/ CT FLAG 
E11Amber mutation 
This study 
pJG207 Crbr; pBAD24 with PBAD::traF/ CT FLAG 
T16Amber mutation 
This study 
pJG208 Crbr; pBAD24 with PBAD::traF/ CT FLAG This study 
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S23Amber mutation 
pJG209 Crbr; pBAD24 with PBAD::traF/ CT FLAG 
G27Amber mutation 
This study 
pJG210 Crbr; pBAD24 with PBAD::traF/ CT FLAG 
N32Amber mutation 
This study 
pJG211 Crbr; pBAD24 with PBAD::traF/ CT FLAG 
V43Amber mutation 
This study 
pJG212 Crbr; pBAD24 with PBAD::traF/ CT FLAG 
L45Amber mutation 
This study 
pJG213 Crbr; pBAD24 with PBAD::traF/ CT FLAG 
L49Amber mutation 
This study 
pJG214 Crbr; pBAD24 with PBAD::traF/ CT FLAG  This study 
pRP100 Kanr; mini-pKM101 containing an IncN origin of 
replication 
This study 
pRP101 Kanr; pRP100 containing a deletion of the traL locus This study 
pRP107 Kanr; pRP100 containing a deletion of the traN locus This study 
pRP109 Kanr; pRP100 containing a deletion of the traO locus This study 
pRP110 Kanr; pRP100 containing a deletion of the traF locus This study 
pYGL24 Spcr; pJG142 containing an HA tag on the C-terminal 
end of TraK, a strep tag on the C-terminal end of 
TraJ, and a 6xHis tag on the C-terminal end of TraI 
This study 
 
 
 
Table 2.4 Agrobacterium tumefaciens expression plasmids 
 
Name Relevant characteristics Source 
pJG1 Crbr Kanr; pKVD10 with a G269R mutation in VirB10 This Study 
pJG2 Crbr Kanr; pKVD10 with a G269K mutation in VirB10 This Study 
pJG3 Crbr Kanr; pKVD10 with a G269W mutation in VirB10 This Study 
pJG4 Crbr Kanr; pKVD10 with a G269C mutation in VirB10 This Study 
pJG5 Crbr Kanr; pKVD10 with a G269D mutation in VirB10 This Study 
pJG6 Crbr Kanr; pKVD10 with a G272R mutation in VirB10 This Study 
pJG7 Crbr Kanr; pKVD10 with a G272K mutation in VirB10 This Study 
pJG8 Crbr Kanr; pKVD10 with a G272W mutation in VirB10 This Study 
pJG9 Crbr Kanr; pKVD10 with a G272C mutation in VirB10 This Study 
pJG10 Crbr Kanr; pKVD10 with a G272D mutation in VirB10 This Study 
pJG11 Crbr Kanr; pKVD10 with a G275R mutation in VirB10 This Study 
pJG12 Crbr Kanr; pKVD10 with a G275K mutation in VirB10 This Study 
pJG13 Crbr Kanr; pKVD10 with a G275W mutation in VirB10 This Study 
pJG14 Crbr Kanr; pKVD10 with a G275C mutation in VirB10 This Study 
pJG15 Crbr Kanr; pKVD10 with a G275D mutation in VirB10 This Study 
pJG40 Crbr Kanr; pKVD10 with a 3xFLAG tag cloned into an 
SphI site at virB10 codon 298. 
This study 
pJG42 Crbr Kanr; pKVD10 with a 3xFLAG tag cloned into an This study 
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SphI site at virB10 codon 329. 
pJG44 Crbr Kanr; pKVD10 with a 3xFLAG tag cloned into an 
SphI site at virB10 codon 332. 
This study 
pJG52 Crbr Kanr; pKVD10 with a 2xFLAG tag inserted 
between virB10 codons 310 and 311. 
This study 
pSJ501 Crbr; pKVD10 with codons 284-337 of virB10 replaced 
with codons 302-353 of traF 
This study 
pSJ502 Crbr; pKVD10 with codons 284-377 of virB10 replaced 
with codons 302-386 of traF 
This study 
pSJ510 Crbr; pBSIISK+ NdeI expressing Plac::virB10.298 SphI  This study    
pSJ511 Crbr; pBSIISK+ NdeI expressing Plac::virB10.329 SphI  This study 
pSJ512 Crbr; pBSIISK+ NdeI expressing Plac::virB10.331 SphI  This study 
 
 
Table 2.5 Native pKM101 deletion primers 
 
 
Name Sequence 
TraM_FWD_SacB/Kan 5’ TCTGCAATCAACAGAAGATAGTGAGTAAGGAGAAA 
CCATGGTCGACCTGCAGGTCGACTC 3’ 
TraM_RVS_SacB/Kan 5’ CGCACCTTTGAAAAGCGGTCTTTTCCCGTCAACGA 
CCATGGGAAAGCCACGTTGTGTCT 3’ 
TraA_FWD_SacB/Kan 5’ GGGGACTTTTGTCCCCCAAAGTGAGGACTACAAAG 
CCATGGTCGACCTGCAGGTCGACTC 3’  
TraA_RVS_SacB/Kan 5’ATCAATTTTTTTTGGCTTCGTAGCGGTGGCAGCTCCCTGG 
CCATGGGAAAGCCACGTTGTGTCT 3’ 
TraB_FWD_SacB/Kan 5’ TCCTCTGTTGACTACTAACGTAAGGGTTTAAAATA 
CCATGGTCGACCTGCAGGTCGACTC 3’ 
TraB_RVS_SacB/Kan 5’ GCCGGTGGTCAGCAGCACTGCCGTAAGTGATTTTT 
CCATGGGAAAGCCACGTTGTGTCT 3’ 
TraC_FWD_SacB/Kan 5’ CTGGCGCCTGACGGCTTAACAACGAGGCAAAACT 
CCATGGTCGACCTGCAGGTCGACTC 3’ 
TraC_RVS_SacB/Kan 5’ CACCAGGAAGAAAGGGATAAGCAGCfAGTAGTTTTT 
CCATGGATCCTGATGTTACATTGCAC 3’ 
TraD_FWD_SacB/Kan 5’ AATTAACTCACCGAAAATTTAAGAGTAAGGAGGCA 
CCATGGTCGACCTGCAGGTCGACTC 3’ 
TraD_RVS_SacB/Kan 5’ GCTAATCAGAAGAACTCCCATAAGCAATAAGCTG 
CCCATGGGAAAGCCACGTTGTGTCT 3’ 
TraE_FWD_SacB/Kan 5’ CGGTTGATACGCAAGGTGGTCGAAATGAAAGCTAA 
CCATGGTCGACCTGCAGGTCGACTC 3’ 
TraE_RVS_SacB/Kan 5’ GACTGACAAAACGACTGCTGAAAGAAGTAGTTTTT 
CCATGGATCCTGATGTTACATTGCAC 3’ 
TraF_FWD_SacB/Kan 5’ ATGTGCGCAGGGTTCAAATTGGGGAGGATAACTGA 
CCATGGTGGTATGAAAGCCTTTGTCA 3’ 
TraF_RVS_SacB/Kan 5’ GCGCAGTGGGCCAAGTTGATAGAAAGCTGCATCAG 
CCATGGGGGAAAGCCACGTTGTGTCTCA 3’ 
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TraG_FWD_SacB/Kan 5’ AAAGTCGCTTAGCGCCCGCTTTTCTTCAGGAGTAA 
CCATGGTCGACCTGCAGGTCGACTC 3’ 
TraG_RVS_SacB/Kan 5’ AAATGCTGCGGCCAGAAGCCAGGTTGCTAATTTTT 
CCATGGATCCTGATGTTACATTGCAC 3’ 
 
 
 
 
Table 2.6 Inverse PCR deletion primers 
 
Name Sequence 
TraL_Del_Inv._FWD 5’ GGTTATGAATGGAACGTTTGTATC 3’ 
TraL_Del_Inv._RVS 5’ TTATGTTTCACCGCGTAATTG 3’ 
TraO_Del_Inv._FWD 5’ ATGGCCCGTAAAAGTGTCG 3’ 
TraO_Del_Inv._RVS 5’ GGGGCAGCCCTCAGTTAAC 3’ 
TraN_Del_Inv._FWD 5’ ATGAAAGCTAATAAAAAAACAGGGC 3’ 
TraN_Del_Inv._RVS 5’ TACGGCATCCATTATCGG 3’ 
TraN Del. RVS SacI 5’ GATATGAGCTCTACGGCATCCATTATCGG 3’ 
TraF_Del._Inv._FWD 5’CTTCAGGAGTAATCATGACTGATGCAGC 3’ 
TraF_Del._Inv._RVS 5’ CAGTTATCCTCCCCAATTTGAACCC 3’ 
TraC_Del._RVS_SacI 5’ ATATATGAGCTCGAGTTTTGCCTCGTTGTTAAGCCGTCAG 3’ 
TraC_Del._FWD_XhoI 5’ATATATACTCGAGTATGAAAAAACTACTGCTGCTTATCCCTTTC
TTCCTGG 3’ 
TraE_Del._RVS_SacI 5’ TATATATGAGCTCATTAGCTTTCATTTCGACCACCTTGCGTATC 
3’ 
TraE_Del._FWD_XhoI 5’ATATATACTCGAGCCCCATGAAAAAACTACTTCTTTCAGCAGT
C 3’ 
TraF Del. RVS SacI 5’ TATATGAGCTCTCAGTTATCCTCCCCAATTTG 3’ 
TraF Del. FWD XhoI  5’ ATATACTCGAGAAAAGTCGCTTAGCGCCC 3’ 
 
Table 2.7 pKM101 gene cloning primers 
 
Name Sequence 
traL_FWD_NcoI 5’CATGCCATGGATGAGTAAACATCCAAAACTCCTGGTTCTC 3’ 
traL_RVS_XhoI_KpnI 5’GATGGTACCATGCTCGAGTCATTCCCCCTTCGCTGTTTC 3’ 
traM_FWD_NcoI 5’ CATGCCATGGATGACCACGTTGTTTAAGAAGTATGGCC3’ 
traM_RVS_XhoI_KpnI 5’ CGGGGTACCCCGCTCGAGTCAGCTTCCTACGCCCGTCA 3’ 
traA_FWD_NcoI 5’ CATGCCATGGATGTTCGTTGACGGGAAAAGACCG 3’ 
traA_RVS_XhoI_KpnI 5’ CGGGGTACCCCGCTCGAGTTAAACCCTTACGTTAGT  
AGTCAACAGAGGAATAAGAC 3’ 
traB_FWD_NcoI 5’ CATGCCATGGATGAGAGCTGCCACCGCTACG 3’ 
traB_RVS_XhoI 5’ CCGCTCGAGTTAAGCCGTCAGGCGCCAG 3’ 
traC_FWD_NcoI 5’ CATGCCATGGATGAAAAAATCACTTACGGCAGTGCTG 3’ 
traC_RVS_XhoI_KpnI 5’ CGGGGTACCCCGCTCGAGTCAGTTAATTGAAGGTGACGC 
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GGTAAC 3’ 
TraC_FWD_SacI 5’ GATATGAGCTCATGAAAAAATCACTTACGGCAGTGCTGCTG 
3’ 
TraC_FLAG_RVS_XhoI 5'CTATATACTCGAGTCATTTGTCATCGTCATCTTTATAATCGTT
AATT GAAGGTGACGCGGTAACGTCC 3’ 
traD_FWD_NcoI 5’ CATGCCATGGCATTCACCCTGGTACAAGACAT 3’ 
traD_RVS_XhoI_KpnI 5’ CGGGGTACCCCGCTCGAGTTATGCAGCCTTCTTCCCGCG 3’ 
traN_FWD_NcoI 5’ CATGCCATGGATGCGCAGCTTATTGCTTATGGGA 3’ 
traN_RVS_XhoI_KpnI 5’CGGGGTACCCCGCTCGAGTTAGCTTTCATTTCGACCACCTTGC 
3’ 
traE_FWD_NcoI 5’CATGCCATGGATGAAAGCTAATAAAAAAACAGGGCTTACAC
GT 3’ 
traE_RVS_XhoI_KpnI 5’ CGGGGTACCCCGCTCGAGTCAGTTAACTTCCGGGTTGACGC 
3’ 
TraE FWD SacI 5’ GATATGAGCTCAAAAAAACAGGGCTTACACGTGAAGCC 3’ 
TraE FLAG RVS XhoI 5’CATATATCTCGAGTCATTTGTCATCGTCATCTTTATAATCGTT
AACTTCCGGGTTGACGCGATAACTC 3’ 
traO_FWD_NcoI 5’CATGCCATGGATGAAAAAACTACTTCTTTCAGCAGTCGTTTT
GT 3’ 
traO RVS XhoI KpnI 5’CGGGGTACCCCGCTCGAGTCAGTTATCCTCCCCAATTTGAAC
CC 3’ 
traG_FWD_NcoI 5’ CATGCCATGGATGACTGATGCAGCTTTCTATCAACTTGG 3’ 
traG_RVS_XhoI_KpnI 5’ CGGGGTACCCCGCTCGAGTTACAGGCTCCCGTTCACACACTG 
3’ 
kikA_sac1_F 5’ AAAGAGCTCAGGAGGAATTCACCATGAAGAAACTCTTAATA 
CCTCTGAT 3’ 
kikA_xba1_R 5’ CCTGTCTAGACTATAAGCGAACTTTCCC 3’ 
 
 
Table 2.8 traF cloning primers 
 
Name Sequence 
TraF_FWD_NcoI 5’ CATGCCATGGCCCGTAAAAGTGTCGATGTAGA 3’ 
TraF_RVS_XhoI 5’ GCTCTCGAGTTAGTTGTCTGCGAGCGTATAAACGCC 3’  
TraF_RVS_L307_B10 5’ GCATGGCTCCGCTCAGACGCTCCCACATATGGGC 3’ 
B10_FWD_S286_TraF 5’ GTGGGAGCGTCTGAGCGGAGCCATGCTCTTGAGTG 3’ 
B10_RVS_XhoI 5’ CAACTCGAGTTAAGAGCGGCGGTTCCTCCC 3’ 
TraF_RVS_A193_B10 5’ GCGGCAAGAGCGTAGCGCGGCTAGCCTTCAGC 3’ 
B10_FWD_T173_TraF 5’ GGCTAGCCGCGCTACGGCTCTTGCCGCACCC 3’ 
B10_AP_RVS_TraF 5’ GAGGGTAGGGGGTATGTTGATGGTCGCCTTAAGGGCTG 3’ 
TraF_CT_FWD_B10 5’ ACCATCAACATACCCCCTACCCTCTACGATCAGCAGG 3’ 
TraF_AP2_RVS_B10 5’ GGTGCTAGCTGCCGTTAAGGTGTCAGAGAACAACGAA 
ATCATG 3’ 
B10_Loop_FWD_TraF 5’ GCAGCTAGCACCTACGCTGGCAG 3’ 
B10_Loop_RVS_TraF 5’ AGTTGTTTGTTCACCGTTATTTTGAAAGCTG 3’ 
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TraF_AP3_FWD_B10 5’ GAACAAACAACTTCTGAAGCACTCCGCTCTTACATGT 
CTATC 3’ 
TraF_NT_His_FWD_NcoI 5’ GATACCATGGGACATCATCATCACCACCACAATAACGA 
TAGTCAGCAAGCGGCACATG 3’ 
TraF_5xGly_FWD 5’ GGAGGTGGAGGTGGATCTGAAGCACTCCGCTCTTACATG 
TCTATCC 3’ 
TraF_5xGly_RVS 5’ TCCACCTCCACCTCCCGTTAAGGTGTCAGAGAACAAC 
GAAATCATG 3’ 
TraF_R373E_RVS 5’GTATCTCGAGTTAGTTGTCTGCGAGCGTATAAACGCCGCT
GAAATCGAGGTCCTCGGCAAC 3’ 
TraF_N386_Amber_RVS 5’GTATCTCGAGTTACTAGTCTGCGAGCGTATAAACGCCGCT
G 3’ 
TraF_S354_RVS_B10 5’ GGTTGGCGGTATAGACATGTAAGAGCGGAGTGCTTC 
AGAC 3’ 
B10_I355_FWD_TraF 5’ TCTTACATGTCTATACCGCCAACCCTGAAGAAGAAT 
CAG 3’ 
TraF_ΔAP_FWD 5’ ATGTGGGAGCGTATCCCCCCTACCCTCTACGATCAGC 3’ 
TraF_ΔAP_RVS 5’ GGTAGGGGGGATACGCTCCCACATATGGGCATCC 3’ 
TraF_FLAG_331_FWD 5’ GATTACAAGGACGATGACGATAAAAACATTCAGTA 
CAACAGCACAGAAAACAGCG 3’ 
TraF_FLAG_330_RVS 5’ TTTATCGTCATCGTCCTTGTAATCATTACTCTGCGTC 
TGGTTAACCAGCGC 3’ 
TraF_ΔAPCT_RVS 5’ GTATCTCGAGCTAGGCATCCACCTGGCCCGG 3’ 
TraF_ΔCT_RVS 5’ GTATCTCGAGCTAAGACATGTAAGAGCGGAGTGC 
TTCAGACG 3’ 
TraF_F377_Amber_RVS 5’ GTATCTCGAGTTAGTTGTCTGCGAGCGTATAAACGC 
CGCTCTAATCGAGGTCGCGGGCAAC 3’ 
TraF_ΔRDLDF_RVS 5’ CTATATCTCGAGTTAGTTGTCTGCGAGCGTATAAACGC 
CGCTGGCAACAAAAATGCTCACCGCATCAC 3’ 
F:TrwE_O.L._APCT_FWD 5’ CCGGGCCAGGTGGATGATCGGCATTTTTGGGAG 
CGTTTCG 3’ 
F:TrwE_O.L._APCT_RVS 5’ CCAAAAATGCCGATCATCCACCTGGCCCGGAATCCC 3’ 
F:PtlG_O.L._FWD 5’ ATGTGGGAGCGTCTGGGCGGTGCACTGTTACTGAGT 
GTTCTGG 3’ 
F:PtlG_O.L._RVS 5’TAACAGTGCACCGCCCAGACGCTCCCACATATGGGCATCC 
3’ 
PtlG_RVS_XhoI 5’ CATATATCTCGAGTCATTCATTTGTGCCGCGCAGG 3’ 
VirB10_FWD_NcoI 5’GATACCATGGGACATCATCATCACCACCACAATAACGATA
GTCAGCAAGCGGCACATG 3’ 
VirB10_NT_RVS_TraF 5’ CATCAGTATGACAAATTTCTGAGACCCCGAAAGACGCC 3’ 
TraF_TM_FWD_VirB10 5’ CGGCGTCTTTCGGGGGCCTTTGTCATACTGATGGCGCTGC 
3’ 
TraF_NT_RVS_B10_TM 5’ TAACGATAACGCGAGAACGACACCTCCGACGATCAA 
TTTCTGAGATTTCATACGAGGAGCCGAACGG 3’ 
B10_TM_FWD 5’ CAGAAATTGATCGTCGGAGGTGTCGTTC 3’ 
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TraF_PRR_FWD_B10_TM 5’ GTCGGAGGTGTCGTTCTCGCGTTATCGTTAAGCCTCA 
TTTGGCTAGGTAAAATTCGCGCCCCGGCTAAAGC 3’ 
TraF_TM _RVS_B10 5’CTTCTTTTGACGCCCACCCATGACCGTAATCCCGATGAAT
AC 3’  
B10 _PRR_FWD_TraF 5’ATTACGGTCATGGGTGGGCGTCAAAAGAAGGTGAATGAC
AAC 3’ 
B10_PRR_RVS_TraF 5’ ATTAGCCATGACTCCGGCCCTGCTGGGCTGCAG 3’  
TraF_FWD_B10_PRR 5’CAGCCCAGCAGGGCCGGAGTCATGGCTAATCCCAGCCTG
ACTG 3’ 
VirB10_RVS_R284_TraF 5’ GATCGCACCAGCCAGACGCTGCCAGAAGTGGCTGTCG 3’ 
TraF_FWD_L307_VirB10 5’ CACTTCTGGCAGCGTCTGGCTGGTGCGATCATGATTTC 3’ 
VirB10_RVS_I335_TraF 5’ GTAGAGGGTAGGGGGTATGTTGATGGTCGCCTTAAGG 
GCTGTCTC 3’ 
TraF_FWD_P356_VirB10 5’GCGACCATCAACATACCCCCTACCCTCTACGATCAGCAGG 
3’ 
TraF_FWD_SacI 5’GATAGAGCTCATGGCCCGTAAAAGTGTCGATGTAGATCAG
GAAC 3’ 
TraF_NT_FLAG_SacI_FWD 5’ GATAGAGCTCATGGATTATAAAGATGACGATGACAAAGC 
CCGTAAAAGTGTCGATGTAGATCAGGAAC 3’ 
TraF_FLAG_CT_RVS_XhoI 5’ CTATCTCGAGTTATTTGTCATCGTCATCTTTATAATCGTTG 
TCTGCGAGCGTATAAACGCCG 3’ 
Lever_FLAG_FWD 5’GATTATAAAGATGACGATGACAAAACTCCTGCAAGGCTG
AAGGCTAGC 3’ 
Lever_FLAG_RVS 5’TTTGTCATCGTCATCTTTATAATCCAGGTTTTTAGCGAGTG
CTGAACTACCTTCGC 3’ 
 
 
 
Table 2.9 traF amber mutant primers 
 
Name Sequence 
2_amber_Inv_FWD 5’ TAGCGTAAAAGTGTCGATGTAGATCAGG 3’ 
2_amber_Inv_RVS 5’ CATGGTGAATTCCTCCTGCTAG 3’ 
6_amber_Inv_FWD 5’ TAGGATGTAGATCAGGAACTCGATGAAAAC 3’ 
6_amber_Inv_RVS 5’ ACTTTTACGGGCCATGGTG 3’ 
11_amber_Inv_FWD 5’ TAGCTCGATGAAAACACCGGAG 3’ 
11_amber_Inv_RVS 5’ CTGATCTACATCGACACTTTTACGG 3’ 
16_amber_Inv_FWD 5’ TAGGGAGACGGTGAATTTGAAAG 3’ 
16_amber_Inv_RVS 5’ TTCACCGTCTCCGGTGTTTTC 3’ 
23_amber_Inv_FWD 5’ TAGAACCGCCGTTCGGCTCCTCG 3’ 
23_amber_Inv_RVS 5’ GCCATTAAATCCGCCACGC 3’ 
27_amber_Inv_FWD 5’ TAGGCTCCTCGTATGAAAGCCTTTG 3’ 
27_amber_Inv_RVS 5’ ACGGCGGTTACTGCCATTAAATC 3’ 
32_amber_Inv_FWD 5’ TAGGCCTTTGTCATACTGATGGCGC 3’ 
32_amber_Inv_RVS 5’ CATACGAGGAGCCGAACGGC 3’ 
 67 
43_amber_Inv_FWD 5’ TAGGTATTCATCGGGATTACGGTCATG 3’ 
43_amber_Inv_RVS 5’ AGCAAGCAGCGCCATCAG 3’ 
45_amber_Inv_FWD 5’ TAGATCGGGATTACGGTCATGGG 3’ 
45_amber_Inv_RVS 5’ TACCAAAGCAAGCAGCGCC 3’ 
49_amber_In_ FWD 5’ TAGGTCATGGGTAAAATTCGCGCC 3’ 
49_amber_Inv_RVS 5’ AATCCCGATGAATACCAAAGCAAG 3’ 
P185_FWD_Overlap 5’ GCTAAAAACCTGACTTAGGCAAGGCTGAAGGCTAGCCGC 3’ 
P185_RVS_Overlap 5’AGCCTTCAGCCTTGCCTAAGTCAGGTTTTTAGCGAGTGCTGAA
CTACCTTC 3’ 
W304_FWD_Overlap 5’ GTGGATGCCCATATGTAGGAGCGTCTGGCTGGTGCGATC 3’ 
W304_RVS_Overlap 5’ ACCAGCCAGACGCTCCTACATATGGGCATCCACCTGGCC 3’ 
F316_FWD_Overlap 5’ ATCATGATTTCGTTGTAGTCTGACACCTTAACGGCGCTGG 3’ 
F316_RVS_Overlap 5’ CGTTAAGGTGTCAGACTACAACGAAATCATGATCGCACCAGC 
3’ 
N325_FWD_Overlap 5’TTAACGGCGCTGGTTTAGCAGACGCAGAGTAATAACATTCAG
TACAACAGCAC 3’ 
N325_RVS_Overlap 5’ATTACTCTGCGTCTGCTAAACCAGCGCCGTTAAGGTGTCAGAG 
3’ 
Y334_FWD_Overlap 5’AGTAATAACATTCAGTAGAACAGCACAGAAAACAGCGGTGGG 
3’ 
Y334_RVS_Overlap 5’GTTTTCTGTGCTGTTCTACTGAATGTTATTACTCTGCGTCTGGT
TAACCAGC 3’ 
Q343_FWD_Overlap 5’ GAAAACAGCGGTGGGTAGCTGGCGTCTGAAGCACTCCGC 3’ 
Q343_RVS_Overlap 5’ TGCTTCAGACGCCAGCTACCCACCGCTGTTTTCTGTGCTG 3’ 
Y352_FWD_Overlap 5’GAAGCACTCCGCTCTTAGATGTCTATCCCCCCTACCCTCTACG
ATCAG 3’ 
Y352_RVS_Overlap 5’ AGGGGGGATAGACATCTAAGAGCGGAGTGCTTCAGACGCC 3’ 
F377_FWD_Overlap 5’ GCCCGCGACCTCGATTAGAGCGGCGTTTATACGCTCGCAG 3’ 
F377_RVS_Overlap 5’CGTATAAACGCCGCTCTAATCGAGGTCGCGGGCAACAAAAAT
G 3’ 
N386_RVS_FLAG_XhoI 5’CTATCTCGAGTTATTTGTCATCGTCATCTTTATAATCCTAGTCT
GCGAGCGTATAAACGCCGC 3’ 
 
 
Table 2.10 Mini-pKM101 primers 
 
pKM101_2700SacI_F 5’ GCGAGCTCTCCGCAAAATCAATAAGTTCG 3’ 
pKM101_2700NcoI_F 5’ TTTCCATGGTCCGCAAAATCAATAAGTTCGC 3’ 
pKM101_13500Xba_R 5’ AATTCTAGAGCCAGAAGCCAGGTTGCTAAT 3’ 
oriT_NcoI_F 5’ GCTCCATGGTACCCTCATTTAGAATGAT 3’ 
TraI_HindIII_R 5’ CGATAAGCTTCATCAGATTTCATGGCC 3’ 
TraJ_CT_Strep_F CAATTCGAAAAGTGAAGGAGGAATTCACCATGCTTGATATAACC
ACGATTACC 
TraJ_CT_Strep_R 5’ AGGATGAGACCAGATCTCCCTCAGTTCAATGCC 3’ 
TraI_CT_6HIS_F 5’ CATCATCATTGATGAAGCTTGGCTGTTTTGGCGGATG 3’ 
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TraI_CT_6HIS_R 5’ ATGATGATGGATTTCATGGCCCCCTTCTTCATGCTC 3’ 
TraK_CT_HA_F 5’CCAGATTATGCTTGAAGGAGGAATTCACCATGGACGATAGAGA
AAGAGGCTTAGCATTTTTATTTGC 3’ 
TraK_CT_HA_R 5’ AACATCATATGGATAGCGCTCCTTTTTTGGTTCCCAGACTTTG 
3’ 
RSP005 5’ ACACACCCATGGCTTCAACTCAGCAAAAGTT 3’ 
RSP006 5’ AAATCGTACTTGTATTGACCGATGTTACATTGCACAAGAT 3’ 
RSP007 5’ ATCTTGTGCAATGTAACATCGGTCAATACAAGTACGATTT 3’ 
RSP008 5’ ACACACTCTAGAATCTATCATGAACAGATCTCAC 3’ 
TrwH_FWD_KpnI_SacI 5’ GATATGGTACCAGGAGGAAGAGCTCATGAAAA 
CCATCATTTTTGCAATTTTGATGACG 3’ 
TrwH_RVS_TraE 5’ TTTTTTTATTAGCTTTCATAGTGCCCCTCGCTGAATTTCC 3’ 
TraE_FWD_TrwH 5’ TCAGCGAGGGGCACTATGAAAGCTAATAAAAAAA 
CAGGGCTTACACGTGAAGC 3’ 
TraE_RVS_TrwF 5’ AGCTAGTTTCTTCATGGGGCAGCCCTCAGTTAACTTCCG 3’ 
TrwF_FWD_TraE 5’ ACTGAGGGCTGCCCCATGAAGAAACTAGCTATCGTT 
GCATTGCTGGC 3’ 
TrwF_RVS_TraF 5’CACTTTTACGGGCCATTAGTTGCCTCCTTTGTTGACGCGAC 
3’ 
TraF_FWD_TrwF 5’ CAAAGGAGGCAACTAATGGCCCGTAAAAGTGTCGATG 
TAGATCAG 3’ 
TraF_RVS_TrwE 5’ GTTGCCAAGGCGGCCAGCGCGGCTAGCCTTCAGCC 3’ 
TrwE_FWD_TraF 5’ AAGGCTAGCCGCGCTGGCCGCCTTGGCAACCGTGAC 3’ 
TrwE_RVS_XhoI 5’ CATATCTCGAGCTACTTAGTGGGGATGCTTTCGAGA 
CTGTAGACATC 3’ 
 
Table 2.11 Agrobacterium tumefaciens virB10 primers 
 
B10_298_SphI_FWD 5’ TGCCAGGCAGCTAGCACCTACGCTGGC 3’ 
B10_298_SphI_RVS 5’ TGCGAAGGCGCCTTGAACAGCACTCAAGAG 3’ 
B10_329_SphI_FWD 5’ TGCAAGGCGACCATCAACATACCGCCAAC 3’ 
B10_329_SphI_RVS 5’ TGCAAGGGCTGTCTCAGTTGTTTGTTCACCG 3’ 
B10_332_SphI_FWD 5’ TGCATCAACATACCGCCAACCCTGAAGAAGA 3’ 
B10_332_SphI_RVS 5’ TGCGGTCGCCTTAAGGGCTGTCTCAGTTGTTTGTTC 3’ 
B10_288_RVS_TraF 5’ CTTCTGGCAGCGTTTTAGCGGAGCCCTGGCTGGTGCGATC 3’ 
TraF_307_FWD_B10 5’ CGTTTTAGCGGAGCCCTGGCTGGTGCGATCATGATTTCG 3’ 
TraF_335_RVS_B10 5’ 
ACCCTGATTCTTCTTGATAGACATGTAAGAGCGGAGTGCTTCAGA
C 3’ 
B10_339_FWD_TraF 5’ TCTTACATGTCTATCAAGAAGAATCAGGGTGACACGGTTTCC 3’ 
3xFLAG_FWD_SphI 5’GATATATAGCATGCGATTACAAGGACGATGACGATAAGGACTA
TAAAGATGACG 3’ 
3xFLAG_RVS_SphI 5’CATATATGCATGCCTTATCATCATCATCCTTATAATCCTTGTCAT
CG 3’ 
3xFLAG_Sense_NcoI_NdeI_Xh
oI_BamHI 
5’GATATATACCATGGGATTACAAGGACGATGACGATAAGGACTA
TAAAGATGACGATGACAAGGATTATAAGGATGATGATGATAAGC
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ATATGCTCGAGGGATCCATATATC 3’ 
3xFLAG_Antisense_NcoI_NdeI
_XhoI_BamHI 
5’GATATATGGATCCCTCGAGCATATGCTTATCATCATCATCCTTA
TAATCCTTGTCATCGTCATCTTTATAGTCCTTATCGTCATCGTCCTT
GTAATCCCATGGTATATATC 3’ 
VirB10_FWD_NdeI 5’GATATATATACATATGGGAAATAACGATAGTCAGCAAGC
GGCACATG 3’ 
virB10_310_2xFLAG_FWD 5’GATGACGATAAGGACTATAAAGATGACGATGACAAGGGG
ATGAGCTTCAACAGCTTTCAAAATAACGGTG 3’ 
virB10_310_2xFLAG_RVS 5’ATCTTTATAGTCCTTATCGTCATCGTCCTTGTAATCGCCAC
CCGAGCTGCCAGCGTAGG 3’ 
B10_AP_Del_RVS 5’ TCCGCTAAAACGCTGCCAG 3’ 
B10_AP_Del_FWD 5’ ACCCTGAAGAAGAATCAGGGTG 3’ 
B10_288_RVS_TraF 5’CTTCTGGCAGCGTTTTAGCGGAGCCCTGGCTGGTGCGATC 
3’ 
TraF_307_FWD_B10 
 
5’CGTTTTAGCGGAGCCCTGGCTGGTGCGATCATGATTTCG 3’ 
TraF_335_RVS_B10 
 
5’ACCCTGATTCTTCTTGATAGACATGTAAGAGCGGAGTGCT
TCAGAC 3’ 
B10_339_FWD_TraF 
 
5’TCTTACATGTCTATCAAGAAGAATCAGGGTGACACGGTTT
CC 3’ 
G269R_FWD 5’ GGACGAACTCCGTCGCCCAGGATTGCCGG 3’ 
G269R_RVS 5’ ATCCTGGGCGACGGAGTTCGTCCGCGCTTGGCG 3’ 
G269K_FWD 5’ GGACGAACTCAAGCGCCCAGGATTGCCGG 3’ 
G269K_RVS 5’ ATCCTGGGCGCTTGAGTTCGTCCGCGCTTGGCG 3’ 
G269W_FWD 5’ GGACGAACTCTGGCGCCCAGGATTGCCGG 3’ 
G269W_RVS 5’ ATCCTGGGCGCCAGAGTTCGTCCGCGCTTGGCG 3’ 
G269C_FWD 5’ GGACGAACTCTGCCGCCCAGGATTGCCGG 3’ 
G269C_RVS 5’ ATCCTGGGCGGCAGAGTTCGTCCGCGCTTGGCG 3’ 
G269D_FWD 5’ GGACGAACTCGACCGCCCAGGATTGCCGG 3’ 
G269D_RVS 5’ ATCCTGGGCGGTCGAGTTCGTCCGCGCTTGGCG 3’ 
G272R_FWD 5’ CTCGGTGCCCACGTTTGCCGGGCTCGGTCGAC 3’ 
G272R_RVS 5’ CGAGCCCGGCAAACGTGGGCGACCGAGTTCGTCC 3’ 
G272K_FWD 5’ CTCGGTGCCCAAAGTTGCCGGGCTCGGTCGAC 3’ 
G272K_RVS 5’ CGAGCCCGGCAACTTTGGGCGACCGAGTTCGTCC 3’ 
G272W_FWD 5’ CTCGGTGCCCATGGTTGCCGGGCTCGGTCGAC 3’ 
G272W_RVS 5’ CGAGCCCGGCAACCATGGGCGACCGAGTTCGTCC 3’ 
G272C_FWD 5’ CTCGGTGCCCATGCTTGCCGGGCTCGGTCGAC 3’ 
G272C_RVS 5’ CGAGCCCGGCAAGCATGGGCGACCGAGTTCGTCC 3’ 
G272D_FWD 5’ CTCGGTGCCCAGACTTGCCGGGCTCGGTCGAC 3’ 
G272D_RVS 5’ CGAGCCCGGCAAGTCTGGGCGACCGAGTTCGTCC 3’ 
G275R_FWD 5’ CCAGGATTGCCGCGTTCGGTCGACAGCCACTTCTGG 3’ 
G275R_RVS 5’ GCTGTCGACCGAACGCGGCAATCCTGGGCGACC 3’ 
G275K_FWD 5’ CCAGGATTGCCGAAGTCGGTCGACAGCCACTTCTGG 3’ 
G275K_RVS 5’ GCTGTCGACCGACTTCGGCAATCCTGGGCGACC 3’ 
G275W_FWD 5’ CCAGGATTGCCGTGGTCGGTCGACAGCCACTTCTGG 3’ 
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G275W_RVS 5’ GCTGTCGACCGACCTCGGCAATCCTGGGCGACC 3’ 
G275C_FWD 5’ CCAGGATTGCCGTGCTCGGTCGACAGCCACTTCTGG 3’ 
G275C_RVS 5’ GCTGTCGACCGAGCACGGCAATCCTGGGCGACC 3’ 
G275D_FWD 5’ CCAGGATTGCCGGACTCGGTCGACAGCCACTTCTGG 3’ 
G275D_RVS 5’ GCTGTCGACCGAGTCCGGCAATCCTGGGCGACC 3’ 
 
Plasmid modifications 
Plasmid pBAD24Spc was created by isolation of the spcr gene as a SmaI fragment from 
pHP45Ω and inserting it into the ScaI site within the crbr gene on pBAD24 (147,148). 
pKM101Spcr was constructed by introduction of the same spcr gene as an EcoRI fragment into 
the unique EcoRI site within the crbr gene of pKM101. 
 
Construction of pKM101 tra gene deletions 
Eight of the 11 tra genes were deleted from pKM101 by recombineering. Briefly, 
pKM101 or pKM101Spcr were transferred by conjugation into E. coli strain HME45, which 
contains the bacteriophage λ red system under the control of the cI857 repressor. For 
construction of each tra gene deletion, the sacB-kanr cassette from plasmid pBB50 was PCR 
amplified, so that it carried flanking NcoI sites and 35 basepairs (bps) of 5’ and 3’ sequences that 
were complementary to regions immediately upstream and downstream of a tra gene of interest. 
HME45(pKM101Crbr) or HME45(pKM101Spcr) cells were temperature-induced for expression 
of the red-gam genes, and the kanr amplicons were introduced by electroporation with Kanr 
selection for transformants. Because pKM101 is a multicopy plasmid, we eliminated plasmids 
lacking the integrated sacB-kan cassette by subculturing the Kanr transformants for 4 days in LB 
broth containing kanamycin (200 g ml-1). Isolated plasmids were digested with NcoI and 
religated to delete the sacB-kanr cassette, and ligation mixes were introduced into DH5α with 
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selection for Crbr or Spcr. Transformants were screened for kanamycin sensitivity, and tra 
deletion mutations were confirmed by sequencing across the deletion junction. 
 
Construction of mini-pKM101 plasmids 
The Christie lab constructed 3 mini-pKM101 plasmids with a goal of simplifying genetic 
manipulations of the tra gene cluster. We constructed pCGR108 by introduction of the tra region 
from pKM101 into pBAD24. For this region, we amplified a ~10-kilobase region of pKM101 
encompassing the upstream regulatory region and tra promoter through traG. This fragment was 
amplified with primers pKM101_2700NcoI_F and pKM101_13500XbaI_R and the resulting 
PCR product was introduced into pBAD24 using NcoI and XbaI restriction sites.  The second 
mini-pKM101 plasmid, pCGR100, was constructed by amplifying the same ~10-kilobase region 
from pCGR108 using primers pKM101_2700SacI_F and pKM101_13500Xba_R with pKM101 
as a template.  The resulting PCR product was digested with SacI and XbaI and ligated into a 
SacI/XbaI digested pBAD33 plasmid.  The third mini-pKM101 plasmid, pRP100, was 
constructed by joining three PCR amplification products: i) the tra gene cluster extending from 
the 3’ end of kikA through the end of traG, ii) the pKM101 oriV replication origin, and iii) an 
nptII gene encoding Kanr. The ~10-kb tra gene cluster was cut from plasmid pCGR125, a variant 
of pCGR108 containing the upstream kikA locus, using SacI and XbaI restriction enzymes, a ~3-
kb region encompassing the replication origin was amplified with primers RSP007 and RSP008, 
and the nptII gene was amplified with primers RSP005 and RSP006 using plasmid pUC4K as a 
template. The replication origin and nptII gene were joined together using overlapping PCR, 
digested with SacI and XbaI, and ligated to the tra operon. The resulting product was 
transformed into E. coli DH5α with Kanr as a selection for self-replicating pRP100. 
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Transformants were screened for plasmids bearing the three PCR fragments followed by 
sequence analysis of the PCR fragment junctions. We also confirmed that each of the mini-
pKM101 plasmids encodes a fully functional Tra T4SS.   
 
Construction of pRP100 and pCGR108 variants and a mobilization plasmid 
Plasmid pJG125 contains a deletion of the traF locus flanked by 5’ SacI and 3’ XhoI restriction 
sites.  It was constructed using inverse PCR using primers TraF_Del._RVS_SacI and 
TraF_Del._FWD_XhoI with pCGR108 as a template. 
Plasmid pJG143 contains a deletion of traN through traF flanked by 5’ SacI and 3’ XhoI 
restriction sites.  It was constructed using inverse PCR using primers TraN_Del._RVS_SacI and 
TraF_Del._FWD_XhoI with pCGR108 as a template. 
Plasmid pRP101 contains a deletion of the traL locus.  It was constructed using inverse PCR 
using primers TraL_Del._Inv._FWD and TraL_Del._Inv._RVS with pRP100 as a template. 
Plasmid pRP107 contains a deletion of the traN locus.  It was constructed using inverse PCR 
using primers TraN_Del._Inv._FWD and TraN_Del._Inv._RVS with pRP100 as a template. 
Plasmid pRP109 contains a deletion of the traO locus.  It was constructed using inverse PCR 
using primers TraO_Del._Inv._FWD and TraO_Del._Inv._RVS with pRP100 as a template. 
Plasmid pRP110 contains a deletion of the traF locus.  It was constructed using inverse PCR 
using primers TraF_Del._Inv._FWD and TraF_Del._Inv._RVS with pRP100 as a template. 
Plasmid pJG142 contains the pKM101 origin of transfer (oriT) as well as the genes encoding 
the TraK accessory protein, TraJ T4CP, and TraI relaxase.  This region was PCR amplified using 
primers oriT_NcoI_F and TraI_HindIII_R with pKM101 as a template.  This PCR product was 
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cloned into a pGB2 plasmid which had been digested with HindIII followed by blunt-ending 
with Klenow polymerase (149).   
Plasmid pJG160 contains a deletion of the traC locus flanked by 5’ SacI and 3’ XhoI restriction 
sites.  It was constructed using inverse PCR using primers TraC_Del._RVS_SacI and 
TraC_Del._FWD_XhoI with pCGR108 as a template. 
Plasmid pJG161 contains a deletion of the traE locus flanked by 5’ SacI and 3’ XhoI restriction 
sites.  It was constructed using inverse PCR using primers TraE_Del._RVS_SacI and 
TraE_Del._FWD_XhoI with pCGR108 as a template. 
Plasmid pJG165 contains mini-pKM101 with a C-terminally FLAG tagged TraC.  It was 
constructed by amplifying traC using primers TraC_FWD_SacI and TraC_FLAG_RVS_XhoI 
with pKM101 as a template.  The resulting PCR product was digested with SacI and XhoI and 
ligated into a SacI/XhoI digested pJG60 plasmid.   
Plasmid pJG166 contains mini-pKM101 with a C-terminally FLAG tagged TraE.  It was 
constructed by amplifying traC using primers TraE_FWD_SacI and TraE_FLAG_RVS_XhoI 
with pKM101 as a template.  The resulting PCR product was digested with SacI and XhoI and 
ligated into a SacI/XhoI digested pJG61 plasmid.   
Plasmid pYGL24 contains the oriT through traI region of pKM101 with TraK, TraJ, and TraI 
tagged with HA, Strep, and 6xHis tags, respectively.  It was made through sequential additions 
of tags using inverse PCR.  A Strep tag was added to TraJ by amplifying pJG142 with primers 
TraJ_CT_Strep_F and TraJ_CT_Strep_R.  Once traJ contained a Strep tag sequence at its 3’ end, 
traI had a 6xHis tag sequence added to its 3’ end with primers TraI_CT_6HIS_F and 
TraI_CT_6HIS_R.  A sequence encoding an HA tag at the 3’ end of traK was added using 
primers TraK_CT_HA_F and TraK_CT_HA_R 
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Construction of pKM101 complementing plasmids 
Plasmid pMS22 expresses PBAD::traL, producing TraL. It was constructed by PCR amplification 
of traL using primers traL_FWD_NcoI and traL_RVS_XhoI_KpnI and pKM101 as a template. 
The resulting PCR fragment was digested with NcoI and KpnI for introduction into NcoI/KpnI-
digested pBAD24Kan.   
Plasmid pMS24 expresses PBAD::traM, producing TraM. It was constructed by PCR 
amplification of traM using primers traM_FWD_NcoI and traM_RVS_XhoI_KpnI and pKM101 
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into 
NcoI/KpnI-digested pBAD24Kan.    
Plasmid pMS26 expresses PBAD::traA, producing TraA. It was constructed by PCR 
amplification of traA using primers traA_FWD_NcoI and traA_RVS_XhoI_KpnI and pKM101 
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into 
NcoI/KpnI-digested pBAD24Kan.   
Plasmid pMS28 expresses PBAD::traB, producing TraB. It was constructed by PCR amplification 
of traB using primers traB_FWD_NcoI and traB_RVS_XhoI_KpnI and pKM101 as a template. 
The resulting PCR fragment was digested with NcoI and KpnI for introduction into NcoI/KpnI-
digested pBAD24Kan.   
Plasmid pMS30 expresses PBAD::traC, producing TraC. It was constructed by PCR 
amplification of traC using primers traC_FWD_NcoI and traC_RVS_XhoI_KpnI and pKM101 
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into 
NcoI/KpnI-digested pBAD24Kan.   
Plasmid pMS32 expresses PBAD::traD, producing TraD. It was constructed by PCR 
amplification of traD using primers traD_FWD_NcoI and traD_RVS_XhoI_KpnI and pKM101 
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as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into 
NcoI/KpnI-digested pBAD24Kan.   
Plasmid pMS35 expresses PBAD::traN, producing TraN. It was constructed by PCR 
amplification of traN using primers traN_FWD_NcoI and traN_RVS_XhoI_KpnI and pKM101 
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into 
NcoI/KpnI-digested pBAD24.   
Plasmid pMS36 expresses PBAD::traE, producing TraE. It was constructed by PCR amplification 
of traE using primers traE_FWD_NcoI and traE_RVS_XhoI_KpnI and pKM101 as a template. 
The resulting PCR fragment was digested with NcoI and KpnI for introduction into NcoI/KpnI-
digested pBAD24Kan.   
Plasmid pMS38 expresses PBAD::traO, producing TraO. It was constructed by PCR 
amplification of traO using primers traO_FWD_NcoI and traO_RVS_XhoI_KpnI and pKM101 
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into 
NcoI/KpnI-digested pBAD24Kan.   
Plasmid pMS40 expresses PBAD::traG, producing TraG. It was constructed by PCR 
amplification of traG using primers traG_FWD_NcoI and traG_RVS_XhoI_KpnI and pKM101 
as a template. The resulting PCR fragment was digested with NcoI and KpnI for introduction into 
NcoI/KpnI-digested pBAD24Kan.   
Plasmid pCGR113 expresses native kikA from the pBAD promoter. It was constructed by PCR 
amplification of kikA using primers kikA_sac1_F and kikA_xba1_R and pKM101 as a template. 
The resulting PCR fragment was digested with SacI and XbaI for introduction into SacI/XbaI-
digested pBAD33.   
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Construction of traF alleles 
 
Plasmid pJG59 expresses PBAD::traF, producing TraF. It was constructed by PCR 
amplification of traF using primers TraF_FWD_NcoI and TraF_RVS_XhoI and pKM101 as a 
template. The resulting PCR fragment was digested with NcoI and XhoI for introduction into 
NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG62 expresses PBAD::his6-traF, producing N-terminally 6xHis-tagged TraF. It was 
constructed by PCR amplification of traF using primers TraF_NT_His_FWD_NcoI and 
TraF_RVS_XhoI and pKM101 as a template. The resulting PCR product was digested with 
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG95 expresses PBAD::traF1-301, producing TraF deleted of its antennae projection 
(AP) and C-terminal tail (CT). It was constructed by amplifying basepairs (bps) 1-903 of traF 
using primers TraF_NT_His_FWD_NcoI and TraF_ APCT_RVS, and pKM101 as a 
template. The resulting PCR product was digested with NcoI and XhoI for introduction into 
NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG96 expresses PBAD::traF1-353, producing TraF deleted of its CT. It was 
constructed by amplifying bps 1-1059 of traF using primers TraF_NT_His_FWD_NcoI and 
TraF_CT_RVS and pKM101 as a template. The resulting PCR product was digested with 
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG76 expresses PBAD::traF 307-354, producing TraF deleted of its AP domain. It 
was constructed by PCR amplifying traF codons 1-307 using TraF_NT_His_FWD_NcoI and 
TraF_AP_RVS and codons 355-386 using TraF_ AP_FWD and TraF_RVS_XhoI_off of 
pKM101. These PCR products were joined together by overlapping PCR, and the resulting 
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fragment was digested with NcoI and XhoI for introduction into NcoI/SalI-digested 
pBAD24Spc. 
Plasmid pJG61 expresses PBAD::traF-5xGly, producing TraF with a pentaglycine substitution 
of the AP loop. It was created by using primers TraF_NT_His_FWD_NcoI and 
TraF_5xGly_RVS to PCR amplify codons 1-322, and primers TraF_5xGly_FWD and 
TraF_RVS_XhoI to amplify codons 346-386. The two PCR products were joined together by 
overlapping PCR, and the resulting product was digested with NcoI and XhoI for introduction 
into NcoI/SalI-digested pBAD24Spc. 
Plasmid JG101 expresses PBAD::traF373-377, producing TraF deleted of the conserved 
RDLDF (residues 369-373) motif in the CT. It was created by using primers 
TraF_NT_His_FWD_NcoI and TraF_RDLDF_RVS and pKM101 as a template for PCR 
amplification. The PCR product was digested with NcoI and XhoI for introduction into 
NcoI/SalI-digested pBAD24Spc. 
Plasmids pJG97 expresses PBAD::traFCT9, producing TraF deleted of its last 9 residues. traF 
CT9 was PCR amplified using primers TraF_NT_His_FWD_NcoI and 
TraF_F377_Amber_RVS and pKM101 as a template. The PCR product was digested with 
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
Plasmids pJG98 expresses PBAD::traFCT1, producing TraF deleted of its last residues. traF 
CT1 was PCR amplified using primers TraF_NT_His_FWD_NcoI and 
TraF_N386_Amber_RVS and pKM101 as a template. The PCR product was digested with 
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
Plasmids pJG99 expresses PBAD::traFR373E, producing TraF with an R373E mutation. traF 
was PCR amplified using primers TraF_NT_His_FWD_NcoI and TraF_R373E_RVS and 
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pKM101 as a template. The PCR product was digested with NcoI and XhoI for introduction 
into NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG68 expresses PBAD::traF/NTvirB10, producing the TraF/NTVirB10 chimera.  It was 
constructed by amplifying virB10 codons 1-29 using primers VirB10_FWD_NcoI and 
VirB10_NT_RVS_TraF with pKVD10 as a template and traF codons 40-386 were amplified 
using primers TraF_TM_FWD_VirB10 and TraF_RVS_XhoI with pKM101 as a template.  
The two fragments were combined using overlapping PCR and the resulting product was 
digested with NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG69 expresses PBAD::traF/TMvirB10, producing the TraF/TMDVirB10 chimera.  It was 
constructed by amplifying traF codons 1-40 using primers TraF_NT_His_FWD_NcoI and 
TraF_NT_RVS_B10_TM and codons 60-386 with TraF_PRR_FWD_B10_TM and 
TraF_RVS_XhoI with pKM101 as a template.  The two fragments were combined using 
overlapping PCR and the resulting product was digested with NcoI and XhoI for introduction 
into NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG2005 expresses PBAD::traF/TM-CTvirB10, producing the TraF/TMD-CTVirB10 
chimera.  It was constructed by amplifying traF codons 1-40 using primers 
TraF_NT_His_FWD_NcoI and TraF_NT_RVS_B10_TM with pKM101 as a template and 
amplifying virB10 codons 29-377 using primers B10_TM_FWD and B10_RVS_XhoI with 
pKVD10 as a template.  The two fragments were combined using overlapping PCR and the 
resulting product was digested with NcoI and XhoI for introduction into NcoI/SalI-digested 
pBAD24Spc. 
Plasmid pJG70 expresses PBAD::traF/PRRvirB10, producing the TraF/PRRVirB10 chimera.  It was 
constructed by amplifying traF codons 1-60 using primers TraF_NT_His_FWD_NcoI and 
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TraF_TM_RVS_B10 and codons 194-386 using primers TraF_FWD_B10_PRR and 
TraF_RVS_XhoI with pKM101 as a template.  Codons 51-172 of virB10 were amplified using 
primers B10_PRR_FWD_TraF and B10_PRR_RVS_TraF with pKVD10 as a template. The 
three fragments were combined using overlapping PCR and the resulting product was digested 
with NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG150 expresses PBAD::traF/BBvirB10, producing the TraF/BBVirB10 chimera.  It was 
constructed by amplifying traF codons 1-193 and virB10 codons 173-286 using 
TraF_NT_His_FWD_NcoI and VirB10_RVS_R284_TraF with pJG58 as a template.  Codons 
307-386 of traF were amplified using TraF_FWD_L307_VirB10 and TraF_RVS_XhoI with 
pKM101 as a template.  The two fragments were combined using overlapping PCR and the 
resulting product was digested with NcoI and XhoI for introduction into NcoI/SalI-digested 
pBAD24Spc. 
Plasmid pJG134 expresses PBAD::traF/BB-APvirB10, producing the TraF/BB-APVirB10 chimera.  
It was constructed by amplifying traF codons 1-193 and virB10 codons 173-335 using primers 
TraF_NT_His_FWD_NcoI and VirB10_RVS_I335_TraF with pJG58 as a template.  Codons 
356-386 of traF were amplified using primers TraF_FWD_P356_VirB10 and TraF_RVS_XhoI 
and pKM101 as a template.  The two fragments were combined using overlapping PCR and the 
resulting product was digested with NcoI and XhoI for introduction into NcoI/SalI-digested 
pBAD24Spc. 
Plasmid pJG57 expresses PBAD::traF/AP-CTvirB10, producing the TraF/AP-CTVirB10 chimera. It 
was constructed by amplifying codons 1-307 of traF using TraF_NT_His_FWD_NcoI and 
TraF_RVS_L307_B10 with pKM101 as a template, and the region of virB10 encoding residues 
286-377 was amplified using B10_FWD S286_TraF and B10_RVS_XhoI with pKVD10 as a 
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template. The two PCR products were joined by overlapping PCR, and the resulting product 
was digested with NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Kan. 
Plasmid pJG58 expresses PBAD::traF/BB-CTvirB10, producing the TraF/BB-AP-CTVirB10 
chimera. It was constructed by amplifying codons 1-193 of traF using 
TraF_NT_His_FWD_NcoI and TraF_RVS_A193_B10 with pKM101 as a template, and the 
region of virB10 encoding residues 173-377 was amplified using B10_FWD T173_TraF and 
B10_RVS_XhoI with pKVD10 as a template. The two PCR products were joined by 
overlapping PCR, and the resulting product was digested with NcoI and XhoI for introduction 
into NcoI/SalI-digested pBAD24Kan. 
Plasmid pJG60 expresses PBAD::traF/APvirB10, producing the TraF/APVirB10 chimera. It was 
constructed by amplifying codons 1-307 of traF and codons 286-335 of virB10 using 
TraF_NT_His_FWD_NcoI and B10_AP_RVS TraF with pJG57 as a template. Codons 356-
386 of traF were amplified using TraF_CT_FWD_B10 and TraF_RVS_XhoI with pKM101 as 
a template. These fragments were joined by overlapping PCR, and the resulting product was 
digested with NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG65 expresses PBAD::traF/APLvirB10, producing the TraF/APLVirB10 chimera. It was 
constructed by amplifying codons 1-322 of traF using TraF_NT_His_FWD_NcoI and 
TraF_AP2_RVS_B10, and codons 364-386 using TraF_AP3_FWD_B10 and TraF_RVS_XhoI 
with pKM101 as a template. Codons 301-325 of virB10 were PCR amplified using 
B10_Loop_FWD_TraF and B10_Loop_RVS_TraF with pKVD10 as a template. The three 
PCR fragments were joined by overlapping PCR, and the resulting fragment was digested with 
NcoI and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
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Plasmid pJG66 expresses PBAD::traF/ CTvirB10, producing the TraF/CTVirB10 chimera. It was 
constructed by amplifying codons 1-354 of traF using primers TraF_NT_His_FWD_NcoI and 
TraF_S354_RVS_B10 with pKM101 as a template, and codons 335-377 of virB10 using 
primers B10_I355_FWD_TraF and B10_RVS_XhoI with pKVD10 as a template. These PCR 
products were joined by overlapping PCR, and the resulting fragment was digested with NcoI 
and XhoI for introduction into NcoI/SalI-digested pBAD24Spc. 
Plasmid pJG152 contains mini-pKM101 which produces NT FLAG TraF.  It was constructed 
by amplifying traF using TraF_NT_FLAG_SacI_FWD and TraF_RVS_XhoI and pKM101 as a 
template.  The resulting fragment was digested with SacI and XhoI and introduced into a 
SacI/XhoI digested pJG125 plasmid.   
Plasmid pJG158 contains mini-pKM101 which produces NT FLAG TraF deleted of its AP 
domain (307-354).  It was constructed by amplifying traF using TraF_NT_FLAG_SacI_FWD 
and TraF_RVS_XhoI and pJG76 as a template.  The resulting fragment was digested with SacI 
and XhoI and introduced into a SacI/XhoI digested pJG125 plasmid. 
Plasmid pJG154 contains mini-pKM101 which produces NT FLAG TraF deleted of the 
conserved RDLDF motif (373-377).  It was constructed by amplifying traF using 
TraF_NT_FLAG_SacI_FWD and TraF_ΔRDLDF_RVS and pJG101 as a template.  The 
resulting fragment was digested with SacI and XhoI and introduced into a SacI/XhoI digested 
pJG125 plasmid. 
Plasmid pJG153 contains mini-pKM101 which produces NT FLAG TraF deleted of the the C-
terminal nine residues (CT9).  It was constructed by amplifying traF using 
TraF_NT_FLAG_SacI_FWD and TraF_F377_Amber_RVS and pJG97 as a template.  The 
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resulting fragment was digested with SacI and XhoI and introduced into a SacI/XhoI digested 
pJG125 plasmid. 
Plasmid pJG155 contains mini-pKM101 which produces NT FLAG TraF/AP-CTVirB10.  It was 
constructed by amplifying traF/AP-CTvirB10 using TraF_NT_FLAG_SacI_FWD and 
B10_RVS_XhoI and pJG57 as a template.  The resulting fragment was digested with SacI and 
XhoI and introduced into a SacI/XhoI digested pJG125 plasmid. 
Plasmid pJG157 contains mini-pKM101 which produces NT FLAG TraF/AP-CTTrwE.  It was 
constructed by amplifying traF codons 1-300 using primers TraF_NT_FLAG_SacI_FWD and 
F:TrwE_O.L._APCT_RVS with pKM101 as a template and trwE codons 303-395 using 
F:TrwE_O.L._APCT_FWD and TrwE_RVS_XhoI with pJG145 as a template.   The resulting 2 
PCR fragments were joined together by overlapping PCR and the resulting fragment was 
digested with SacI and XhoI and introduced into a SacI/XhoI digested pJG125 plasmid.   
Plasmid pJG156 contains mini-pKM101 which produces NT FLAG TraF/AP-CTPtlG.  It was 
constructed by amplifying traF codons 1-307 using primers TraF_NT_FLAG_SacI_FWD and 
F:PtlG O.L. RVS with pKM101 as a template and ptlG codons 294-374 using 
F:PtlG_O.L._FWD and PtlG_RVS_XhoI using pJG203 as a template.  The resulting 2 PCR 
fragments were joined together by overlapping PCR and the resulting fragment was digested 
with SacI and XhoI and introduced into a SacI/XhoI digested pJG125 plasmid.   
Plasmid pJG162 contains mini-pKM101 which produces AP FLAG TraF.  It was constructed 
by amplifying traF codons 1-330 using primers TraF_FWD_SacI and TraF_FLAG_330_RVS 
and codons 331-386 with primers TraF_FLAG_331_FWD and TraF_RVS_XhoI with pKM101 
as a template.  The resulting fragments were joined via overlapping PCR and the resulting PCR 
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fragment was digested with SacI and XhoI and introduced into a SacI/XhoI digested pJG125 
plasmid.  
Plasmid pJG163 contains mini-pKM101 which produces CT FLAG TraF.  It was constructed 
by amplifying traF using primers TraF_FWD_SacI and TraF_FLAG_CT_RVS_XhoI with 
pKM101 as a template.  The resulting fragment was digested with SacI and XhoI and introduced 
into a SacI/XhoI digested pJG125 plasmid. 
Plasmid pJG164 contains mini-pKM101 which produces Lever FLAG TraF.  It was constructed 
by amplifying traF codons 1-183 using primers TraF_FWD_SacI and Lever_FLAG_RVS and 
codons 184-386 with primers Lever_FLAG_FWD and TraF_RVS_XhoI with pKM101 as a 
template.  The resulting fragments were joined via overlapping PCR and the resulting PCR 
fragment was digested with SacI and XhoI and introduced into a SacI/XhoI digested pJG125 
plasmid. 
 
Construction of chimeric operons 
Plasmid pJG202 contains the chimeric tra:virB operon.  A DNA fragment encoding virB7-traE-
virB9-traF/BB-CTvirB10 was designed with each gene codon optimized for expression in E. coli.  
The DNA fragment contained flanking SacI and XhoI restriction sites and was cloned as a blunt-
ended fragment into an EcoRV-digested pUC57-Amp plasmid.  DNA fragment synthesis and 
cloning was performed by Genewiz Inc.  
Plasmid pJG203 contains the chimeric tra:ptl operon.  A DNA fragment encoding ptlI-traE-
ptlF-traF/BB-CTptlG was designed with each gene codon optimized for expression in E. coli. The 
chimeric traF:ptlG gene contains codons 1-172 of traF followed by codons 160-374 of ptlG.  
The DNA fragment contained flanking SacI and XhoI restriction sites and was cloned as a blunt-
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ended fragment into an EcoRV-digested pUC57-Amp plasmid.  DNA fragment synthesis and 
cloning was performed by Genewiz Inc. 
Plasmid pJG144 contains mini-pKM101 producing the chimeric Tra:VirB T4SS.  The tra:virB 
fragment from pJG202 was digested from the plasmid using SacI and XhoI and introduced into a 
SacI/XhoI digested pJG143 plasmid.   
Plasmid pJG151 contains mini-pKM101 producing the chimeric Tra:Ptl T4SS.  The tra:ptl 
fragment from pJG203 was digested from the plasmid using SacI and XhoI and introduced into a 
SacI/XhoI digested pJG143 plasmid.   
Plasmid pJG145 contains mini-pKM101 producing the chimeric Tra:Trw T4SS.  It was 
constructed by amplifying trwH using primers TrwH_FWD_KpnI_SacI and TrwH_RVS_TraE, 
trwF using primers TrwF_FWD_TraE and TrwF_RVS_TraF, and trwE codons 197-395 using 
primers TrwE_FWD_TraF and TrwE_RVS_XhoI using pSU1443 as a template (150).  traE was 
amplified using primers TraE_FWD_TrwH and TraE_RVS_TrwF and traF codons 1-193 were 
amplified using primers TraF_FWD_TrwF and TraF_RVS_TrwE using pKM101 as a template.  
The five PCR products were joined together by overlapping PCR and the resulting product was 
digested with using SacI and XhoI and introduced into a SacI/XhoI digested pJG143 plasmid.   
 
Construction of traF amber mutants for photocrosslinking 
Plasmid pJG111 expresses PBAD::traF-P185amber producing TraF with pBpa incorporated at 
position 185.  It was constructed by amplifying codons 1-184 using primers 
TraF_NT_His_FWD_NcoI and P185_RVS_Overlap and codons 186-386 using primers 
P185_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template.  These 
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fragments were joined through overlapping PCR and the resulting PCR fragment was digested 
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.    
Plasmid pJG112 expresses PBAD::traF-W304amber producing TraF with pBpa incorporated at 
position 304.  It was constructed by amplifying codons 1-303 using primers 
TraF_NT_His_FWD_NcoI and W304_RVS_Overlap and codons 305-386 using primers 
W304_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template.  These 
fragments were joined through overlapping PCR and the resulting PCR fragment was digested 
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc. 
Plasmid pJG113 expresses PBAD::traF-F316amber producing TraF with pBpa incorporated at 
position 316.  It was constructed by amplifying codons 1-315 using primers 
TraF_NT_His_FWD_NcoI and F316_RVS_Overlap and codons 317-386 using primers 
F316_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template.  These 
fragments were joined through overlapping PCR and the resulting PCR fragment was digested 
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.     
Plasmid pJG114 expresses PBAD::traF-N325amber producing TraF with pBpa incorporated at 
position 325.  It was constructed by amplifying codons 1-324 using primers 
TraF_NT_His_FWD_NcoI and N325_RVS_Overlap and codons 326-386 using primers 
N325_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template.  These 
fragments were joined through overlapping PCR and the resulting PCR fragment was digested 
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.    
Plasmid pJG115 expresses PBAD::traF-Y334amber producing TraF with pBpa incorporated at 
position 334.  It was constructed by amplifying codons 1-333 using primers 
TraF_NT_His_FWD_NcoI and Y334_RVS_Overlap and codons 335-386 using primers 
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Y334_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template.  These 
fragments were joined through overlapping PCR and the resulting PCR fragment was digested 
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.    
Plasmid pJG116 expresses PBAD::traF-Q343amber producing TraF with pBpa incorporated at 
position 343.  It was constructed by amplifying codons 1-342 using primers 
TraF_NT_His_FWD_NcoI and Q343_RVS_Overlap and codons 344-386 using primers 
Q343_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template.  These 
fragments were joined through overlapping PCR and the resulting PCR fragment was digested 
NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc. 
Plasmid pJG117 expresses PBAD::traF-Y352amber producing TraF with pBpa incorporated at 
position 352.  It was constructed by amplifying codons 1-351 using primers 
TraF_NT_His_FWD_NcoI and Y352_RVS_Overlap and codons 353-386 using primers 
Y352_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template.  These 
fragments were joined through overlapping PCR and the resulting PCR fragment was digested 
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc. 
Plasmid pJG118 expresses PBAD::traF-F377amber producing TraF with pBpa incorporated at 
position 377.  It was constructed by amplifying codons 1-376 using primers 
TraF_NT_His_FWD_NcoI and F377_RVS_Overlap and codons 378-386 using primers 
F377_FWD_Overlap and TraF_FLAG_CT_RVS_XhoI with pKM101 as a template.  These 
fragments were joined through overlapping PCR and the resulting PCR fragment was digested 
NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc. 
Plasmid pJG119 expresses PBAD::traF-N386amber producing TraF with pBpa incorporated at 
position 386.  It was constructed by amplifying traF using primers TraF_NT_His_FWD_NcoI 
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and N386_RVS_FLAG_XhoI with pKM101 as a template.  This PCR product was digested 
with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.    
Plasmid pJG214 expresses PBAD::traF-CT_FLAG, producing TraF with a C-terminal FLAG 
tag. It was constructed by PCR amplification of traF using primers TraF_FWD_NcoI and 
TraF_CT_FLAG_RVS_XhoI and pKM101 as a template. The resulting PCR fragment was 
digested with NcoI and XhoI and ligated into an NcoI/SalI digested pBAD24Spc.  
Plasmid pJG204 expresses PBAD::traF-A2amber producing TraF with pBpa incorporated at 
position 2.  It was constructed using inverse PCR using primers 2_amber_Inv_FWD and 
2_amber_Inv_RVS with pJG214 as a template. 
Plasmid pJG205 expresses PBAD::traF-V6amber producing TraF with pBpa incorporated at 
position 6.  It was constructed using inverse PCR using primers 6_amber_Inv_FWD and 
6_amber_Inv_RVS with pJG214 as a template. 
Plasmid pJG206 expresses PBAD::traF-E11amber producing TraF with pBpa incorporated at 
position 11.  It was constructed using inverse PCR using primers 11_amber_Inv_FWD and 
11_amber_Inv_RVS with pJG214 as a template. 
Plasmid pJG207 expresses PBAD::traF-T16amber producing TraF with pBpa incorporated at 
position 16.  It was constructed using inverse PCR using primers 16_amber_Inv_FWD and 
16_amber_Inv_RVS with pJG214 as a template. 
Plasmid pJG208 expresses PBAD::traF-S23amber producing TraF with pBpa incorporated at 
position 23.  It was constructed using inverse PCR using primers 23_amber_Inv_FWD and 
23_amber_Inv_RVS with pJG214 as a template. 
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Plasmid pJG209 expresses PBAD::traF-G27amber producing TraF with pBpa incorporated at 
position 27.  It was constructed using inverse PCR using primers 27_amber_Inv_FWD and 
27_amber_Inv_RVS with pJG214 as a template. 
Plasmid pJG210 expresses PBAD::traF-N32amber producing TraF with pBpa incorporated at 
position 32.  It was constructed using inverse PCR using primers 32_amber_Inv_FWD and 
32_amber_Inv_RVS with pJG214 as a template. 
Plasmid pJG211 expresses PBAD::traF-V43amber producing TraF with pBpa incorporated at 
position 43.  It was constructed using inverse PCR using primers 43_amber_Inv_FWD and 
43_amber_Inv_RVS with pJG214 as a template. 
Plasmid pJG212 expresses PBAD::traF-L45amber producing TraF with pBpa incorporated at 
position 45.  It was constructed using inverse PCR using primers 45_amber_Inv_FWD and 
45_amber_Inv_RVS with pJG214 as a template. 
Plasmid pJG213 expresses PBAD::traF-L49amber producing TraF with pBpa incorporated at 
position 49.  It was constructed using inverse PCR using primers 49_amber_Inv_FWD and 
49_amber_Inv_RVS with pJG214 as a template. 
 
Construction of A. tumefaciens plasmids 
Plasmid pJG1 expresses Plac::virB10-G269R encoding VirB10 with a G269R mutation.  It was 
constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and G269R_RVS 
and codons 270-377 using primers G269R_FWD and B10_RVS_XhoI with pKVD10 as a 
template.  These two fragments were joined together via overlapping PCR and the resulting 
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
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Plasmid pJG2 expresses Plac::virB10-G269K encoding VirB10 with a G269K mutation.  It was 
constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and G269K_RVS 
and codons 270-377 using primers G269K_FWD and B10_RVS_XhoI with pKVD10 as a 
template.  These two fragments were joined together via overlapping PCR and the resulting 
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG3 expresses Plac::virB10-G269W encoding VirB10 with a G269W mutation.  It 
was constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and 
G269W_RVS and codons 270-377 using primers G269W_FWD and B10_RVS_XhoI with 
pKVD10 as a template.  These two fragments were joined together via overlapping PCR and 
the resulting PCR product was cloned into NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG4 expresses Plac::virB10-G269C encoding VirB10 with a G269C mutation.  It was 
constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and G269C_RVS 
and codons 270-377 using primers G269C_FWD and B10_RVS_XhoI with pKVD10 as a 
template.  These two fragments were joined together via overlapping PCR and the resulting 
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG5 expresses Plac::virB10-G269D encoding VirB10 with a G269D mutation.  It was 
constructed by amplifying codons 1-268 using primers VirB10_FWD_NdeI and G269D_RVS 
and codons 270-377 using primers G269D_FWD and B10_RVS_XhoI with pKVD10 as a 
template.  These two fragments were joined together via overlapping PCR and the resulting 
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG6 expresses Plac::virB10-G272R encoding VirB10 with a G272R mutation.  It was 
constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and G272R_RVS 
and codons 273-377 using primers G272R_FWD and B10_RVS_XhoI with pKVD10 as a 
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template.  These two fragments were joined together via overlapping PCR and the resulting 
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.    
Plasmid pJG7 expresses Plac::virB10-G272K encoding VirB10 with a G272K mutation.  It was 
constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and G272K_RVS 
and codons 273-377 using primers G272K_FWD and B10_RVS_XhoI with pKVD10 as a 
template.  These two fragments were joined together via overlapping PCR and the resulting 
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG8 expresses Plac::virB10-G272W encoding VirB10 with a G272W mutation.  It 
was constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and 
G272W_RVS and codons 273-377 using primers G272W_FWD and B10_RVS_XhoI with 
pKVD10 as a template.  These two fragments were joined together via overlapping PCR and 
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG9 expresses Plac::virB10-G272C encoding VirB10 with a G272C mutation.  It was 
constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and G272C_RVS 
and codons 273-377 using primers G272C_FWD and B10_RVS_XhoI with pKVD10 as a 
template.  These two fragments were joined together via overlapping PCR and the resulting 
PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG10 expresses Plac::virB10-G272D encoding VirB10 with a G272D mutation.  It 
was constructed by amplifying codons 1-271 using primers VirB10_FWD_NdeI and 
G272D_RVS and codons 273-377 using primers G272D_FWD and B10_RVS_XhoI with 
pKVD10 as a template.  These two fragments were joined together via overlapping PCR and 
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
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Plasmid pJG11 expresses Plac::virB10-G275R encoding VirB10 with a G275R mutation.  It 
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and 
G275R_RVS and codons 276-377 using primers G275R_FWD and B10_RVS_XhoI with 
pKVD10 as a template.  These two fragments were joined together via overlapping PCR and 
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG12 expresses Plac::virB10-G275K encoding VirB10 with a G275K mutation.  It 
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and 
G275K_RVS and codons 276-377 using primers G275K_FWD and B10_RVS_XhoI with 
pKVD10 as a template.  These two fragments were joined together via overlapping PCR and 
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG13 expresses Plac::virB10-G275R encoding VirB10 with a G275W mutation.  It 
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and 
G275W_RVS and codons 276-377 using primers G275W_FWD and B10_RVS_XhoI with 
pKVD10 as a template.  These two fragments were joined together via overlapping PCR and 
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pJG14 expresses Plac::virB10-G275C encoding VirB10 with a G275C mutation.  It 
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and 
G275C_RVS and codons 276-377 using primers G275C_FWD and B10_RVS_XhoI with 
pKVD10 as a template.  These two fragments were joined together via overlapping PCR and 
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.    
Plasmid pJG15 expresses Plac::virB10-G275D encoding VirB10 with a G275D mutation.  It 
was constructed by amplifying codons 1-274 using primers VirB10_FWD_NdeI and 
G275D_RVS and codons 276-377 using primers G275D_FWD and B10_RVS_XhoI with 
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pKVD10 as a template.  These two fragments were joined together via overlapping PCR and 
the resulting PCR product was cloned into a NdeI/XhoI digested pKVD10 vector.   
Plasmid pSJ501 expresses Plac::virB10-TraF_AP encoding VirB10 containing the AP of TraF.  
It was constructed through PCR amplification of virB10 codons 1-287 with primers 
VirB10_FWD_NdeI and B10_288_RVS_TraF and codons 339-377 with primers 
B10_339_FWD_TraF and B10_RVS_XhoI with pKVD10 as a template.  Codons 307-335 of 
traF were amplified using primers TraF_307_FWD_B10 and TraF_335_RVS_B10 with 
pKM101 as a template.  These three fragments were joined together using overlapping PCR 
and and the resulting PCR fragment was digested with NdeI and XhoI and ligated into an 
NdeI/XhoI digested pKVD10 vector.   
Plasmid pSJ502 expresses Plac::virB10-TraF_AP-CT encoding VirB10 containing the AP and 
C-terminal tail of TraF.  It was constructed through PCR amplification of virB10 codons 1-287 
with primers VirB10_FWD_NdeI and B10_288_RVS_TraF with pKVD10 as a template and 
traF codons 307-386 with primers TraF_307_FWD_B10 and TraF_RVS_XhoI.  These 
fragments were joined together with overlapping PCR and the resulting PCR fragment was 
digested with NdeI and XhoI and ligated into an NdeI/XhoI digested pKVD10 vector.   
Plasmid pSJ503 contains a 3x FLAG sequence cloned into a pZZ11 plasmid.  It was 
constructed by annealing primers 3xFLAG_Sense_NcoI_NdeI_XhoI_BamHI and 
3xFLAG_Antisense_NcoI_NdeI_XhoI_BamHI followed by digestion with NcoI and XhoI and 
ligating into an NcoI/XhoI digested pZZ11 plasmid.    
Plasmid pSJ504 expresses Plac::virB10-∆AP encoding VirB10 with an AP deletion (residues 
288-337).  It was constructed through inverse PCR with primers B10_AP_Del_FWD and 
B10_AP_Del_RVS with pKVD10 as a template.   
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Plasmid pSJ510 expresses Plac::virB10-298.SphI encoding VirB10 with an Ala-Cys insertion 
at position 298.  It was constructed through inverse PCR with primers B10_298_SphI_FWD 
and B10_298_SphI_RVS with pKVD10 as a template.   
Plasmid pSJ511 expresses Plac::virB10-329.SphI encoding VirB10 with an Ala-Cys insertion 
at position 329.  It was constructed through inverse PCR with primers B10_329_SphI_FWD 
and B10_329_SphI_RVS with pKVD10 as a template.   
Plasmid pSJ512 expresses Plac::virB10-332.SphI encoding VirB10 with an Ala-Cys insertion 
at position 332.  It was constructed through inverse PCR with primers B10_332_SphI_FWD 
and B10_329_SphI_RVS with pKVD10 as a template.   
Plasmid pJG40 expresses Plac::virB10-298.3xFLAG encoding VirB10 with a 3x FLAG 
insertion at position 298.  It was constructed by amplifying the 3x FLAG sequence using 
primers 3xFLAG_FWD_SphI and 3xFLAG_RVS_SphI with pSJ503 as a template.  The 
resulting PCR product was digested with SphI and ligated into an SphI digested pSJ510 
plasmid.   
Plasmid pJG42 expresses Plac::virB10-329.3xFLAG encoding VirB10 with a 3x FLAG 
insertion at position 329.  It was constructed by amplifying the 3x FLAG sequence using 
primers 3xFLAG_FWD_SphI and 3xFLAG_RVS_SphI with pSJ503 as a template.  The 
resulting PCR product was digested with SphI and ligated into an SphI digested pSJ511 
plasmid.   
Plasmid pJG44 expresses Plac::virB10-332.3xFLAG encoding VirB10 with a 3x FLAG 
insertion at position 332.  It was constructed by amplifying the 3x FLAG sequence using 
primers 3xFLAG_FWD_SphI and 3xFLAG_RVS_SphI with pSJ503 as a template.  The 
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resulting PCR product was digested with SphI and ligated into an SphI digested pSJ512 
plasmid.   
Plasmid pJG52 expresses Plac::virB10-310.2xFLAG encoding VirB10 with a 2x FLAG 
insertion at position 310.  It was constructed by amplifying codons 1-309 using primers 
VirB10_FWD_NdeI and virB10_310_2xFLAG_RVS and codons 311-377 using primers 
virB10_310_2xFLAG_FWD and B10_RVS_XhoI with pKVD10 as a template.  These two 
fragments were joined together via overlapping PCR and the resulting PCR product was 
digested with NdeI and XhoI and ligated into an NdeI/XhoI digested pKVD10 vector.   
 
Conjugation assays 
Donor and recipient cells were inoculated from glycerol stocks into 2 ml of LB 
containing antibiotics and grown overnight at 37°C with shaking. Cells were diluted 1:100 in 
antibiotic-free media and incubated for 1 h with shaking at 37°C. For induction from the PBAD 
promoter, arabinose was added (0.2 % final concentration) followed by incubation for 1 h with 
shaking at 37°C. Donors and recipients (2.5 µl) were mixed on a nitrocellulose filter on LB 
media containing 0.2% arabinose and the mating mix was incubated for 2 h at 37°C. For broth 
matings, induced donors were mixed with recipients at a 1:1 volumetric ratio and incubated at 
37°C for 2 h. Filter and broth mating mixtures were serially diluted and plated on media 
selective for transconjugants and donors. Frequency of transfer was calculated as the number of 
transconjugants per donor (Tcs/D). Experiments were performed at least three times in duplicate 
or triplicate, and results are reported as the mean frequency of transfer. 
 
 
 95 
Phage infection assays 
Strains carrying plasmids of interest were grown and, when necessary, induced with 
arabinose as described above for the conjugation assays. Fifty microliters of cells at a 
concentration of ~108 ml-1 were spread on an LB plate containing appropriate antibiotics and 
arabinose, and allowed to dry. Five microliters of the bacteriophages PRD1 (106 pfu, final 
concentration) or IKe (108 pfu, final concentration) were spotted onto the lawns of cells, and 
plates were incubated overnight at 37°C. Sensitivity to PRD1 and IKe was quantified in a plaque 
assay, as described previously (45). Briefly, cells were grown and induced with 0.2% arabinose. 
Approximately 107 cells were incubated with a series of 10-fold dilutions of PRD1 or IKe for 20 
min at room temperature. The mix was added to 5 ml of 0.4% melted LB agar, which was then 
overlaid on a 1.5% LB agar plate containing antibiotics and arabinose. Plates were incubated at 
37°C overnight, and phage sensitivity was reported as the concentration of phage in plaque 
forming units (pfu)/ml. 
 
Steady state level detection 
E. coli strains were grown and induced for production of TraF variants of interest in LB 
media, harvested, and normalized to equivalent optical densities (OD600). Total protein extracts 
were subjected to SDS-PAGE, proteins were transferred to nitrocellulose membranes, and blots 
were developed with primary antibodies and HRP-conjugated secondary antibodies for 
detection of the TraF proteins by chemiluminescence. 
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Pseudomonas aeruginosa type VI killing assay 
T4SS-mediated killing of E. coli by the Pseudomonas aeruginosa type VI secretion 
system (T6SS) was carried out as previously described (140). Briefly, 2 ml of E. coli DH5α 
donors and a P. aeruginosa PAO1 retS mutant were incubated overnight with shaking at 37°C, 
then resuspended in 2 ml of antibiotic-free LB followed by a 1:100 dilution in 5 ml of 
antibiotic-free LB. Cells were then incubated with shaking at 37°C for 2 h, pelleted and 
resuspended in 100 µl LB. P. aeruginosa (17 µl) were mixed with E. coli (3µl) on filters placed 
on LB plates and incubated for 3 h at 37°C. Cells were resuspended in 1 ml of LB and serial 
dilutions were spotted onto plates containing spectinomycin 300 µg/ml and rifampicin 100 
µg/ml to select for growth of E. coli. T6SS killing of E. coli is presented as E. coli cell viability 
in colony forming units (CFU) per ml. 
 
pBpa incorporation and UV crosslinking 
Site-directed photocrosslinking of pBpa-incorporated TraF variants was carried as 
described previously (151).  Briefly, E. coli TOP10 cells containing the amber mutant of 
interest and the pEVOL plasmid were grown overnight at 37ºC with shaking in the presence of 
antibiotics.  The next day, cells were diluted 1:20 into fresh LB containing antibiotics and 
grown at 37ºC to an OD600 between 0.6 and 0.9.  The cells were then concentrated 20-fold in 
antibiotic-free LB containing 0.2% arabinose and 1mM pBpa.  The cells were incubated at 37ºC 
with shaking for 1 hour.  When testing for interactions between TraF and other proteins, cells 
were resuspended in PBS and exposed to UV light at 365nm for 10 minutes, while incubated on 
ice in the dark.  Cells were spun down and stored at -80ºC until further processing. 
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Membrane solubilization and TraF purification 
Cells frozen at -80ºC were thawed and resuspended in TE buffer (Tris-HCl pH8.0, 1mM 
EDTA pH 8.0).  Cells were next lysed with a bead beater homogenizer.  Beads and unbroken 
cells were spun out at 13,000 RPM for 30 minutes at 4ºC.  The whole cell lysate was spun down 
at ~200,000 x g  for 1 hour.  The membrane pellet was resuspended in solubilization buffer 
(100 mM Tris-HCl pH 8.0, 300 mM NaCl, 1mM EDTA, 2% Triton-X 100) and incubated at 
4ºC for 2 hours with gentle shaking.  Samples were spun again at 200,000 x g for 1 hour to 
remove insoluble material.  The supernatant was incubated with 20 l of pre-equilibrated α-
FLAG magnetic beads (Sigma) overnight at 4ºC with gentle shaking.  Magnetic beads were 
washed 3 times with 1ml of solubilization buffer per wash.  α-FLAG magnetic beads were 
incubated with 3xFLAG peptide (Sigma) at a concentration of 200 g/ml at 4ºC for 1 hour to 
elute TraF off of the beads.  The beads were removed from the supernatant, mixed with 2x 
Laemmli’s buffer, and run on an SDS-PAGE gel followed by Western blotting.   
 
T-DNA transfer assays 
 A. tumefaciens cells were streaked onto MG/L plates containing the appropriate 
antibiotics and grown from 2-3 days at 28ºC.  Leaves from Kalanchoe daigremontiana were 
wounded with a sterile toothpick followed by an inoculation of A. tumefaciens cells from the 
MG/L plate into the wound.  Following inoculation, wounded Kalanchoe daigremontiana were 
incubated at room temperature in the dark for 5-7 days followed by incubation in light for 1-2 
months.  Plant tumors were scored based on their size relative to tumors formed by the wild-
type A348 strain.   
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Colony immunoblot (Agrobacterium tumefaciens) 
 Colony immunoblots were used to detect the presence of VirB2 on the cell surface.  A. 
tumefaciens were streaked onto MG/L plates and incubated at 28ºC for 2-3 days.  Following 
growth on agar plates, colonies were inoculated into 2 ml of MG/L broth containing appropriate 
antibiotics and grown overnight at room temperature (~25ºC).  The next day, cells were spun 
down and resuspended in 2.5 ml ABIM broth containing 100 M acetosyringone followed by 
incubation at room temperature for 24 hours.  Cells were spotted on ABIM agar and incubated 
at 18ºC for four days.  Cells were then blotted onto nitrocellulose membranes for 30 minutes.  
Membranes were then incubated in 5% non-fat dry milk for 20 minutes in order to block the 
membrane as well as wash off excess cells.  Cells were then incubated with primary α-VirB2 
antibodies followed by secondary antibodies and development with chemiluminescence 
reagents.   
 
Colony immunoblot (Escherichia coli) 
 E. coli cells were inoculated from glycerol stocks into 2 ml LB broth containing 
antibiotics and incubated overnight at 37ºC with agitation.  The next day, cells were subcultured 
1:100 into fresh LB without antibiotics.  These cells were incubated at 37ºC with agitation for 
2.5 hours.  Nitrocellulose was placed on a fresh LB plate without antibiotics and 5 l of each 
subculture was added to the nitrocellulose and incubated at 37ºC for 2 hours.  Afterwards, 
nitrocellulose membranes were blocked in 5% non-fat dry milk for 20 minutes.  Membranes 
were then incubated with α-FLAG primary antibodies followed by secondary antibodies and 
development with chemiluminescence reagents.    
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Chapter 3: Contributions of the VirB10 GxxGxxG 
Motif and Antenna Projection in T-DNA Transfer and 
Pilus Biogenesis  
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Introduction 
 The Agrobacterium tumefaciens VirB/VirD4 type IV secretion system (T4SS) is 
assembled from 11 VirB proteins and the VirD4 substrate receptor, also termed the type IV 
coupling protein (T4CP) (5).  A. tumefaciens uses this T4SS to deliver oncogenic T-DNA and 
effector proteins to plant cells.  Previous analyses established that all of the VirB proteins except 
VirB1 are essential for delivery of T-DNA and effector proteins to plants and for mobilization of 
an RSF1010 plasmid substrate to A. tumefaciens recipient cells (67).  The VirB/VirD4 T4SS is 
similar to the Escherichia coli pKM101-encoded Tra conjugation system in terms of its transfer 
loci and subunit composition (152).  A structure of the pKM101 outer membrane “core complex” 
was solved by the Waksman laboratory by cryo-electron microscopy, and a portion of this 
complex (the O-layer) also was solved by X-ray crystallography (82,90).  The core complex is 
predicted to extend from the periplasmic face of the inner membrane across the periplasm to the 
cell exterior. It consists of 14 copies each of the VirB7-like TraN, VirB9-like TraO and VirB10-
like TraF subunits arranged in a ~1 MDa barrel-shaped structure. In the X-ray structure, TraF 
lines the inner chamber of the translocation channel, TraO comprises the outer wall, and TraN 
anchors the subassembly to the outer membrane (Figure 1.10).   
 In collaboration with Dr. Lois Banta, the Christie lab identified and characterized a 
mutation in VirB10 at position 272 (G272R) that conferred non-specific release of the secretion 
substrate VirE2 to the cell exterior (125).  This mutation had no effect on intercellular 
transmission of T-DNA or effector proteins, but completely blocked biogenesis of the T-pilus 
(125).  In the crystal structure of the TrapKM101 O-layer, the corresponding Gly residues in TraF 
line the interior chamber of core complex near the OM-spanning cap domain.  G272 is one of 
three highly conserved Gly residues arrayed as a GxxGxxG motif among VirB10 homologs 
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(Figures 3.1 and 3.2) (125). Results of the G272R mutational analyses led to a prediction that 
these conserved Gly residues might mark the site of a gate within the core complex chamber that 
controls substrate release as well as extension of the T pilus across the OM.  In agreement with 
this proposal, the Christie lab provided evidence that the G272R mutation locks VirB10 in an 
activated conformation required for substrate transfer that is achieved in wild-type cells only 
when DNA substrates are docked with the VirD4 receptor and when both VirD4 and VirB11 are 
competent for hydrolysis of ATP (107,125). When I joined the Christie laboratory, I decided to 
further define the importance of the GxxGxxG motif in regulating substrate transfer and pilus 
biogenesis.  
The crystal structure of the pKM101 core complex also shows that the conserved 
GxxGxxG motif is located near the antennae projection (AP) of TraF, which as mentioned in 
Chapter 1, assembles as a putative OM-spanning cap domain.  As part of a mutational analysis of 
VirB10At, the Christie lab had shown that a “deletion” of the AP attenuated DNA transfer, but 
blocked detectable pilus biogenesis (127).  However, the assignment of this AP domain was 
based on a previous X-ray structure of the ComB10 subunit associated with the ComB DNA-
uptake T4SS in Helicobacter pylori (111).  With the availability of an X-ray structure of the O-
layer of the TrapKM101 T4SS, we reassigned VirB10’s AP domain boundaries and I also evaluated 
the contributions of the AP to T-DNA transfer and pilus assembly in A. tumefaciens.    
The goals of my studies in A. tumefaciens, therefore, were to further define the 
contributions of VirB10’s conserved GxxGxxG motif and the AP domain to elaboration of the 
translocation channel and the T pilus.   In the course of my studies, through a collaboration with 
Dr. Gabriel Waksman’s laboratory, we also succeeded in purifying the core complex from the A. 
tumefaciens VirB/VirD4 T4SS and solving its structure by negative-staining transmission  
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Figure 3.1 Alignment of VirB10 and homologs.  VirB10 along with its homologs from 
plasmid pKM101 (TraF), plasmid R388 (TrwE) and the Bordetella pertussis Ptl T4SS (PtlG).  
Sequences were aligned with Multalin (http://multalin.toulouse.inra.fr/multalin); "Multiple 
sequence alignment with hierarchical clustering" F. Corpet, 1988, Nucl. Acids Res., 16 (22), 
10881-10890)and recreated for the AP and C-terminal regions.  Regions of interest, including 
the GxxGxxG motif and AP α2 and α3 helices, are highlighted above the sequence and were 
annotated based on the structure and sequence of TraF.   
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Figure 3.2 Location of the conserved GxxGxxG motif. (A) Structural model of the C-
terminal half of VirB10, derived from the TraF structure within the pKM101 O-layer X-ray 
structure using the Pymol algorithm (http://pymol.org).   The location of the G269 (Green), 
G272 (Red), and G275 (Yellow) residues at the base of the helix-loop-helix AP domain 
(Blue) are shown. (B) Top-down view of the core complex with the position of G275 circled 
in yellow.  (C) Cut-away view of the core complex O-layer highlighting the position of G727 
circled in red.  (D) Side view depicting the positions of G269 and G275 circled in green and 
yellow, respectively.  The structure of the core complex O-layer was generated using Pymol 
(http://pymol.org) based on the 3ZBI file deposited into the NCBI protein database. 
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electron microscopy at a resolution of 21Å.  Results of these studies, coupled with additional 
experiments focusing on the TrapKM101 system (see next chapters), underscored the structural and 
functional conservation of core complexes associated with the type IVa secretion systems.    
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Results 
Mutations in G269 and G272 attenuate T-DNA transfer into plant cells   
To evaluate the functional importance of the conserved GxxGxxG motif located between 
residues 269 and 275 of VirB10, I substituted each of the Gly residues with amino acids varying 
in sized or charge: Arg or Lys (positively-charged), Asp (negatively-charged), Trp (bulky 
aromatic), Cys (neutral, potentially useful for crosslinking studies) (Figure 3.3). Plasmids 
expressing the virB10 mutant alleles were introduced into the virB10 mutant strain PC1010.  I 
next tested for the capacities of the mutant strains to deliver oncogenic T-DNA to plant cells.  
Interestingly, all strains delivered T-DNA to plants, as monitored by formation of tumors on 
infected plants (Figure 3.4). Strains expressing virB10 alleles bearing Gly275 substitutions 
generally incited robust tumor development, with the exception of virB10G275C, which 
supported only very attenuated tumor formation.  Strains expressing alleles with Gly269 or G272 
substitutions were avirulent (G269R), strongly attenuated in virulence (G269K/D, 
G272R//K/W/D), or moderately attenuated in virulence (G269W/C, G272C).  These Gly 
residues, which are more highly conserved than G275 among the VirB10 homologs, thus do not 
tolerate distinct types of substitutions. 
 I next evaluated the effects of Gly substitutions on assembly of the T pilus, whose 
production can be monitored using a colony immunoblot assay to detect extracellular VirB2 pilin 
(125,128).  Interestingly, Gly275 tolerated all substitutions without detectable effects on 
accumulation of surface-exposed VirB2 pilin.  By contrast, Arg substitutions of both Gly269 and 
Gly272 abolished detectable surface pilin, as did a Trp substitution of G272 (Figure 3.4).  These 
findings confirm and extend findings from the Christie lab by showing substitutions not only of 
positively-charged Arg, but also a bulky Trp residue at position 272 completely blocked pilus  
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Figure 3.3 Substitution of the conserved glycines.  Locations of the G269 G272, and 
G275 residues on a structural model of the C-terminal half of VirB10 (residues 151 – 
377) derived from TraF’s structure in the TrapKM101 O-layer X-ray structure (EMDB – 
5031) At left, amino acids substituted for each of the conserved Gly residues. The 
structure of TraF was generated using Pymol (http://pymol.org) based on the 3ZBI file 
deposited into the NCBI protein database.   
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Figure 3.4 Effects of glycine belt mutations on T-DNA transfer and pilus biogenesis. 
Histograms depicting the level of T-DNA transfer as relative tumor size on Kalanchoe 
daigremontiana leaves and surface-displayed VirB2 for each GxxGxxG mutant.  Each strain was 
placed on six separate leaves and tumors were scored compared to tumors formed by the wild-
type A348 strain.  Each strain was inoculated on six leaves and tumors were scored after 1 month 
incubation.  Tumor size on K. daigremontiana leaves were scaled from no detectable tumors (-) to 
tumors similar both in size and kinetics of appearance to tumors incited by wild-type A348 (+++).  
Tumors that were barely detectable were scored as one plus and tumors that were appreciably 
smaller than those incited by A348 as two pluses.  Surface-localized VirB2 was detected by 
colony immunostaining using α-VirB2 antibodies as previously described.   
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production while permitting at least a low level of substrate transfer to plant cells.   Other 
mutations in G272, as well as mutations in G269, conferred attenuated virulence, suggestive of 
perturbing effects on assembly of the translocation channel.  By contrast, the less-highly 
conserved G275 residue was more tolerant of the engineered substitutions. 
 
The VirB10 AP is essential for pilus production, but not for substrate transfer.  
The VirB10 AP helices are predicted to form the OM pore.  As mentioned in the 
introduction for this chapter, a previously-constructed VirB10 AP deletion mutation did not 
completely abolish the AP (127).  I deleted the VirB10 AP using boundaries based on the 
alignment with TraF within the TrapKM101 O-layer (90). This new mutant protein, VirB10ΔAP, 
supported T-DNA transfer but not pilus biogenesis.  The VirB10 AP, which is predicted to span 
the OM, is therefore critical for pilus polymerization but not for intercellular substrate transfer. 
 I next wanted to determine which regions of the AP contributed to pilus production. I 
inserted 3x FLAG tags into the 2 or 3 helices, which are predicted to span the OM, and a 2x 
FLAG tag into the flexible loop presumptively extending from the cell surface.  None of these 
epitope insertions blocked substrate transfer or pilus biogenesis despite the presence of many 
negatively-charged residues in the FLAG sequence (Figure 3.5).  The presence of an AP domain 
is critical for pilus biogenesis, but this motif is able to withstand sizable mutations without 
disruption of function.    
The AP domains of TraF and VirB10 share approximately 31% identity with no 
concentrated regions of homology.  We next tested whether the AP domains of TraF and VirB10 
were functionally exchangeable.  S. Jakubowski constructed two chimeras of TraF and VirB10:    
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Figure 3.5 Effects of AP FLAG tag insertion on T-DNA transfer and pilus biogenesis. (A) 
Depiction of the VirB10 C-terminal half along with 2x and 3x FLAG insertions. (B) Western blot 
depicting the steady state levels of the VirB10 AP mutants.  Cells numbers were normalized based on 
OD600 readings and cell lysates were run on an SDS-PAGE gel followed by Western blotting with α-
VirB10 antibodies. (C) Surface detection of VirB2 pilin subunits using colony immunoblotting.  
Colonies were grown on acidic ABIM inducing agar for four days at 18°C followed by detection of 
pilin subunits on the cell surface with α-VirB2 antibodies.  (D)  Histogram depicting the levels of T-
DNA transfer for each of the AP mutants into K. daigremontiana leaves.  Tumor size on K. 
daigremontiana leaves were scaled from no detectable tumors (-) to tumors similar both in size and 
kinetics of appearance to tumors incited by wild-type A348 (+++).  Tumors that were barely 
detectable were scored as one plus and tumors that were appreciably smaller than those incited by 
A348 as two pluses 
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(i) one containing an AP substitution (VirB10/APTraF) and (ii) the other including the C-terminal 
tail as well (VirB10/AP-CTTraF).  Similar to the other AP mutant proteins, VirB10/APTraF and 
VirB10/AP-CTTraF supported T-DNA transfer, establishing that the APs of these homologs were 
exchangeable.  However, only VirB10/APTraF supported pilus production, indicating that the C-
terminal tail is important for production of an extracellular pilus (Figure 3.5).    
 
The structure of the A. tumefaciens VirB core complex resembles those of pKM101 and 
R388.   
The VirB/VirD4At, TrapKM101, and TrwR388 T4SSs are similar in gene arrangements and 
subunit compositions.  Structures of the OMCC subassemblies from the TrapKM101 and TrwR388 
have been solved by cryo-electron microscopy or negative-staining electron microscopy 
(82,84,90).  Both of these structures are highly similar, suggesting the possibility that OMCCs 
associated with the type IVa T4SSs are highly conserved in overall architecture and function.  To 
evaluate this idea further, we collaborated with the Waksman laboratory to obtain a structure of 
the OMCC from the A. tumefaciens VirB/VirD4 T4SS.  We inserted a Strep-tag sequence at the 
end of virB10 carried on the pTi plasmid, and were able to confirm that subassemblies enriched 
from the corresponding A. tumefaciens strain (A348.B10ST) by detergent solubilization and 
Strep-tag affinity pull-down assays yielded ring-shaped complexes that were similar in 
appearance to the pKM101 and R388 OMCCs, as determined by negative-staining EM.  We sent 
this strain to the Waksman laboratory where the VirB/VirD4 OMCC was further purified and 
structurally resolved at 21Å resolution using negative staining electron microscopy.  Similar to 
the pKM101 OMCC, the VirB complex can be divided into an inner layer (I-layer) and an outer 
layer (O-layer).  The dimensions of the VirB complex are similar to the TrapKM101, and TrwR388 
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OMCCs (Figure 3.6).  However, the VirBAt structure is more cylindrical than its TrapKM101 and 
TrwR388 OMCC counterparts and contains a broad pore-forming cup domain at the cell surface.  
The significance of these differences is not understood at this time.  Future studies on the VirBAt 
core complex producing higher resolution images are required to better define the functional 
significance of any structural differences observed among the core complexes solved to date.   
 At this time, however, the findings strongly support a proposal that the OMCCs of the 
type IVa T4SSs employed by Gram-negative bacterial species share a common structural 
arrangement, function, and ancestry.  
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Figure 3.6 Structure of the A. tumefaciens VirB core complex. Negative-stain EM structure of 
the A. tumefaciens outer-membrane core complex (OMCC) and comparison with the NS-EM 
structure of the OMCC (EMDB-5032) encoded by E.coli pKM101.  A) A. tumefaciens OMCC 
side view (left) and cut-away side view (right).  B) E.coli pKM101 OMCC side view (left) and 
cut-away side view (right).  C) Representation of the cut-away side view of the overlay of A. 
tumefaciens and E.coli pKM101 OMCC’s. D) Cross-section of overlaid A. tumefaciens and E.coli 
pKM101 OMCC complexes. Dashed line S in panel C indicates the level of the cross section 
shown in panel D.  
 
This figure was modified from Figure 6 in Gordon et al. Use of chimeric type IV secretion 
systems to define contributions of outer membrane subassemblies for contact-dependent 
translocation Molecular Microbiology 2017 doi: 10.1111/mmi.13700.  It was re-published with 
permission from John Wiley and Sons Publishing Group. License # 4113880880825 
 
 
 118 
   
 119 
Discussion 
Previous studies in the Christie lab identified unique phenotypes associated with 
mutations in the VirB10 GxxGxxG motif and AP domain (125,127).  Both a G272R and AP 
partial deletion blocked pilus biogenesis, but still allowed for detectable T-DNA transfer into 
plant cells.  When I joined the Christie lab, I decided to further define the role of G272 and the 
surrounding G269 and G275 residues through a series of mutations substituting at each position  
amino acids of different sizes and charges.  Additionally, I intended to further define the role of 
the AP helices through re-construction of another AP deletion as well as FLAG tag insertions.  
Below, I will discuss my findings in greater detail and propose a model for their role in pilus 
biogenesis and T-DNA transfer.   
Mutations at G269 and G272 had the most detrimental effect on T-DNA transfer. In 
contrast, most mutations at G275 were generally phenotypically silent.  G269 and G272 are 
located on the side and inner wall of the chamber, respectively where as G275 is predicted to be 
situated on the outside of the -barrel possibly in juxtaposition with VirB9 (Figure 3.7).  Based 
on these structural findings, I predicted that G269 and G272 might mark a critical interface of the 
OMCC and the translocation channel housed within this structural scaffold.    
 With respect to the AP, we had previously attempted to define the role of the VirB10 AP 
through construction of an AP deletion (127).  The deletion was based on an alignment of 
VirB10 with H. pylori ComB10.  However, in view of the new X-ray structure of the pKM101 
O-layer, we reassigned the boundaries of APs of TraF and VirB10, the latter through sequence 
alignments and Phyre 2 modeling. I made a new deletion of the AP and re-tested it for its ability 
to restore T-DNA transfer and pilus biogenesis to the a ∆virB10 strain.  This mutant phenocopied  
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 Figure 3.7 Summary of phenotypes associate with GxxGxxG motif.  Depiction of 
three phenotypes observed during characterization of the GxxGxxG motif.  (A) G275W 
and G275D mutations, located on the outer face of the O-layer, were silent in terms of 
T-DNA transfer and pilus biogenesis.  (B) Uncoupling mutations at positions at G272, 
located in the channel lumen, allowed for attenuated T-DNA transfer, but blocked 
detectable pilus biogenesis.  (C) A mutation of G269, positioned on the outside of the 
core complex, to an Arg residue block both T-DNA transfer and pilus biogenesis.   
 
The structure of the core complex O-layer was generated using Pymol (http://pymol.org) 
based on the 3ZBI file deposited into the NCBI protein database. 
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the previous AP mutant with respect to substrate transfer but completely abolished our ability 
to detect VirB2 pilin on the cell surface.   
 
Models depicting the contributions of the GxxGxxG and the AP domain for pilus 
biogenesis. 
My data are consistent with two models for pilus biogenesis.  In both models, upon 
synthesis, VirB2 pilin subunits are delivered into the inner membrane where they are cleaved of 
their signal sequences and covalently cyclized by a head-to-tail reaction.  Upon receipt of signals 
that presently are not specified, the pilins are extracted from the inner membrane pool via the 
ATPase activities of VirB4, together with contributions by VirB11. 
Model 1: Outer membrane nucleation.  The membrane-extracted VirB2 pilin subunits are 
delivered into the core complex channel where they transit to the distal region of the OMCC.  At 
the OMCC they interact with the AP either directly or via interaction with another subunit such 
as the pilus tip protein VirB5 (Figure 3.8).  The AP contacts then drive polymerization of the 
pilin monomers into the extended pilus.  According to this model, the AP plays a critical role in 
pilus biogenesis by dynamically interacting with pilin monomers to direct their self-assembly 
into the pilus.  The G269 and G272 substitutions, which are positioned within the interior of the 
OMCC chamber, might block pilus biogenesis through steric effects impeding delivery of the 
pilins to the AP or, by interfering with formation of AP–pilin subunit contacts.  Mutations at 
G275, which interestingly map on the outer face of the -barrel, do not affect pilus biogenesis.  
Model 2: Inner membrane platform model. Pilin subunits nucleate as the growing pilus 
from an inner membrane platform possibly consisting of VirB6 and VirB8.  The pilus extends to 
the distal end of the OMCC where it is blocked from further extension by the AP domain of  
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 Figure 3.8 Models for pilus biogenesis in A. tumefaciens.  Depiction of two models 
for pilus biogenesis.  (A) In Model 1, the VirB2 pilin subunit enters the OMCC chamber 
after being dislodged from the IM.  VirB5 will then exit the cell and make contact with 
the AP helices, triggering the release of VirB2 from the channel.  The AP will then serve 
as an OM platform during pilus polymerization.  (B) Model 2 states that VirB2 pilin 
subunits enter the channel in the IM.  Once extracellular VirB5 comes into contact with 
the AP, the AP will allow for the passage of pilin subunits through the channel and 
outside of the cell.  
 
The core complex was modified from Figure 6 in Gordon et al. Use of chimeric type IV 
secretion systems to define contributions of outer membrane subassemblies for contact-
dependent translocation Molecular Microbiology 2017 doi: 10.1111/mmi.13700.  It was 
re-published with permission from John Wiley and Sons Publishing Group. License # 
4113880880825 
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VirB10 (Figure 3.8).  Dr. Christian Gonzalez-Rivera has shown that the VirB5 homolog, 
TraCpKM101, is secreted outside of the cell in the absence of a T4SS.  We postulate that these pilus 
tip proteins form contacts with the AP on the cell surface and with the tip of the pilus, and that 
these contacts cause a conformational change in the AP to allow for pilus extraction.  
At this time, it is not possible to discriminate between these models.  However, my 
further studies of the pKM101 Tra T4SS further establish the compositional and structural 
flexibility of the OMCC for substrate transfer, as well as the importance of the OMCC cap for 
pilus biogenesis.    
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Chapter 4: Genetic Requirements for Plasmid Transfer 
and Phage Sensitivity Through the pKM101-encoded 
Type IV Secretion System 
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Introduction 
Gram-negative bacterial T4SSs are comprised of a core set of subunits that are required 
for substrate translocation and pilus biogenesis.  The Christie laboratory has been characterizing 
structure and function relationships of the VirB/VirD4 T4SS from A. tumefaciens for over 25 
years. As mentioned in the Introduction, this T4SS is assembled from the 11 VirB subunits and 
the VirD4 type IV coupling protein (T4CP) (Figure 4.1).  By construction of individual virB 
gene deletions, combined with appropriate complementation analyses, the Christie laboratory 
established that 10 of the 11 VirB subunits are required to build a functional translocation 
channel, whereas all 11 subunits are required to build the T-pilus (67).  The 11th gene, virB1, 
encodes a lytic transglycosylase whose deletion strongly diminishes T-DNA transfer to plants, 
but completely abolishes assembly of detectable pili.  Corresponding genetic analyses of the 
R388-encoded Trw T4SS and the RP4-encoded Tra/Trb T4SS similarly established the 
importance of the associated lytic transglycosylases for pilus biogenesis, as monitored by 
sensitivity to male-specific phage, but not for elaboration of functional translocation channels 
(45,123).  Surprisingly, in the TrwR388 system, the VirB7-like lipoprotein TrwH is not required 
for assembly of the translocation channel (123).  In A. tumefaciens, by contrast, VirB7 plays an 
essential role in stabilizing the outer membrane-associated subunit VirB9 through formation of 
an intermolecular disulfide bridge (118,120–122). 
The early construction of a complete set of virB gene deletions and complementing 
plasmids greatly facilitated studies of the A. tumefaciens VirB/VirD4 system in the Christie 
laboratory as well as many other laboratories devoted to studies of this system.  When I entered 
the laboratory, we were interested in incorporating studies of the E. coli pKM101-encoded  Tra 
T4SS (TrapKM101) in order to capitalize on the ease of genetic manipulation and growth of E. coli,  
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Figure 4.1 Structure of the operons encoding the VirB, Tra, and Trw T4SSs 
Operon arrangement of the A. tumefaciens VirB T4SS along with the operons 
encoding the pKM101 Tra and R388 Trw T4SSs.  Each of the homologs is depicted in 
identically colored arrows and the function of each of the proteins is indicated above 
the corresponding gene.   
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the availability of large numbers of E. coli mutant strains, and in vivo assays developed using this 
model organism for refined studies of this T4SS. I first sought to define the genetic requirements 
for TrapKM101 T4SS function by construction of a complete set of tra gene deletion mutations and 
a corresponding set of tra expression plasmids for complementation studies.   In fact, early 
studies by Winans and Walker (1985) had identified the tra gene cluster and provided evidence 
for the requirements of most of the tra genes through a Tn5 transposon mutational analysis 
(153).  However, these Tn insertions potentially have polar effects on downstream gene 
expression, preventing any firm conclusions regarding the essentiality of each tra gene.  
Construction of precise gene deletions, together with genetic complementation, would not only 
confirm the importance of each tra gene, but also provide a ‘molecular toolkit’ of strains and 
plasmids for our future studies.   
In this chapter, I developed a combination of genetic approaches including λ red 
recombineering and inverse PCR to create a pKM101 “molecular toolkit” (154).  This toolkit 
consists of non-polar deletions of each of the tra genes, as well as each tra gene expressed 
separately from the tightly-controlled PBAD promoter.  Among the most striking outcomes from 
these studies, I gained evidence that traL, which encodes a putative lytic transglycosylase, is 
completely dispensable for elaboration of a fully functional TrapKM101 transfer channel as well as 
the conjugative pilus.  Additionally, traC, which encodes a putative pilus tip protein, is also 
dispensable for elaboration of a functional transfer channel, but required for pilus production.  I 
discuss these findings in the context of available information for other T4SSs and additional data 
from the Christie laboratory suggesting that TraC coordinates with another, previously 
uncharacterized protein called KikA to promote donor-recipient cell contacts even in the absence 
of pilus production. 
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Results 
 
Complementation of tra Mutants in Filter Matings.  I deleted 8 of 11 tra genes from the 
pKM101 plasmid by recombineering.  I was not able to make deletions of traL, traN, and traO.  I 
characterized the phenotypes of the 8 tra gene mutations, and through further studies by 
Roosheel Patel, we were able to evaluate the contributions of the remaining tra genes to 
assembly and function of the TrapKM101 T4SS.   Most of the deletions abolished plasmid transfer 
(Figure 4.2).  Similar to previous reports from Winans and Walker, deletion of traC did not 
abolish plasmid transfer in solid-surface matings (153) (Figure 4.2). Complementation of each 
tra gene deletion with its respective native gene in trans from a PBAD promoter restored pKM101 
transfer.  (Figure 4.2).  Although most of the complementing tra genes restored transfer to levels 
similar to wild-type pKM101, complementation of IMC genes traA, traD, and traE only partially 
restored transfer (Figure 4.2).  These results demonstrate that each of the tra gene deletions is 
able to be complemented with the respective native gene in trans.  
 
Susceptibility of tra Mutants to PRD1 and IKe bacteriophages.  Donor-specific 
bacteriophages utilize the T4SS, and more specifically the conjugative pilus, as a point of entry 
into the cell.  Previous studies have sought to determine the genetic requirements for phage 
infection of host cells carrying pKM101 or other conjugative T4SSs.  Mutations in the tra and 
trb genes of pKM101 and RP4, respectively, confer resistance to PRD1 phage (45,153).  While 
PRD1 sensitivity was restored to RP4 trb mutants through complementation tests, no such 
experiments have been performed with pKM101 mutants.  All eight of the tra mutations on the 
native pKM101 abolished PRD1 and IKe uptake.   However, only the ∆traM, ∆traF, and ∆traG 
mutants exhibited phage sensitivity when the native gene was expressed in trans (Figure 4.3).   
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Figure 4.2 Genetic requirements for plasmid transfer through the pKM101 T4SS. 
Bar diagram of E. coli matings monitoring the transfer of native pKM101 and the 
deletion mutants both with and without the complementing plasmid. Black bars 
represent non-complemented mutants, gray bars represent mutants complemented in 
filter matings, and white bars represent mutants complemented in broth matings.  
Experiments were performed in triplicate and the histograms represent the average 
results with standard deviations. 
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Figure 4.3 Restoration of PRD1 and IKe sensitivity.  Bar diagram of E. coli 
infection assays monitoring uptake of PRD1 and IKe in complemented ΔtraM, ΔtraF, 
and ΔtraG mutants.  Sensitivity is measured as the number of plaque forming units/ml 
(PFU/ml). Black bars represent PRD1 infection while gray bars represent IKe 
infection. Experiments were performed in triplicate and the histograms represent the 
average results with standard deviations.   
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Lack of complementation of the other tra mutations is not easily explained, although it is 
possible that nonstoichiometric production of certain Tra proteins from the strong PBAD promoter 
might interfere with phage binding or uptake. 
 Taken together, these results demonstrate that production of an intact TrapKM101 T4SS is 
required for infection by the male-specific phages PRD1 and IKe.  
 
Complementation of tra mutants in broth matings 
  E. coli cells efficiently transfer the F plasmid to recipients in liquid culture.  This is due 
to the long, flexible pilus carried by F-plasmid-containing cells which is capable of attaching to 
recipient cells and retracting to form mating junctions (155,156).  Plasmids such as pKM101, 
R388, and RP4 encode short, rigid pili, which are not thought to undergo dynamic rounds of 
extension and retraction (155).  Therefore, cells containing these plasmids are not predicted to 
transfer DNA efficiently in broth.  
 Interestingly, however, I discovered that pKM101-containing donors are capable of 
transferring the plasmid in broth matings, albeit at levels 100-fold lower than on filters (Figure 
4.2).  The three complemented mutants, ∆traM, ∆traF, and ∆traG, exhibiting phage sensitivity 
also served as efficient plasmid donors in broth matings. Additionally, complemented ∆traC and 
∆traE mutants conjugatively transferred pKM101, although the ∆traE mutant was more 
attenuated than the others.  The capacity of cells to transfer in liquid generally correlated with 
their phage sensitivity profiles, although some strains resistant to phage uptake served as 
proficient donors in broth.   
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Complementation of tra mutants in mini-pKM101 
 As mentioned previously, we were unable to create deletions of traL, traN, and traO on 
native pKM101.  The ~10 kb region of pKM101 from the 3’ end of korB through the 3’ end of 
traG was cloned into pBAD33 to create pCGR100.  I tested its ability to deliver plasmid pJG142, 
which contains the oriT sequence as well as genes encoding the TraI relaxase, TraK accessory 
factor, and TraJ substrate receptor, which collectively are responsible for oriT processing and 
delivery of the plasmid substrate to the T4SS channel.  pCGR100 mediated transfer of pJG142 at 
levels 1,000-fold lower than native pKM101 (Figure 4.4).  Complementation of a ∆traO mutant 
restored plasmid transfer to pCGR100 levels where as the ∆traN mutant only had plasmid 
transfer partially restored (Figure 4.4).   The ∆traO and ∆traN mutant strains remained resistant 
to phage even when expressing the corresponding traO or traN genes were expressed in trans 
(data not shown).   
In previous studies, deletions of the cell wall hydrolases VirB1 and p19 associated with 
the VirB and F plasmid T4SSs, respectively, resulted in attenuated DNA transfer and loss of 
sensitivity to male-specific phages (67,157). Interestingly, however, deletion of traL from the 
pKM101 system had no detectable effect on plasmid transfer or phage susceptibility. 
Furthermore, complementation of a ∆traL mutant by expression of traL from the PBAD promoter 
enhanced plasmid transfer by ~100-fold (Figure 4.4).  I also observed a similar enhancement of 
plasmid transfer by donors carrying both the WT pKM101 and pCGR100 plasmids (Figure 4.5).   
These results confirm that TraN and TraO are essential for building a functional 
translocation channel, whereas the TraL hydrolase is completely dispensable.  However, cells 
that overproduce TraL might be capable of elaborating quantitatively more channels across the 
cell wall than traL mutants or even cells expressing traL at WT levels.    
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Figure 4.4 Plasmid transfer through the mini-pKM101.  Bar diagram of E. coli 
matings monitoring transfer of oriT-IJKpGB2 using either wild-type pCGR100 or 
deletion mutants with and without the complementing plasmid. Black bars represent 
non-complemented mutants, gray bars represent mutants complemented in filter 
matings, and white bars represent mutants complemented in broth matings. 
Experiments were performed in triplicate and the histograms represent the average 
results with standard deviations. 
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Figure 4.5 Enhancement of plasmid transfer through overexpression of traL 
Bar diagram of E. coli matings monitoring the transfer of native pKM101 and pJG142 
in the presence and absence of overproduced TraL.  Black bars indicate the absence of 
traL in trans while gray bars indicate the presence of overexpressed traL.  
Experiments were performed in triplicate and the histograms represent the average 
results with standard deviations.   
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Discussion 
 Here, I developed a pKM101 “molecular toolkit” for the addressing current and future 
questions related to T4SS structure and function.  I used complemented and uncomplemented 
pKM101 tra deletion mutants to identify the genetic requirements for construction of a 
functional machine.  My studies represented the first systematic effort, other than that carried out 
by the Christie lab for the A. tumefaciens VirB/VirD4 T4SS, to define the contributions of 
individual T4SS genes through construction of markerless deletions.  Below, I discuss my 
findings in comparison with previous analyses of other T4SSs. 
 Predictions about the genetic requirements for pKM101 were based on our previous 
studies in the VirB system.  Similar to those studies and others in R388 and RP4, pKM101 tra 
gene deletions abolished all activity as monitored by mating assays and sensitivity to PRD1 and 
IKe phages.  Similar to the results from Winans and Walker (153), I also showed that TraC is not 
essential for plasmid transfer.  However, I also found that the cell wall hydrolase, TraL, is 
dispensable, and overexpression of traL in either a wild-type or ∆traL background enhanced 
transfer.   
 
Contributions of TraC and KikA to pKM101 plasmid transfer 
 VirB5 has been described as the minor pilin subunit and has been observed at the A. 
tumefaciens pilus tip (158).  Studies on pKM101-encoded TraC have demonstrated that it can be 
localized to the cell surface and form high molecular weight complexes in the presence of a 
functional T4SS (87).  Because VirB5 in A. tumefaciens is located at the pilus tip, TraC is also 
predicted to be the pilus tip protein as point mutations can drastically alter cell susceptibility to 
filamentous phage IKe (142).  Therefore, it is likely that TraC is involved in forming and 
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stabilizing recipient cell contact as part of the pilus.  However, my results as well as those from 
Winans and Walker have demonstrated that TraC is not essential component of the pKM101 
T4SS (153).  Therefore, it is likely that other surface proteins are able to mediate recipient cell 
contact.  Based on other studies from our lab, one possible candidate protein is KikA.  The kikA 
(killing in Klebisella A) locus is located upstream of the tra operon and encodes a small surface 
protein.  Although KikA is not critical for pKM101 mobilization on solid surfaces, previous 
studies have highlighted its importance in uptake of PRD1 phage (159).  Recently, our lab has 
demonstrated that KikA is essential for processes including plasmid transfer in broth matings and 
mediating recipient cell contact as monitored by the Pseudomonas aeruginosa T6SS killing 
assay (discussed in the following chapter).  Our lab has also demonstrated that creation of a 
double ∆traC/∆kikA mutant abolished residual plasmid transfer, indicating that KikA might 
partially substitute for TraC.  Further characterization of the role of KikA in T4SS and its 
physical relationship with the channel is currently being investigated by our lab.   
 
Contributions of TraL to pKM101 plasmid transfer and pilus biogenesis 
 Deletion of virB1 in A. tumefaciens reduced T-DNA transfer to plants and abolished pilus 
biogenesis (67).  Similar results were seen during analysis of the F-plasmid-encoded P19 cell 
wall hydrolase (157).  However, my results revealed that the pKM101-endoded homolog, TraL, 
is nonessential.  Additionally, overexpression of traL increased plasmid transfer.  Therefore, 
TraL could be considered a rate limiting factor in plasmid transfer.  By overproducing TraL, this 
could allow for production and insertion of more translocation channels into the membrane.  
Alternatively, TraL could be secreted into recipient cells and allow for more efficient 
translocation through degradation of the recipient cell wall.  In order to address these questions, 
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future experiments should test the steady state levels of other Tra proteins in the presence and 
absence of overproduced TraL.  Finally, export of TraL to the recipient cell periplasm can be 
tested using fluorescence microscopy to observe localization of fluorescently-labeled TraL and 
other recipient-encoded periplasmic proteins.     
 It is curious why the traL locus is present in the pKM101 tra operon if it is not essential.  
One plausible explanation relates to the fact that pKM101 is capable of transferring among a 
broad range of Gram-negative bacterial species.  It is possible that TraL interacts with other 
T4SS components to localize cell wall degradation.  In E. coli, the dispensability of TraL might 
be explained by redundant activities of other cell wall hydrolases or the assembly of the T4SS 
during the early growth phase when the cell wall is being actively remodeled.  In other species, 
pKM101 might require its own lytic transglycosylase due to a lack of a compensating hydrolase 
or temporal differences in T4SS machine assembly in relation to the growth phase.   
Evolutionary pressures, therefore, might have maintained traL on pKM101 for retention of its 
broad-host-range properties.  
 
Complementation of tra mutants for PRD1 and IKe infection 
   Complementation of virB, RP4 trb, and F-plasmid deletion mutants restored detectable 
pilus production, PRD1 and R17 sensitivity respectively (45,67,132).  In my analysis of pKM101 
tra deletion mutants, all of the deletion mutants with the exception of traL were resistant to both 
PRD1 and IKe.  However, complementation only restored sensitivity to ∆traM, ∆traF, and 
∆traG mutants.  
 For those tra mutants in which phage sensitivity was not restored by expression of the 
complementing gene in trans, there are a couple of possible explanations. They may not 
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elaborate pili or alternatively, they may elaborate wild-type pili, but sustain blocks in the phage 
uptake pathway subsequent to phage binding to the pilus receptor.  While the PRD1 uptake 
pathway is not well understood, filamentous bacteriophages such as M13 and IKe utilize the 
TolQRA proteins to cross the IM (160,161). It is possible that overproduction of the Tra proteins 
blocks the ability of IKe to bind the cell surface or to interact with TolQRA. Future studies 
focused on elucidating the requirements for pKM101 pilus production as well as defining the 
pilus assembly pathway will require antibodies against the TraM pilus protein. 
 
Transfer of pKM101 in broth matings 
 Conjugation in broth media is a well-documented phenomenon in studies of the F-
plasmid.  This is due to physical structure of the conjugative pilus, which is long and flexible, 
making it easy to feel around its physical environment and grab onto a recipient cell.  Following 
attachment, these pili are able to retract and bring the recipient cell into close contact in spite of 
shear forces in the environment (156).  Unlike the F-plasmid, pili encoded by pKM101, R388 
and RP4 plasmids are short and brittle. Furthermore, there is no evidence of pili retracting or 
being involved in recipient cell contact and mating pair stabilization.  My data suggests that 
production of conjugative pili is important for successful plasmid transfer in broth.  However, 
further studies carried out by Dr. Christian Gonzalez-Rivera, a postdoctoral fellow in the Christie 
lab, suggest that two surface-exposed proteins, the pilus tip protein TraC and KikA, can promote 
donor-recipient contacts in broth even in the absence of detectable pilus production.  
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Chapter 5: Defining the Role of a Novel Outer 
Membrane Alpha Helical Domain in pKM101-encoded 
TraF for Plasmid Transfer, Donor-Specific 
Bacteriophage Sensitivity, and Recipient Cell Contact  
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Introduction 
 The T4SSs from Gram-negative bacteria are comprised of two large subassemblies: an 
inner membrane complex (IMC) and an outer membrane core complex (OMCC). The IMC is 
comprised the three inner membrane (IM) ATPases (VirD4, VirB4, and VirB11) and three IM 
subunits (VirB3, VirB6, and VirB8).  Recent studies also suggest that VirB5 could also comprise 
a significant part of the IMC (84).  The predicted role of the IMC is to recruit substrates to the 
T4SS and help transfer them across the IM.  The OMCC is comprised of 14 copies of VirB7, 
VirB9, and VirB10 arranged into a large 1 MDa structure (82,90).  The OMCC is predicted to be 
primarily involved in moving substrates across the OM and establishing contact with recipient 
cells (Figure 5.1) (162).  Structural studies on the TrwR388 T4SS identified two distinct IMC and 
OMCC subassemblies connected together by a central stalk structure (84).  All of these 
components were shown to be necessary to build a functional translocation channel in the VirB 
T4SS (67). 
 Unlike the other components of the T4SS, VirB10 is a unique protein in that it spans the 
length of the cell envelope.  Because it makes contacts with subunits in both the IMC and the 
OMCC, it is predicted to act as a scaffolding protein linking the two subassemblies together 
(90,98).  At the IM, it is predicted to make essential contacts with IM ATPases which are 
essential for initiating ATPase-mediated conformational changes in VirB10 (Figure 5.2) 
(95,98,107).  These contacts are likely mediated through the VirB10 N-terminus as gradual 
truncations in this region reduced the affinity of VirD4 for VirB10 (127).  The conformational 
change brought about by IM ATPase activity is predicted to transduce energy to the OMCC 
subunits, such as VirB7 and VirB9. VirB10 makes extensive contacts along its -barrel with 
VirB9, which is anchored at the OM by the VirB7 lipoprotein (Figure 5.1) (90).  Additionally,  
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Figure 5.1 The OMC and its potential role in plasmid transfer (A) Structure of the 
pKM101 OMC demonstrating the arrangements of TraN (yellow), TraO (blue), and 
TraF (red).  The structure of the core complex O-layer was generated using Pymol 
(http://pymol.org) based on the 3ZBI file deposited into the NCBI protein database (B) 
Cryo-EM images of E.coli donors containing RP4 mixed with E. coli recipients.  Black 
arrows indicate the positions of mating junctions.  
 
 Bottom images are from Samuels AL, Lanka E, Davies JE. Conjugative junctions in 
RP4-mediated mating of Escherichia coli. J Bacteriol. 2000 182:2709–15.  The 
American Society for Microbiology allows for re-publication of its materials in a 
doctoral thesis. 
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Figure 5.2 Plasmid transfer through the conjugative pilus. This model demonstrates the 
path of DNA through the conjugative T4SS.  The positions of the TraJ and TraG ATPases and 
the conjugative pilus composed of TraM are indicated.  The position of TraF within the cryo-
EM structure of the is highlighted in green. 
 The structure of TrwB is Figure 2C from Gomis-Rüth FX et al. The bacterial 
conjugation protein TrwB resembles ring helicases and F1-ATPase. Nature 2001 409:637–41.  
This image was re-published with permission from Nature Publishing Group. License 
Number 4078401439237. The structure of the VirB11-like HP0525 was published as Figure 
3C in Yeo HJ et al. Crystal structure of the hexameric traffic ATPase of the Helicobacter 
pylori type IV secretion system Mol Cell. 2000 6:1461–72.  This image was re-published with 
permission from Elsevier.  License Number 4078430588294.  The pKM101 core complex 
structure is Figure 4 from Fronzes R, et al. The structural biology of type IV secretion systems. 
Nat Rev Microbiol. 2009 7:703–14.  This image was re-published with permission from 
Nature Publishing Group. License # 4092681298982. 
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VirB10 likely makes critical contacts with VirB2 pilin subunits (Figure 5.2).  While VirB2 is 
primarily localized to the IM before pilus biogenesis, VirB2 is essential for transfer of T-DNA 
across the OM (74).  Because T-DNA does not make contact with VirB10, it likely makes 
contact with VirB2, possibly assembled as a short pilus in the OMCC lumen.  This short pilus 
might comprise the translocation channel, allowing for passage of substrates to the cell surface 
(Figure 5.2).   
In Chapter 3 of this thesis, I analyzed the importance of the VirB10 antenna projection 
(AP) domain and C-terminal tail.  Both of these regions were amenable to mutations without 
affecting plant tumor formation.  However, these mutations either attenuated or abolished T-pilus 
production.  One notable example was a substitution of the VirB10 AP and C-terminal tail for 
that of TraF.  The C-terminal tail of VirB10 is 43 residues and is ~71% identical to that of TraF 
(Figure 5.3).  Both of these tails contain a highly-conserved RDLDF sequence that was shown to 
be essential for T-DNA transfer and pilus biogenesis in VirB10 (127).  Additionally, the crystal 
structure of TraF indicates that the C-terminal tail folds back into the lumen of the barrel (90).  
Accordingly, this domain might make contacts with substrates and/or pilin subunits as they pass 
through the channel (Figure 5.3).   
 In the previous chapter of this thesis, I highlighted the importance of the pKM101 Tra 
subunits for plasmid transfer and phage sensitivity.  Complementation of a ΔtraF mutant with 
wild-type traF restored both plasmid transfer and phage sensitivity to pKM101.  In light of the 
structural information from the pKM101 TraN-TraO-TraF core complex and the functional data 
from the VirB10 AP, I hypothesized that the TraF AP is a surface exposed domain that is 
dispensable for the formation of an OM pore, but critical for pilus biogenesis and the formation 
of stable mating junctions through the formation of recipient cell contact.  Here, I used chimeric  
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Figure 5.3 Similarities between the TraF and VirB10 AP and C-terminal domains.  
(A) Crystal structure of TraF with the AP (residues 306-354) highlighted in red and the 
C-terminal tail (residues 355-386) highlighted in green. The structure of TraF was 
generated using Pymol (http://pymol.org) based on the 3ZBI file deposited into the NCBI 
protein database (B) Alignment of the TraF AP and C-terminal tails.  The residues 
comprising the AP are surrounded by red brackets and the C-terminal tail residues are 
bracketed in green.  Red letters indicate conserved residues between TraF and VirB10.     
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TraF/VirB10 proteins and TraF truncation mutants in order to identify regions within the AP and 
C-terminal tail that were critical for plasmid transfer and phage sensitivity.  Additionally, I used 
chimeric T4SSs containing the IMC of pKM101 and the OMCC of either the VirB/VirD4Ti, 
TrwR388, or PtlBp T4SSs to evaluate the importance of the OMCC, and in particular the AP, in 
establishing donor-recipient cell contacts.  
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Results 
The TraF AP is critical for phage sensitivity, but dispensable for plasmid transfer 
 According to the pKM101 O-layer crystal structure, TraF lines the inner wall of the 
channel and forms an OM pore using its AP domain. Based on the functional conservation of the 
AP domains in VirB10 and TraF in addition to the dispensability of the VirB10 AP seen in 
Chapter 3, I predicted that the TraF AP domain is similarly dispensable for plasmid transfer, but 
required for pilus biogenesis.  Here, I assayed strains producing various TraF AP and C-terminal 
mutants for plasmid transfer and phage sensitivity as an indicator of pilus production.   
I began by making deletion mutations throughout the TraF AP.  I first replaced the 
flexible loop region with a pentaglycine bridge (5xGly), which had no detectable effects on 
plasmid transfer (Figure 5.4).  A larger deletion of the TraF AP (residues 302-355) resulted in 
only a modest decrease in intercellular pKM101 transfer (Figure 5.4).  Additionally, neither of 
these mutations had any discernable effect on TraF protein accumulation (Figure 5.4).  Taken 
together with the data presented in Chapter 3, we can conclude that the AP regions of both TraF 
and VirB10 are dispensable for DNA transfer, although their presence results in more efficient 
conjugation.   
 Replacement of the flexible loop with a pentaglycine bridge did not abolish IKe 
sensitivity, indicating that these mutants restore the presence of a functional conjugative pilus.  
However, the ∆AP mutant did not restore sensitivity to either PRD1 or IKe, suggesting that cells 
producing this TraF mutant lack pKM101-encoded pili.  The TraF ∆AP strain behaved similarly 
to its VirB10 counterpart indicating that the AP helices are an essential factor for pilus 
biogenesis.   
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Figure 5.4 Functionality of TraF truncation mutants.  (A) Bar diagram depicting the level 
of native pKM101 transfer from donors containing TraF truncation mutants. Frequencies are 
depicted as transconjugants per donor.  Matings were repeated 3 times and the histogram 
represents the average with standard deviations.  (B) Bar diagram representing the sensitivity 
of donors to PRD1 and IKe.  Sensitivity is depicted as the number or plaque forming units per 
ml (PFU/ml).  Black bars represent PRD1 infections while gray bars represent IKe infections. 
Plaque assays were repeated 3 times and the histogram represents the average value with the 
standard deviations. (C) Steady state levels of TraF truncation mutants containing an N-
terminal 6xHis tag. 
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Because the AP domains of both TraF and VirB10 were permissive for mutations, 
another substitution was constructed by placing the VirB10 AP helices (residues 284-337) onto 
TraF (TraF/VirB10AP).  This chimera phenocopied wild-type TraF by restoring plasmid transfer 
and phage sensitivity to wild-type levels, (Figure 5.5).  As with the previous AP swap, these 
results are striking due to the generally low level of identity (~31%) between the TraF and 
VirB10 AP domains.  Further substitution of the VirB10 AP flexible loop onto TraF 
(TraF/VirB10AP_Loop) still allowed for for plasmid transfer and IKe sensitivity (Figure 5.5).  
However, this mutant was not able to restore PRD1 sensitivity.    
Taken together, these results demonstrate that the AP is dispensable for DNA transfer, 
but critical for pilus biogenesis in both TraF and VirB10.  Despite its importance for pilus 
production, these domains are able to withstand mutations without significant phenotypic 
alterations.   
 
The C-terminal domain of TraF is critical for both plasmid transfer and phage sensitivity 
 The region of highest identity between TraF and VirB10 is located in the C-terminal tail.  
These regions share ~71% identity with most of the homology occurring at the C-terminal end of 
the proteins (Figure 5.3).  This region contains a highly conserved RDLDF motif found in all 
sequenced VirB10 family proteins.  According to the TraF crystal structure, the C-terminal tail 
folds back into the channel lumen and is buried in the periplasmic -barrel domain.  Deletions of 
either the AP and C-terminal tail (∆APCT) or just the C-terminal tail (∆CT) resulted in the 
abolishment of both pKM101 transfer and phage sensitivity (Figure 5.4).  However, these results  
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Figure 5.5 Functionality of the TraF/VirB10 chimeras. (A) Bar diagram depicting different 
swaps between TraF and VirB10. (B) Histogram depicting transfer frequencies of pKM101 
from donors containing TraF/VirB10 chimeras during 2 hour filter matings. Frequencies are 
presented as transconjugants per donor.  Matings wererepeated 3 times and the histogram 
depicts the average values with standard deviations.  (C) Bar diagram depicting the sensitivity 
of donors containing the TraF/VirB10 chimeras to PRD1 and IKe.  Sensitivity is presented as 
the number of plaque forming units per ml (PFU/ml).  Black bars represent PRD1 infections 
while gray bars represent IKe infections.  Plaque assays were repeated 3 times and the 
histogram depicts the average values with standard deviations.  (D) Steady state levels of 
TraF/VirB10 chimeras containing an N-terminal 6xHis tag.   
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are difficult to interpret as overall TraF levels in the donor cells was highly diminished.  Deletion 
of the C-terminal 9 residues (∆9) or the RDLDF sequence (∆RDLDF) did not affect protein  
accumulation but abolished all detectable activity (Figure 5.4), suggesting that the C-terminal tail 
is critical for plasmid transfer and pilus biogenesis. 
Because of the high level of identity of the C-terminal tails, I predicted that substitution 
of VirB10 C terminus (residues 335-377) for that of TraF (residues 354-386) would not affect 
plasmid transfer or phage sensitivity.  Interestingly, the TraF chimera (TraF/VirB10CT) as well as 
a chimera producing both the AP and C-terminal tail of VirB10 (TraF/VirB10AP-CT) were not 
able to restore phage sensitivity, despite accumulating at abundant levels (Figure 5.5). These 
findings are consistent with the results seen with the VirB10/TraFAP-CT chimera, further 
suggesting that the C terminus plays a critical role in biogenesis of the cognate pilus.   
 Taken together, these results demonstrate that the TraF and VirB10 C-terminal tails are 
critical for both DNA transfer and pilus biogenesis. 
 
The N-terminal region of TraF does not tolerate substitutions of corresponding VirB10 
domains. 
 The -barrel regions of TraF (194-301) and VirB10 (173-284) share only ~35% identity.   
Because TraF tolerated mutations throughout the AP and C-terminal tail, I next wanted to test if 
TraF could withstand more extensive domain substations throughout its C-terminal half. A 
substitution of the VirB10 -barrel, AP, and C-terminal tail onto TraF (TraF/VirB10BB-CT) 
restored transfer to a ΔtraF mutant, albeit at levels 10,000-fold lower than wild-type TraF 
(Figure 5.5).  This mutant did not restore PRD1 or IKe sensitivity.  These results demonstrate 
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that the -barrel of VirB10 can functionally substitute for that of TraF, despite the low level of 
identity between the two domains. 
 Because the TraF C-terminal tail is critical for phage sensitivity, I predicted that addition 
of the TraF C-terminal tail back onto the TraF/VirB10BB-CT could restore phage uptake.  I 
constructed two new TraF mutants to test this hypothesis.  One of these TraF mutants produced 
the -barrel and AP of VirB10 (TraF/VirB10BB-AP), where as the other produced only the 
VirB10 -barrel (TraF/VirB10BB).  These mutants restored plasmid transfer to a ΔtraF mutant at 
levels greater than the TraF/VirB10BB-CT mutant (Figure 5.5).  However, they were still unable to 
restore phage sensitivity (Figure 5.5).  These results also implicate the TraF -barrel as essential 
indicating a potential complex interplay between the -barrel and C-terminal tail during pilus 
biogenesis.   
 The role of the N-terminal half of TraF remains undefined.  Previous studies suggest that 
its N-terminal domain of VirB10 is required for interactions with the VirD4 T4CP (127). Other 
experiments with regards to regions such as the TM domain are not as clear.  In the VirBAt T4SS, 
substitutions of the VirB10 TM domain with that of E.coli FtsN did not have an effect on T-
DNA transfer (128).  However, this was not the case in the TrwR388 system as the TM domain of 
TrwE appears to be critical for forming interactions with the TrwB T4CP (95,163).  In order to 
elucidate the role of these domains in TraF, I created four new TraF chimeric proteins containing 
either the VirB10 N-terminal tail (TraF/VirB10NT), TM domain (TraF/VirB10TM), proline-rich 
region (TraF/VirB10PRR) or TM through C-terminal tail (TraF/VirB10TM-CT).  These mutants 
were not able to restore plasmid transfer or phage sensitivity to a ΔtraF mutant (Figure 5.6).  The 
N-terminal half of TraF does not tolerate substitutions of VirB10 domains, suggesting that this 
region forms critical contacts with components of TrapKM101’s IMC subassembly.  
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Figure 5.6 Functionality of the TraF/VirB10 N-terminal chimeras. A) Bar diagrams 
depicting the N-terminal swaps of VirB10 onto TraF.  (B) Histogram displaying the 
transfer frequencies of traF mutants complemented with either the genes either for wild-
type TraF or N-terminal chimeric TraF/VirB10 proteins.  Mating frequencies are 
presented as transconjugants per donor and mating assays were repeated 3 times with the 
histogram depicting the average values with standard deviations. (C) Histogram depicting 
the sensitivity of traF mutants to PRD1 and IKe when complemented with genes 
encoding either WT TraF or the TraF/VirB10 N-terminal chimeras.  Sensitivity is 
presented as the number of plaque forming units per ml (PFU/ml).  Black bars represent 
PRD1 infections while gray bars represent IKe infections.  Plaque assays assays were 
repeated 3 times and the histogram depicts the average values with standard deviations. 
(D) Western blots measuring the steady state levels the TraF/VirB10 N-terminal chimeras.   
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Neither the AP nor the C-terminal tail are surface displayed 
 Previous reports have suggested that the TraF AP is surface displayed (90).  However, 
these experiments lacked critical controls and conclusions were drawn based on the production 
of the TraN-TraO-TraF core complex rather than the entire T4SS.  Additionally, my data 
suggests that the C-terminal tail is critical for pilus biogenesis.  Based on my data with regards to 
the TraF/VirB10 chimeras, I predicted that the TraF AP and C-terminal tail are surface 
displayed.  In order to test this hypothesis, I performed a dot blot experiment similar to those 
done with the OM lipoprotein RcsF (164).  In these experiments, I placed FLAG tags in the AP 
loop (between residues 330 and 331) and at the end of the C-terminal tail.  For a positive control, 
I put a FLAG tag at the C-terminal end of TraC, which has been demonstrated by our lab and 
others to be surface displayed (87).  For negative controls, I inserted FLAG tags at the TraF N-
terminal tail, in the lever arm at the periplasmic base of the -barrel, and at the C-terminal 
domain of TraE predicted to be in the periplasm.  Contrary to our hypothesis, the AP and the C-
terminal FLAG tags were not detected on the cell surface (Figure 5.7).  Additionally, C. 
Gonzalez-Rivera used BSA-conjugated malaeimide to label cysteine residues placed at the C-
terminal end of the AP (residue 360) and at the C-terminal tail (residue 386).  Neither of these 
cysteine residues were labeled in whole cells.  Together, these results suggest that the TraF AP 
and C-terminal tail are not surface accessible at least in the absence of target cell contact.   
 
Heterologous OMCCs paired with the pKM101 IMC support plasmid transfer 
 Although the extensive contacts between TraF and TraO were not critical for building a 
functional translocation channel, they may be important for building an efficient one.  If this 
prediction is correct, replacing TraO with VirB9 might lead to more efficient transfer. Therefore,   
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Figure 5.7 Surface display of TraF (A) Colony immunoblots depicting the detection of 
FLAG tags placed throughout TraF and the C termini of TraE and TraC. (B) Western 
blots detecting the steady state levels of the different FLAG-tagged TraF proteins as well 
as C-terminal FLAG-tagged TraE and TraC. 
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I constructed a chimeric T4SS containing the IMC of pKM101 and the OMCC from the VirBAt 
system.  The pKM101 IMC contained TraA, TraB, TraC, TraD, TraE, and the N-terminal half of 
TraF (residues 1-193) while the VirB OMCC consisted of VirB7, VirB9, and the C-terminal half 
of VirB10 (residues 173-377).  To ensure that the codon usage of A. tumefaciens didn’t prevent 
optimal production of the VirB proteins, the virB genes were codon optimized for expression in 
E. coli.  This chimeric Tra/VirB T4SS mediated transfer of the oriT plasmid pJG142, albeit at 
levels several orders of magnitude lower than observed for WT pKM101 (Figure 5.8).  The 
Tra/VirB chimeric T4SS did not mediate PRD1 or IKe uptake, however, suggesting that these 
cells do not produce conjugative pili (Figure 5.8).   
 It is interesting that OMCCs from functionally distinct T4SSs can substitute for one 
another.  We next wanted to test whether OMCCs from other T4SSs could substitute for that of 
pKM101.  I first tested for functionality of a chimeric system composed of the OMCC from 
plasmid R388 and the IMC from pKM101.  TraN and TraO were replaced with R388-encoded 
TrwH and TrwF, respectively.  TraF was replaced with a TraF/TrwE chimera consisting of the 
the N-terminal half of TraF (residues 1-193) and the C-terminal half of TrwE (residues 197-395).  
This chimeric T4SS mediated plasmid transfer at levels appreciably higher than observed for the 
Tra/VirB chimera (Figures 5.8).  Similar to the Tra/VirB chimera, however, this machine did not 
mediate uptake of PRD1 and IKe, indicating a lack of pilus production.  
 I next tested whether a more phylogenetically and functionally distinct OMCC would 
functionally pair with the Tra IMC.  For this, I made a chimeric Tra/Ptl T4SS.  The Ptl T4SS is 
produced and utilized by Bordetella pertussis and is functionally unique in three ways.  First, it 
does not contain a T4CP to recognize pertussis toxin subunits (5).  Toxin subunits must go 
through the general secretory pathway prior to movement across the OM.  Secondly, it does not  
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Figure 5.8 Functionality of chimeric T4SSs.  (A) Genetic organization of the chimeric 
operons in mini-pKM101pBAD24.  (B)  Bar diagram depicting the level of transfer of 
oriT-IJKpGB2 in donors containing either wild-type mini-pKM101pBAD24 or mini-
pKM101pBAD24 encoding the chimeric T4SSs as well as the sensitivity to PRD1 and IKe.  
Mating frequencies are presented as transconjugants per donor and mating assays were 
repeated in triplicate the histogram represents the average of three experiments along 
with standard deviation. S:Sensitive, R:Resistant 
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contain a VirB5 or TraC homolog leading to an absence of detectable pili on the cell surface.  
Finally, it secretes pertussis toxin independently of recipient cell contact (165).  TraN and TraO 
were replaced with PtlI and PtlF, respectively.  TraF was substituted with a chimeric TraF/PtlG 
protein containing the N-terminal half of TraF (residues 1-172) and the C-terminal half of PtlG 
(residues 160-374).  Similar to the tra/virB gene cluster, the tra/ptl gene cluster was codon 
optimized for expression in E. coli.  The Tra/Ptl chimera mediated plasmid transfer at levels 
lower than the Tra/VirB, but above a threshold of detection.  As with the other chimeras, the 
Tra/Ptl system did not mediate PRD1 or IKe uptake (Figure 5.8).  
 Together, these results support a proposal that the type IVa T4SSs are composed of 
functionally distinct IMC and OMCC subassemblies, and furthermore, that the OMCCs from 
different systems are highly conserved not only their overall architectures as shown by the 
structural studies (see Chapter 3), but also in their functions as structural scaffolds for the 
translocation channel.  While all of the heterologous OMCCs were able to functionally pair with 
the pKM101 IMC, the more closely-related Trw OMCC paired in a more productive manner 
than its VirB and Ptl counterparts. 
 
Neither the TraF AP nor the C-terminal tail are required for recipient cell contact 
 Pseudomonas aeruginosa contains a bactericidal type VI secretion system (T6SS), which 
is activated upon sensing membrane perturbation.  When its membrane is perturbed through 
contacts by a neighboring cell, the P. aeruginosa T6SS is activated and in turn injects toxic 
effectors that kill the adjoining cell (13).  The Mekalanos lab has previously demonstrated that E. 
coli containing a functional pKM101 T4SS are killed when incubated with P. aeruginosa 
containing a functional T6SS (140).  This is likely due to mating junctions formed between E. 
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coli and P. aeruginosa.  In recent years, the Christie lab has taken advantage of this in order to 
define the requirements for recipient cell contact.  By measuring the sensitivity of E. coli 
containing pKM101 mutants to P. aeruginosa, we can further identify which steps in conjugation 
are blocked by various mutants.   
 I wanted to measure the sensitivity of E. coli containing the chimeric T4SSs to P. 
aeruginosa T6SS killing.  Similar to previously described results, DH5α without a T4SS was not 
susceptible to T6SS killing.   The cell viability of DH5α containing a wild-type pKM101 tra 
operon was reduced by ~ 10-fold (Figure 5.9).  Cells containing the chimeric operons were also 
susceptible to T6SS killing, but at attenuated levels (Figure 5.9).  These results demonstrate that 
the reduced levels of transfer are likely not due to the ability of these chimeric T4SSs to mediate 
recipient cell contact.   
Utilizing the P. aeruginosa T6SS killing assay, I wanted to test my prediction about the 
importance of the TraF AP and C-terminal tail in establishing recipient cell contact.  A series of 
alleles encoding the AP and C-terminal tail mutants were cloned in the native traF locus in mini-
pKM101.  Cells containing these plasmids were tested for their sensitivity to killing by P. 
aeruginosa.  Wild-type traF cloned into its native locus restored sensitivity to ~10-fold (Figure 
5.10).  The TraF/TrwEAP-CT mutant also gave similar levels of sensitivity as wild-type TraF.  
Surprisingly, the TraF∆AP also gave similar levels of sensitivity as wild-type TraF as well.  These 
results indicate that the TraF AP is not necessary for establishing contact with recipient cells.  
TraF∆RDLDF and TraF∆CT9 also restored sensitivity, albeit at lower levels (Figure 5.10).  The other 
AP-CT chimeras, TraF/VirB10 and TraF/PtlG, mediated sensitivity as well.  Taken together, 
these results indicate that the AP and the C-terminal end of TraF are not essential for contacting 
recipient cells.     
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Figure 5.9 Measuring the ability of the chimeric T4SSs to make efficient recipient-cell 
contact.  (A)  Representative plate from the P. aeruginosa T6SS killing assay.  (B)  
Quantification of the results in panel A.  Results are presented in cell viability (CFU/ml).  The 
P. aeruginosa T6SS killing assay was performed in triplicate and the histogram represents the 
average along with standard deviation.  Statistical significance of the T6SS-mediated killing 
results was calculated using a Student’s t test corresponding to plasmid-free E. coli cells 
(*P<0.05, **P<0.01) 
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Figure 5.10 Determining the role of the TraF AP-CT in recipient cell contact (A) 
Histogram depicting the sensitivity of either wild-type TraF or TraF AP-CT mutants when 
each of the alleles were cloned into the native traF locus on mini-pKM101.  Results are 
presented in cell viability (CFU/ml).  The P. aeruginosa T6SS killing assay was performed in 
triplicate and the histogram represents the average along with standard deviation.  (B) 
Western blots of the WT TraF and AP-CT mutants when each traF allele is expressed from its 
native locus.        
 
Statistical significance of the T6SS-mediated killing results was calculated using a Student’s t 
test corresponding to plasmid-free E. coli cells (*P<0.05, **P<0.01, NS: not significant) 
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Discussion 
 Bacteria containing a conjugative T4SS will utilize a conjugative pilus to attach to 
recipient cells prior to the formation of a stable mating junction.  Once donor and recipient cells 
are in close contact, DNA will be transferred into the recipient cells.  When I joined the Christie 
lab, one of my initial goals was to determine which regions of the OMCC were responsible for 
making direct contact with recipient cells.  The crystal structure of the pKM101 OMCC O-layer 
highlighted a unique region of the VirB10 homolog, TraF, which seemed to project outwards 
towards the cell surface.  I hypothesized that this region was critical for pilus biogenesis and 
recipient cell contact.   
 I began my investigation by making deletion mutations throughout the TraF and C-
terminal tail in addition to TraF/VirB10 chimeras.  Similar to the results seen with VirB10, the 
TraF AP helices are only required for building a cognate pilus.  Additionally, I paired 
heterologous OMCCs from either VirB/VirD4Ti, TrwR388, or PtlBp with the IMC of pKM101 and 
demonstrated that these chimeric T4SSs were capable of transferring DNA to recipient cells.  
These results highlight the plasticity of the Gram-negative bacterial T4SS and demonstrate that 
other factors besides OMCC-localized proteins play a significant role in recipient cell contact.  
Below, I will discuss my findings in more detail.   
 
Contributions of the TraF AP to plasmid transfer and pilus biogenesis  
 The crystal structure of the pKM101 core complex features the TraF AP helices as a 
potential pore forming domain.  However, my analysis of VirB10 suggested that the AP helices 
are not critical for substrate transfer.  Based on these results, I predicted that deletion of the TraF 
AP helices (residues 302-353) would still allow for attenuated plasmid transfer. The TraF∆AP 
 179 
mutant restored transfer to levels only 1,000-fold lower than wild-type TraF.  Therefore, it is 
likely that the TraF AP is part of the OM pore, but is not essential for its formation.  
 Because the structure of the pKM101 core complex only highlights TraN, TraO, and 
TraF, it is likely that the OM pore contains other pKM101 components.  As discussed in Chapter 
3, pilus polymerization occurs either at an OM platform formed by the AP domain or at an IM 
platform within the channel.  In both of these models, the pilus structure is protruding through 
the OMCC with assistance from the AP.  Therefore, the conjugative pilus is likely the candidate 
pore-forming structure and the AP is solely involved in aiding the pilus outside of the OM 
efficiently.     
Unlike plasmid transfer, the TraF AP is critical for pilus biogenesis. As mentioned above, 
TraM is likely in the core complex aiding substrates across the OM.  However, the AP might 
make essential contacts with TraM subunits in the channel lumen and bring them to the surface.  
Additionally, our lab has observed TraC subunits secreted outside of the cell in the absence of 
the T4SS.  In addition to formation of a pilus tip, TraC is also predicted to act as a pilus 
nucleation factor (discussed below).  Therefore, the AP might also coordinate and localize 
extracellular TraC to the channel in order to trigger pilus biogenesis.   
 
Contributions of the TraF C-terminal tail to plasmid transfer and pilus biogenesis  
The crystal structure of TraF places the C-terminal tail (residues 354-386) inside the 
channel lumen buried within the -barrel.  The C-terminal tails of TraF and VirB10 share the 
highest region of identity between the two proteins (~71% identical) suggesting that this region 
has a conserved function.  Deletion of the conserved RDLDF motif in VirB10 abolished T-DNA 
transfer and pilus biogenesis.  My results demonstrated a similar phenomenon in TraF where 
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deletion of these residues abolished plasmid transfer and phage sensitivity.  Therefore, this 
conserved sequence might be involved in pilus biogenesis through direct contact with pilin 
subunits and plasmid transfer through critical contacts with substrates such as the TraI relaxase.   
Because of the high degree of homology between the TraF and VirB10 C-terminal tails, I 
predicted that the VirB10 C-terminal tail would functionally substitute for that of TraF.  
Although plasmid transfer was relatively unaffected, phage sensitivity was completely abolished.  
The C-terminal tail of VirB10 contains 11 extra residues.  Therefore, it is likely that these 
mutants do produce pili, but the extra 11 residues from VirB10 interfere with phage infection.  
This prediction is based on other observations where a C-terminal FLAG tag on TraF does not 
abolish IKe sensitivity, indicating that the TraF C-terminal end can tolerate extensions and still 
support phage sensitivity.   
While the C-terminal tail of TraF can handle the addition of epitope tags, it appears to be 
less tolerant to deletions.  Deletion of the C-terminal residue, N386, abolished sensitivity to 
PRD1 and deletion of the C-terminal 9 residues abolished all phage sensitivity and plasmid 
transfer.  Taken together, these results suggest that the length of the TraF C-terminal tail is 
critical for functionality.  During plasmid transfer and pilus production, the C-terminal tail might 
be dynamic in that it might move inside and outside the OM as it shunts pilin subunits and 
substrates outside the cell.  Therefore, the length of the TraF C-terminal tail would be critical for 
these steps.  Unfortunately, I was unable to demonstrate surface display of TraF C-terminal tail.  
Other OM proteins or surface lipopolysaccharide might occlude this domain from various 
methods of detection.  Future work in the Christie lab will focus on determining the spatial 
localization of the TraF C-terminal tail with respect to the OM.   
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The role of the TraF N-terminal half 
 Previous work from the Christie lab has highlighted the flexibility of the VirB10 N-
terminal tail and TM domain.  Insertions of Ala-Cys residues along the length of the VirB10 N- 
terminal tail and TM domain were phenotypically silent and replacement of the VirB10 TM 
domain with that of FtsN still allowed for T-DNA transfer (127,128).  These results suggest that 
there are loose sequence requirements in the IMC.  To examine whether N-terminal domains of 
VirB10 could be substituted for those in TraF, chimeric proteins were constructed.  None of 
these chimeras were functional, however, suggesting that TraF’s N-terminal domains might form 
specific contacts with subunits of the IMC.  Future work in the Christie lab will focus on the use 
of unnatural amino acid-mediated photocrosslinking (discussed in Chapter 6) to determine the 
regions of contact between TraF and the TraJ T4CP.   
 
Flexibility throughout Gram-negative bacterial T4SSs 
 While my experiments were the first to show sequence flexibility in the TraF and VirB10 
family of proteins, other experiments have shown that a few other T4SS subunits can be 
functionally exchanged with homologs from other T4SS machines.   Replacement of the 
periplasmic domain of Brucella suis VirB8 with that of the pSB102 VirB8 homolog, TraJ, 
partially restored the ability of B. suis to survive in macrophages (166).  Additionally, previous 
work in the Christie lab has demonstrated that TraJ T4CPs containing the soluble domain of 
heterologous T4CPs are able to recognize and deliver heterologous substrates across the the IM 
(29).  Finally, with regards to pKM101, expression of either traC, traL, or traD was able to 
partially complement an A. tumefaciens ∆virB5, ∆virB1, or ∆virB6 mutant respectively (87–89). 
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Together, these results highlight a common ancestry and most likely a common architecture for 
these T4SSs despite having diverse purposes.   
 
Separation of the IMC from the OMC  
 Previous work from the Christie lab has suggested that the IMC is a functionally distinct 
subassembly from the OMC.  When defining the pathway of T-DNA through the VirBAt T4SS, 
removal of VirB9, VirB10, or the VirB2 pilin subunit prevented movement of T-DNA across the 
OM, but did not affect contact with IM subunits VirB6 and VirB8 (74).  Additionally, the R388 
TrwM/VirB3-TrwE/VirB10 core structure revealed the presence of an IMC consisting of 
TrwM/VirB3, TrwK/VirB4, TrwJ/VirB5, TrwI/VirB6, and TrwG/VirB8 and an OMCC with 
TrwH/B7, TrwF/VirB9, and TrwE/VirB10 connected by a thin, central stalk (84).   
These observations have lead to the “two-subassembly” model for building a T4SS where 
the IMC is responsible for recognition and delivery of substrates across the IM while the OMCC 
is responsible for translocation across the OM and recipient cell recognition.  My data support 
this model.  The sequence stringency at the IMC with regards to TraF appears to be stricter than 
in the OMCC indicating they contain different assembly requirements. Additionally, I was able 
to pair the pKM101 IMC with a heterologous OMCC, suggesting that these subassemblies are 
functionally different and are still able to interact in a productive manner.  However, the OMCC 
does not appear to be responsible for contacting recipient cells as demonstrated by the Tra/Ptl 
T4SS.  As B. pertussis secretes toxins into the extracellular milieu, the Ptl OMCC does not 
require the ability to contact recipient cells.  Therefore, it is likely that other pKM101-encoded 
subunits other than the OMCC contribute to the formation of productive contacts with recipient 
cells.     
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Conclusions 
Taken together, these results highlight the importance of the different domains within 
TraF with regards to plasmid transfer, phage sensitivity, and recipient-cell contact. In line with 
our initial prediction, the AP is not essential for forming the outer membrane pore, where as the 
C-terminal tail is critical for plasmid transfer and phage sensitivity.  Despite being part of the 
OMCC, neither of these domains nor pilus is required for recipient-cell contact.  Taking into 
account the data presented in this chapter, I am proposing the following unifying model for the 
role of the AP and C-terminal tail: 
Model: In the absence of a recipient cell, the pKM101 T4SS exists as a “pilus machine” 
producing conjugative pili, which extend and slough into the extracellular environment.  Once a 
target cell is contacted, the channel will switch from a pilus machine to a “substrate channel”.  
This switch is accompanied by the docking of the TraJ T4CP to the channel in addition to 
substrate processing and docking by the TraI relaxase.  During pilus biogenesis, the AP and C-
terminal tail are involved in producing an extracellular pilus by allowing the pilus to extend from 
the IM to the extracellular mileu.  This region of TraF is involved in physical interactions with 
the growing pilus, which force it to the cell surface.  As pilus structures are often sloughed off, 
the AP and C-terminal tail are likely candidate proteins for detaching the pilus from the cell 
surface.   
 Once the T4SS has switched to a substrate channel, TraJ will dock onto the IMC and will 
induce an ATPase-mediated conformational change in TraF upon substrate docking.  TraF will 
then assist the pilus structure in pore formation.  This conformational change is not critical for 
mating junction formation as a ∆AP mutation was still able to mediate efficient recipient cell 
contact as monitored by the T6SS killing assay.  Substitution of the pKM101 OMCC for those of 
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VirB/VirD4Ti, TrwR388, or PtlBp had little effect on recipient cell contact.  This is surprising in 
light of the evidence to suggest that B. pertussis does not require recipient cell contact for Ptl-
dependent toxin secretion.  These data suggest that OMCC is not directly contacting recipient 
cells or the structural similarities between the TrapKM101, VirB/VirD4Ti and TrwR388 with the PtlBp 
allow for recipient contact, despite not being required for the formation of a mating junction.   
 Another protein predicted to be a central component during target cell contact is the 
surface protein KikA.  Although not important for plasmid transfer on filters, our lab has recently 
established the importance of KikA in processes such as broth matings, the T6SS killing assay, 
and biofilm formation.  C. Gonzalez-Rivera established that KikA produced in the absence of a 
T4SS is not sufficient to make contact with recipient P. aeruginosa cells.  Therefore, I predict 
that the KikA is likely able to interact with all of these heterologous OMCCs in order to establish 
stable mating junctions.  Current work in the Christie lab is focused on determining the role of 
KikA in building a functional T4SS.   
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Chapter 6: Summary and Future Directions 
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Summary 
 Gram-negative bacterial T4SSs contain separate IMCs and OMCCs responsible for 
recognizing and delivering substrates into the extracellular milieu or into target prokaryotic or 
eukaryotic cells.  The goal of the work presented in this thesis was to develop the pKM101 
molecular toolkit and define the role of the pKM101 OMCC in biologically relevant processes 
including plasmid transfer, pilus biogenesis, and recipient cell contact.   When beginning my 
studies on the OMCC, I hypothesized that the AP and C-terminal tail were surface-localized 
domains that played a critical role in plasmid transfer through the formation of the OM pore, 
pilus biogenesis through direct contact with pilin subunits TraM and TraC, and recipient cell 
contact through target membrane perturbation.   
 In Chapter 3, I continued the analysis of the conserved GxxGxxG motif initiated by J. 
Kerr and demonstrated that each of the glycine residues is critical for T-DNA transfer as various 
mutations at each position attenuated tumor formation on plants.  However, only G269 and G272 
were critical for pilus biogenesis as G269R and G272R/W mutations abolished detectable levels 
of VirB2 on the cell surface. Although my mutational analyses did not uncover a mechanistic 
role of the GxxGxxG residues, my findings support the model that the distal end of the OMCC 
plays an important role especially for assembly of the T pilus.    
 Follow-up studies on the VirB10 AP cap began with creating a correct AP deletion.  
Previous deletions were based on the sequence alignment with the H. pylori ComB10 homolog 
and led to a partial AP deletion.  This partial deletion of the VirB10 AP cap abolished detectable 
levels of pili as demonstrated by shearing assays.  However, T-DNA transfer into plant cells was 
only partially attenuated.  A full deletion based on the alignment with TraF phenocopied 
previous results demonstrating only a partial loss in T-DNA transfer and a full abolishment of 
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detectable VirB2 on the cell surface.  Further mutagenesis involved insertion of large, 2x and 3x 
FLAG tags in the AP helices, none of which abolished T-DNA transfer or pilus biogenesis 
highlighting the importance for maintaining the AP domain, despite its ability to withstand large 
mutations.  Finally, I tested for the functional conservation of the AP caps between VirB10 and 
TraF by substituting the AP of TraF on VirB10.  This VirB10/TraFAP chimera phenocopied WT 
VirB10, highlighting their functional similarity, despite a low level of sequence identity.     
Taken together with previous data from the Christie lab, the VirB10 AP cap is required to build a 
functional T-pilus, but dispensable for T-DNA transfer.   
 Chapter 4 focused on the development of our new pKM101 molecular toolkit now being 
used by the Christie lab to address important functional questions related to the T4SS structure.  
I, along with other members of our laboratory, created markerless deletions of each tra gene in 
the traL-traG (virB1-virB11) operon.  We also constructed plasmids containing each of the tra 
genes cloned individually behind the tightly-regulated PBAD promoter.  In this study, I tested each 
of the cloned tra genes for the ability to complement its respective deletion for plasmid transfer 
and phage sensitivity.  Similar lines of investigation have been performed in the VirBTi, TrwR388, 
and TrbRP4, and TrapKM101.  Previous analyses of each of the conjugative plasmids have relied on 
the usage of transposon mutagenesis in each of the T4SS-encoding genes.  Although it is simpler 
to utilize transposon mutagenesis on large, mutlicopy plasmids such as pKM101, these often 
impose polar effects on downstream genes.  Therefore, these complementation experiments were 
critical for re-evaluation of the genetic requirements for plasmid transfer in addition to 
determining if we would be utilizing pKM101 as a model T4SS.   
 My initial deletion and complementation analysis showed that all of the tra genes except 
traL and traC are essential for substrate transfer.  My results with the pKM101∆traC mutant 
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were not surprising as Winans and Walker (153) previously showed that a traC transposon 
insertion mutation did not abolish pKM101 transfer.  However, my results with the 
pKM101∆traL mutant differ from previous cell wall hydrolase deletion mutants.  VirB1 and P19 
do not contribute to the assembly of a functional VirBTi and TraF T4SS respectively, but removal 
of these proteins abolishes detectable levels of pili (67,157).  Deletion of traL from pKM101 had 
no discernable effect on its ability to transfer plasmid pJG142 or mediate IKe uptake.  
Additionally, trans-expression of traL in a wild-type or a ∆traL background increased transfer by 
~100-fold, raising the possibility that TraL is a rate-limiting factor for achieving wild-type levels 
of transfer.   
 In chapter 5, I utilized this new pKM101 molecular toolkit to continue my investigations 
into the role of the AP and C-terminal tail in plasmid transfer and pilus biogenesis.  Truncations 
and internal deletions within these 86 residues identified the C-terminal tail as a critical factor in 
maintaining the functionality and stability of TraF.  TraF mutants containing regions of the 
VirB10 AP and C-terminal tail restored plasmid transfer to a ∆traF mutant.  Further substitutions 
along the length of the -barrel identified a complex interplay in the periplasm critical for pilus 
production.  In line with our initial hypothesis, the TraF AP is nonessential for plasmid transfer 
suggesting that other Tra OM subunits are responsible for forming the substrate pore.   
 In addition to the TraF AP cap region, Chapter 5 also highlighted the structural flexibility 
of the pKM101 T4SS through joining of the pKM101 IMC with the OMCCs of either 
VirB/VirD4At, TrwR388, and PtlBp.  I hypothesized that substitution of TraN and TraO for VirB7 
and VirB9 respectively would increase the frequency of transfer through a channel containing 
the TraF/VirB10BB-CT chimera.  This chimera formed a functional translocation channel as 
monitored by pJG142 mobilization, though transfer frequencies were not elevated.  Similar 
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results were seen with Tra/Trw and Tra/Ptl chimeric systems.  None of these T4SSs were able to 
mediate sensitivity to PRD1 or IKe, suggesting that these cells lack conjugative pili.  These data 
implicate stringent requirements at the OM for building a conjugative pilus.   
 With the use of T6SS killing assay, I was able to provide new insight into the role of the 
pKM101 OMC in mediating recipient cell contact.  None of the TraF truncation mutants or 
AP/C-terminal tail chimeras reduced susceptibility to T6SS-mediated killing.  These unexpected 
results demonstrate that these cells are able to mediate efficient contact with target cells, despite 
containing a non-functional TraF protein.  I also tested my chimeric Tra/VirB, Tra/Trw and 
Tra/Ptl T4SSs in order to identify other OMCC components, which may play a role in recipient 
cell contact.  All of these mutants made efficient contact, despite their reduced conjugation 
efficiency, highlighting the role of other pKM101-encoded surface components, such as KikA, in 
mediating the formation of mating junctions.   
 
Remaining questions and future experiments 
 The data presented in this thesis has shed light on the role of the VirB and pKM101 
OMCC with an emphasis on the OM cap region. However, many of the mechanisms that 
underlie these observations remain unclear.  Below, I will address a subset of the questions that 
have been raised as a result of these data. 
 Do the TraF AP and C-terminal tail directly interact with pilin subunits TraM and 
TraC?  In Chapters 3 and 5, I presented evidence to suggest that the AP and C-terminal tails of 
TraF and VirB10 are critical for pilus biogenesis.  In order to gain a mechanistic insight into the 
role of the AP and C-terminal tail and the pilus biogenesis pathway, I along with other members 
of the Christie lab tested for interactions between TraF and TraC.  C. Gonzalez-Rivera gained 
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evidence for a TraF-TraC interaction using BS3 crosslinking (Figure 6.1).  However, these data 
do not present evidence for direct interactions.   
 I, along with other members of the Christie lab, have invested a large amount of time and 
effort into the development of unnatural amino acid-mediated photocrosslinking for detection of 
direct interactions between adjacent protein subunits.  This technology has been utilized in the 
T2SS, T5SS, and the OM lipoprotein, RcsF, for detection of close interactions (164,167,168).  
For utilizing this technology, amber stop codons (TAG) are placed at a position in the allele of 
interest.  This allele is co-transformed into the same strain as the plasmid pEVOL (151).  The 
pEVOL plasmid contains the genes encoding a tRNA capable of recognizing the amber stop 
codon and an aminoacyl tRNA synthestase responsible for covalently linking the unnatural 
amino acid with the tRNA (Figure 6.2).  The unnatural amino acid, p-benzoyl-l-phenylalanine 
(pBpa), is a phenylalanine derivative capable of crosslinking to any C-H bond within a 3Å 
distance (Figure 6.3). 
 During my initial attempts, I was able to demonstrate efficient incorporation of pBpa into 
8 positions within the AP and C-terminal tail and one position in the periplasmic lever arm 
(Figures 6.4 and 6.5).  Most pBpa-incorporated TraF proteins also displayed UV-dependent 
photocrosslinking as demonstrated by high-molecular weight bands in Figure 6.5.  As only TraF 
was FLAG tagged at its C-terminal end, I combined cultures producing different pBpa  
incorporated TraF proteins followed by membrane isolation, solubilization, and anti-FLAG 
protein pulldowns (Figure 6.6).  The combined sample was sent for protein identification using 
mass spectrometry.  Unfortunately, I was not able to detect interactions with any pKM101-
encoded Tra protein.   
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Figure 6.1 BS3 crosslinking of TraF and TraC. Alleles encoding C-terminally Strep-tagged 
TraC and N-terminally FLAG-tagged TraF were expressed in a mini-pKM101 pCGR108 
backbone.  Protein pulldowns were preformed using α-Strep tag beads and elutions were run on 
SDS-PAGE gels followed by western blotting using α-Strep and α-FLAG antibodies to detect 
TraC and TraF respectively.  These results were genereated by Dr. Christian Gonzalez-Rivera.  
The structure of TraF was generated using Pymol (http://pymol.org) based on the 3ZBI file 
deposited into the NCBI protein database.  The structure of TraC was generated using Pymol 
(http://pymol.org) based on the 1R8I file deposited into the NCBI protein database.   
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Figure 6.2 pBpa incorporation into TraF. (Left) Depiction of the pEVOL plasmid 
and pBAD24::traF plasmid.  pEVOL contains genes encoding the tRNA responsible 
for recognizing amber stop codons and aaRS required for linking pBpa to the tRNA.  
pBAD24::traF contains a traF allele with an amber stop codon (indicated by a red 
circle).  (Right) Once the tRNA is charged with the pBpa, it then recognizes the 
amber stop codon during translation and incorporates pBpa into the growing 
polypeptide chain. 
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Figure 6.3 Mechanism of p-benzoyl-l-phenylalanine crosslinking.  (Left) The structure of p-
benzoyl-l-phenylalanine (pBpa).  When exposed to UV light at 365nm, pBpa will crosslink to other 
proteins at a 3A distance. (Right) Once crosslinked, pBpa will form non-breakable covalent links 
which can be analyzed biochemically.   
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Figure 6.4 Locations of TraF pBpa incorporation.  Crystal structure of the C-terminal half of TraF 
with pBpa positions highlighted.  Positions include P185 (Lever arm), W304 and F316 (AP α2 helix), 
N325 and Y334 (flexible loop), Q343 and Y352 (AP α3 helix), F377 (conserved RDLDF motif), and 
N386 (C-terminal end).  Each of these TraF mutants contains a C-terminal FLAG tag for protein 
enrichment and western blot detection.  The structure of TraF was generated using Pymol 
(http://pymol.org) based on the 3ZBI file deposited into the NCBI protein database.   
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Figure 6.5 pBpa-mediated crosslinking of TraF. (Top) Steady state levels of TraF were observed 
when cells were grown in the presence versus absence of pBpa.  TraF was detected with western 
blotting using α-FLAG antibodies.  (Bottom)  UV-mediated crosslinking of select TraF pBpa mutants.  
After pBpa incorporation and crosslinking,  membranes were isolated and solubilized followed by 
purification with α-FLAG beads.  Elutions from each sample were run on an SDS-PAGE gel followed 
by western blotting with α-FLAG antibodies.   
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Figure 6.6 Sample preparation for mass spectrometry analysis.  Three 1L cultures were 
grown and cells were incubated in the presence of 0.2% arabinose and 1mM pBpa followed by 
exposure to UV light.  Following crosslinking TraF was enriched and sent for protein 
identification.  The three samples analyzed were (1) All 8 AP/C-terminal pBpa, (2) C-terminally 
FLAG-tagged TraF, and (3) untagged TraF.  From left to right, each gel contains the following 
lanes: (1) Whole cell lysate (2) Soluble fraction (3) Solubilized membrane fraction (4) Insoluble 
membrane fraction (5) Elution from α-FLAG magnetic beads.  After washes, affinity beads were 
boiled for 5 minutes in Laemmli’s buffer followed by sepeartion of beads from the supernatant.  
TraF was detected by western blotting with α-FLAG antibodies.  Elution samples were run on a 
separate SDS-PAGE gel, followed by extraction of the lane and mass spectrometry analysis. 
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Although not as versatile as pBpa-mediated photocrosslinking, Cys crosslinking provides an 
alternative route for detection of interactions between the TraF AP/C-terminal tail and pilin 
subunits.  This method would rely on the insertion of Cys residues throughout the TraF AP/C-
terminal tail, TraM, and TraC.  Additionally, a crosslinking distance of 2Å or less is required for 
forming a detectable interaction.  C. Gonzalez-Rivera and Maxim Bogisch, a former 
undergraduate student in the Christie lab, identified a close interaction between KikA and TraC 
using Cys residues placed in both proteins.  These Cys mutants, along with Cys-substituted 
TraM, can be tested for interactions with Cys-substituted TraF. 
 What is the role of the conserved GxxGxxG sequence?  Although a subset of 
mutations in the GxxGxxG sequence lead to reduced levels of T-DNA transfer and surface-
displayed VirB2, there appeared to be a high degree of flexibility despite being conserved 
amongst all known VirB10 family of proteins.  I hypothesized that these glycines allow for the 
structural flexibility required for substrates and pili to pass through.  If this prediction is correct, 
there is likely close contacts being made between these glycine residues and substrates or pili.  
One approach to test this model involves the use of cysteine crosslinking.  A G272C mutation 
still allowed for T-DNA transfer and detectable pilus biogenesis.  Once a double virB10/virB2 
deletion is constructed on the Ti plasmid, the G272C virB10 allele along with various other virB2 
Cys mutants can be co-expressed in the same cell and the mutant VirB10 and VirB2 proteins can 
be tested for close interactions through the formation of a disulfide bond.  In addition to VirB2, 
Cys mutations can be constructed in substrates such as the VirD2 relaxase and VirE2.  As these 
proteins are unfolded prior to translocation, Cys mutations at any location throughout the protein 
can be captured by Cys crosslinking provided that it creates close contact with the GxxGxxG 
sequence.   
 204 
 Due to the conservation of the GxxGxxG sequence in TraF, these experiments can also 
be performed using pKM101 through insertion of a Cys residue at G294 and throughout the 
length of TraI.  Despite the recent utilization of pBpa-mediated photocrosslinking in the Christie 
lab, Cys crosslinking remains the ideal methodology for two reasons: (i) the crosslinking 
distance for Cys crosslinking is shorter (2Å) than the distance for pBpa crosslinking (3Å) and (ii) 
insertion of bulky aromatic residues at this location is less desirable than Cys residues (Figure 
3.3).   
How can phage sensitivity be restored to pKM101 deletion mutants?  Previous 
studies on the VirB/VirD4At and TrbRP4 T4SSs demonstrated a restoration of pilus biogenesis 
when deletion mutants were complemented with their respective gene in trans.  This is not the 
case with our collection of pKM101tra deletion mutants as only ∆traM, ∆traF, and ∆traG 
mutants developed phage sensitivity when the native gene was expressed in trans.  These results 
are peculiar as all of the complemented tra mutants had plasmid transfer restored, indicating the 
presence of a functional T4SS.  I predicted that overproduction of these proteins interferes with 
the ability of IKe to interact with the TolQRA proteins in the IM, which are essential for 
infection (160).  If Tra proteins are interfering with IKe’s ability to interact with TolQRA, then 
overproduction of these proteins should allow for a restoration of phage sensitivity if the cells 
produce a conjugative pilus.  These experiments would force us to reconsider our conclusions 
with regards to restoration of pilus biogenesis.   
What is the composition of the OM pore?  Based on the crystal structure of the 
pKM101 OMC, I predicted that the TraF AP helices are the primary factors involved in pore 
formation.  Contrary to this prediction, deletions of the AP helices in both VirB10 and TraF only 
had a modest effect on DNA transfer.  These experiments still have yet to identify the major   
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components of the OM pore.  Possibilities include the other OMCC proteins, TraN/VirB7 and 
TraO/VirB9, or the pilin subunit, VirB2.   
Gram-negative bacteria are normally resistant to the antibiotic vancomycin as it is not 
able to penetrate the OM.  However, A. tumefaciens containing a viable T4SS has been 
demonstrated to uptake vancomycin due to the presence of an OM pore which allows the 
antibiotic to cross into the periplasm (125).  Therefore, testing deletion mutants of traO, traN, 
and traM in a strain with wild-type TraF and TraF∆AP mutant should provide insight as to which 
proteins form the pore.     
Are the IMC and OMC subassemblies functionally independent?  The structure of 
the R388 TrwM/VirB3-TrwE/VirB10 structure highlights the unique structural composition of 
the IMC and OMCC assemblies.  As mentioned earlier, work from E. Cascales demonstrated that 
OMCC subunits VirB9 and VirB10 are not essential for T-DNA interactions with IMC subunits 
(74).  These data raise the interesting possibility of the IMC and OMCC functioning 
independently of one another.  If these subassemblies are functionally separate, then secretion of 
substrates through the T4SS likely resembles the pathway of substrates through the T2SS in that 
they are first translocated to the periplasm followed by T4SS-dependent delivery past the OM 
(7).   My experiments with the chimeric Tra/VirB, Tra/Trw, and Tra/Ptl T4SS support this model 
as each of these compositionally unique systems was able to efficiently contact target cells and 
deliver the pJG142 plasmid.  I was not able to increase the frequency of transfer of the 
TraFVirB10BB-CT and TraF/TrwEBB-CT chimeras (10
-6 and 10-2 transconjugants per donor 
respectively) through the assembly of the cognate OMCC as essential interactions with the IMC 
subunits were likely not present.   
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 Although not discussed in this thesis, I also attempted to address this model this through 
the use of chimeric T4CPs at the IMC.  T. Berry demonstrated that chimeric TraJ proteins 
containing the native N-terminal TM domain and a heterologous soluble domain were able to 
mediate transfer of heterologous substrates through the pKM101 T4SS (29).  It was 
demonstrated around this time that the VirB T4SS from the phytopathogen Xanthomonas citri is 
able to mediate the transfer of the toxic cell wall hydrolase Xac2609 to target E. coli cells (169).  
When E. coli cells containing pKM101∆traJ along with plasmids encoding TraJ/VirD4Xac_SD, 
and Xac2609 were incubated with E. coli target cells, the donor cells were killed in a manner that 
was dependent on the presence of the T4SS, the chimeric T4CP, and the Xac2609 substrate 
(Figures 6.7 and 6.8).  Production of the Xac2610 anti-toxin protein rescued these cells (Figure 
6.8).  These results suggest that Xac2609 is delivered into the periplasm in a manner that is 
dependent of the T4CP and T4SS, supporting a two-step translocation and two subassembly 
model for T4SSs.   
 In order to test for the functional independence of the IMC, our lab has expressed interest 
in creating an independent IMC through removal of VirB7, VirB9, and VirB10.  To set up a 
strict screening process, the N terminus of TraI can be fused to beta lactamase and cells 
containing the IMC can be tested for growth in the presence of beta lactam antibiotics.  A similar 
screening process can be set up with a PhoA-TraI fusion to test for periplasmic transfer.   
 Which pKM101-encoded proteins are responsible for recipient cell contact?  My 
results with the T6SS killing assay highlight the dispensability of the TraF AP and C-terminal 
tail for contacting target cells.  Therefore, there are other pKM101-encoded factors which 
perturb the target cell membrane.  Recently, the Christie lab has focused on the role of the KikA 
surface protein.  C. Gonzalez-Rivera demonstrated that addition of a plasmid encoding KikA  
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Figure 6.7 Schematic of TraJ/VirD4Xac periplasmic translocation assay.  Depiction of the 
chimeric T4CP containing the N-terminal TM domain of TraJ and the soluble domain of VirD4 from 
the bactericidal T4SS from Xanthomonas citri.  Through recognition of the Xac2609 signal sequence 
(XacSig), this substrate should be delivered into the periplasm. This assay can be used to further test 
the genetic requirements for periplasmic translocation of T4SS substrates. The structure of TrwB is 
Figure 2C from Gomis-Rüth FX et al. The bacterial conjugation protein TrwB resembles ring 
helicases and F1-ATPase. Nature 2001 409:637–41.  This image was re-published with permission 
from Nature Publishing Group. License Number 4078401439237. 
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Figure 6.8 Xac2609 kills donor cells in a manner dependent on the presence of a functional T4SS.  
Histogram depicting the results of donor killing assays.  Cell viability was decreased in the presence of 
the TraJ/VirD4Xac T4CP and the pKM101 T4SS as well as when Xac2610 is co-prodcued.  Key: ∆J: 
Native pKM101 containing a markerless deletion of traJ. JD4: The TraJ/VirD4Xac chimeric T4CP.   
 
While missing from the figure, expression of Xac2609 and JD4 individually did not lead to a decrease 
in cell viability. 
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restored the ability of cells containing mini-pKM101 plasmid pCGR108 to uptake PRD1, 
transfer pJG142 in broth and be killed by the P. aeruginosa H1 T6SS.  KikA also interacts with 
the TraC pilus tip protein, suggesting that it could play a role in pilus extension. As KikA is 
localized to the cell surface, it is likely that KikA makes initial contact with target cells prior to 
translocation.  In a manner similar to that observed in Myxococcus xanthus, one model suggests 
that KikA promotes membrane fusion with the recipient cell prior to DNA transfer (170).  In 
order to test this hypothesis, donor and recipient cells would be labeled with different fluorescent 
lipids and membrane exchange could be examined using fluorescence microscopy in the 
presence and absence of donor-produced KikA.    
Conclusion 
 During my time in the Christie lab, I significantly contributed to the development of the 
pKM101 model T4SS which our lab is currently using and continued previous lines of 
investigation into the role of the OMCC in both the VirB and pKM101 systems.  My work has 
demonstrated that the OMCC is a functionally distinct subassembly from the IMC and this 
complex is primarily involved in pilus formation.  This pilus, while not essential for recipient 
cell contact or plasmid transfer on filters, appears to be important for broth matings, highlighting 
its role in bringing recipient cells into close contact.  Future directions in the Christie lab will 
focus on the contacts made along the length of TraF and how these contacts differ in pilus T4SSs 
versus substrate T4SSs.  
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